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Abstract 
Uridylyl insertion/deletion mRNA editing is essential for mitochondrial gene 
expression in Trypanosoma brucei and governed by multi-protein complexes called 
editosomes. The final step in each cycle of this post-transcriptional process is that of 
re-ligating the edited mRNA fragments. The ~20S RNA editing core complex 
contains two RNA editing ligases, REL1 and REL2, located, respectively, in a 
deletion and an insertion subcomplex. While REL1 is clearly essential for RNA 
editing, REL2 knockdown by RNAi has not resulted in a detectable phenotype. To 
explain these findings, alternative scenarios have been suggested: (a) REL2 is not 
functional in vivo; (b) REL1 can function in both insertion and deletion editing, 
whereas REL2 can only function in insertion editing; (c) REL1 has an additional role 
in repairing erroneously cleaved mRNAs. 
To further investigate respective functions of the two RELs this study used 
three complimentary approaches: (i) genetic complementation with chimeric ligase 
enzymes, (ii) deep sequencing of RNA editing intermediates after ligase inactivation, 
and (iii) evolutionary analysis.  
In vivo expression of two chimeric ligases, providing a REL2 catalytic 
domain at REL1’s position in the deletion subcomplex and a REL1 catalytic domain 
at REL2’s position in the insertion subcomplex, did not rescue the growth defect 
caused by REL1 ablation. Although the results were not fully conclusive they 
suggest that it is the specific catalytic properties of REL1 rather than its position 
within the deletion subcomplex that makes it essential.  
In order to identify in vivo substrates of REL1, specific editing intermediates 
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that accumulated after genetic knockdown of REL1 expression were captured by 5’ 
linker and deep sequenced using Ion Torrent and Illumina technology. Analyses of 
such unligated editing intermediates with bespoke bioinformatics tools suggest that 
REL1 functions in deletion editing as expected, but also in the repair of miscleaved 
mRNAs, implying a novel role for this ligase. Neither role can be fulfilled by REL2, 
at least not with sufficient efficiency. Sequencing data also suggest that either REL1 
is not involved in ligation of addition editing substrates, or that REL2 in this case can 
fully compensate for loss of REL1. 
REL1, REL2 and KREPA3 sequences were subjected to analysis using 
MEGA5 and the HyPhy package available on the Datamonkey adaptive evolution 
server. Results indicated that all three editosome genes are under much stronger 
purifying than diversifying selective forces. In general this selection pressure to 
conserve protein sequence increased from KREPA3 to REL2 to REL1, suggesting a 
requirement to maintain catalytic function for both ligases.  
Taken together, these experiments reveal a novel function for REL1 during 
RNA editing, providing a rationale for its essentiality. Deductively, the results also 
suggest REL2, which was previously thought to be non-essential, may still be 
required by the cell at its position in the addition subcomplex. Evolutionary analysis 
suggests that the RELs and KREPA3 are under the same evolutionary forces to 
maintain their respective functions in RNA editing. 
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1.1 African trypanosomes and trypanosomiasis 
African, or salivarian, trypanosomes (Genus Trypanosoma) are the causative agents 
of sleeping sickness in humans and nagana, dourine and surra in domesticated 
livestock. The collective clinical manifestations of trypanosomiasis are referred to as 
human African trypanosomiasis (HAT) and animal African trypanosomiasis (AAT), 
respectively, although mechanically transmitted salivarian trypanosomes (such as 
Trypanosoma vivax, T. evansi and T. equiperdum) have escaped their evolutionary 
origins in Africa to be transmitted globally, independently of tsetse flies (Jordan, 
1986).  
Species of trypanosome differ, not only in their pathogenic abilities, but also 
in their host specificity. When HAT and AAT are described they refer to distinct, but 
occasionally overlapping, species of disease organisms. For example, T.brucei 
brucei, T. brucei rhodesiense, T. vivax, T congolense. T. evansi, T. equiperdum and 
T. simiae cause AAT and T. brucei rhodesiense and T. brucei gambiense cause HAT 
(Jordan, 1986).  T. brucei sp are limited in geographical distribution by their tsetse 
fly vectors, which are restricted to sub-Saharan Africa (See Figure 1.1 for HAT 
specific distribution). As a consequence, the spread of human settlement and 
agriculture in this area has been markedly influenced by their presence. HAT is 
predominantly a disease affecting rural communities, however tsetse flies have 
adapted to urban environments (Courtin et al., 2009).  
HAT still remains one of the 13 neglected tropical diseases, affecting people 
across some 36 endemic sub-Saharan countries today 
(http://www.who.int/mediacentre/factsheets/fs259/en/).  
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Figure 1.1. Cases of African trypanosomiasis reported from 2000 to 2009. 
The distribution of T. brucei unlike mechanically transmitted trypanosome species is 
governed by the availability of tsetse fly hosts. Areas in sub-Saharan Africa most 
affected are those with prolonged periods of civil unrest, such as the Democratic 
Republic of Congo, the Central African Republic and Chad. 
Reproduced from (Simarro et al., 2011). 
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Historically, the worst afflicted countries are the Democratic Republic of 
Congo, Sudan and Angola, where re-emergence of the disease is closely associated 
with conflict and civil unrest (Ford, 2007). More recently, the worst afflicted 
countries are the Democratic Republic of Congo, the Central African Republic and 
Chad (Simarro et al., 2011). The number of new cases dropped below 10,000 in 
2009; a drop of 63% of reported cases since 2000. In 2009, 19 countries, of the 
original 36, reported no disease and in 2010 less than 8,000 new cases were reported 
(http://www.who.int/mediacentre/factsheets/fs259/en/). 
HAT is a product of two Trypanosoma brucei subspecies; T. brucei 
rhodesiense and T. brucei gambiense, which are distributed in East and West Africa 
respectively and largely segregated geographically by the rift valley, only coexisting 
within Uganda where the subspecies are still separated geographically (Welburn et 
al., 2001). T. b rhodesiense is zoonotic and the movements of cattle provide a 
constant source of focal outbreaks (Fèvre et al., 2001). AAT may be found 
worldwide, since some (sub)species have evolved means of transmission that are 
independent of the tsetse fly vector (Brun et al., 1998- see Section 1.2.2). AAT and 
HAT are constraints to both social and economic development in Africa; however 
the persistence of AAT is the greatest burden as unlike HAT, it is widespread 
throughout Africa, whereas HAT is focally distributed (Jordan, 1986). 
The decrease of HAT and AAT cases around the turn of the 20th century 
coincided with the deaths of several ungulates and cattle around Africa due to 
rinderpest epidemics, which were thought to cause an initial decrease in tsetse 
numbers due to loss of an important reservoir host (Jordan, 1986; Rogers and 
Randolf, 1988). However, soon after rinderpest had left its mark, the number of HAT 
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cases exploded, spurring the excessive slaughter of game animals and bush clearing 
in an attempt to control the disease. The 1901 to 1910 epidemics of HAT in Uganda 
were thought to be caused by T. b. gambiense and therefore thought to be largely 
down to the migration of people, either through forced or voluntary movements. It is 
likely that abandonment of farm land and subsequent encroachment of tsetse-infested 
vegetation had its effect (Jordan, 1986), however in 2004, a study by Fèvre et al 
demonstrated that these outbreaks were due to T. b. rhodesiense. It was also 
speculated that AAT outbreaks were triggered by the restocking of infected cattle to 
replace those lost in the rinderpest pandemics (Fèvre et al., 2004). The most recent 
outbreak highlighted by the WHO was in 1970, after the near disappearance of the 
disease in the 1960s. This was due to the subsequent relaxation of control efforts. 
(http://www.who.int/mediacentre/factsheets/fs259/en/)   
 
1.1.1 Diagnosis and current control of trypanosomiasis 
The differential diagnosis of HAT into T. b gambiense or T. b rhodesiense, and 
determining the stage of infection are essential to effective treatment of 
trypanosomiasis. Whilst clinical symptoms and serological or molecular methods 
give indirect diagnosis of the subspecies of T. brucei, parasitological identification of 
trypomastigotes in blood (finger prick) or cerebral spinal fluid (lumbar puncture) is 
key to identifying the stage of infection (Wastling and Welburn, 2011). There has 
been extensive research into potential biomarkers of subspecies and indicators of the 
stage of infection for HAT. PCR-based methods of identification have been reviewed 
by Gibson, (2009).  
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The diagnosis of HAT is based on screening and subsequent confirmation of 
parasitemia and identification of the stage of infection (Malvy and Chappuis, 2011). 
The card agglutination test for trypanosomiasis (CATT) provides a means of 
serological screening, and is regularly used in countries of endemicity (Magnus et 
al., 1978). Stage specific diagnosis must be made from parasitological confirmation 
from blood and cerebral spinal fluid (CSF) samples. This is achieved through 
analysing blood and lumbar puncture smears microscopically, the former of which 
may require microhaematocrit centrifugation due to low sensitivity (Woo, 1970). The 
diagnosis of T. b. rhodesiense is slightly different from that of T. b. gambiense, since 
its diagnosis is also based upon clinical symptoms and history of exposure (Malvy 
and Chappuis, 2011). 
History has shown previously that relaxing of control methods, usually during 
periods of civil unrest and often with large population movements of people and 
livestock, leads to epidemics, even with relatively low number of tsetse present. 
Therefore, the most important aspects of control are that of organisation and 
commitment for vector control and trypanosome treatment to be effective against the 
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1.1.2 The infectivity and pathogenesis of T. brucei 
Only two subspecies of T. brucei typically infect humans. Humans have innate 
immunity to T. b. brucei due to the presence of a trypanolytic high density 
lipoprotein bound to a human specific lipoprotein called apolipoprotein L1 (ApoL1) 
(Vanhamme et al., 2003). ApoL1 is taken up the parasite via endocytosis, and from 
within produces pores within the lysosome, rendering the organelle susceptible to 
osmotic swelling that eventually lyses the cell (Pérez-Morga et al., 2005; Pays et al., 
2006). Human infective T. b. rhodesiense resists lyses due to the presence of a 
serum-resistance-associated gene (SRA); a truncated variable surface glycoprotein 
(VSG) that can neutralise the effects of ApoL1 through physical interaction. The 
expression of the SRA gene in T. brucei is sufficient on its own to confer human 
infectivity (Van Xong et al., 1998; Vanhamme et al., 2003; Oli et al., 2006). T. 
brucei gambiense, however, lacks an SRA gene, but evades TLF through a mutation 
accumulated in its Hp/Hb (haptoglobin/haemoglobin) receptor (Kieft et al., 2010; 
Capewell et al., 2011). It is entirely possible that the spread of T. b gambiense, which 
makes up to 90% of total HAT cases, in West Africa was favoured by the emergence 
of ApoL1 variants (with G1 and G2 mutations) in the human population of this 
region, which made up 38% and 8% of the population for G1 and G2 variants, 
respectively. ApoL1 mutations strongly correlate with an increased risk of renal 
disease by an unknown mechanism, which may prevent the mutations from reaching 
fixation. This population is naturally resistant to T. b rhodesiense (Genovese et al., 
2013). 
Living extracellularly presents the problem of immunological attack by the 
hosts’ defences. To overcome this T. brucei exhibits clonal antigenic variation 
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(AGV) (Turner, 1999; Matthews et al., 2004). This is the process by which the VSG 
protein coat is switched to another isoform to produce a distinct variable antigen type 
(VAT). Proliferation of these new VATs requires a new specific immune response, 
which takes time, allowing a new wave of parasitemia to take hold. This switch is 
pre-emptive and not induced by antibody production and a new and distinct VAT 
presents itself approximately every 1000 doublings (Turner and Barry, 1989; Becker 
et al., 2004).  
VSGs are only expressed when positioned within an active expression site 
(Borst, 1986). The clonal phenotypic expression of VSGs can be modulated since 
only one of the 10 - 20 VSG expression sites (ESs) is transcribed at any one time, 
whilst the rest are silenced. Whilst VSGs in silent ESs may be activated, VSGs at 
subtelomeric regions may also switch by conversion (Hertz-Fowler et al., 2008). 
Gene conversion events can occur due to the VSGs homologous flanking sequences 
which allows VSG switching that is independent of sequence (Horn and Barry, 2005; 
Boothroyd et al., 2009). Conversion events may occur simply with a gene switch, but 
the VSG expressed may not be completely replaced leaving a hybrid VSG gene at an 
active ES (Bernards et al., 1981). Often mosaic genes are formed from segmental 
conversions of pseudogenes and silent VSG gene families, which would not be able 
to be expressed through a simple switch (Thon et al., 1989; Roth et al., 1991; Barbet 
and Kamper, 1993). The presence of multiple ES's allows the potential switching 
between two VSGs, of which there are <1000 at sub-telomeric locations. For these 
aforementioned reasons, and due to the polycistronic arrangement of genetic material 
in T. brucei, infections may span many months or years without the hosts’ immune 
system clearing them (Borst, 1986; Johnson et al., 1987; Berriman et al., 2005; Horn 
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and McCulloch, 2010; MacGregor et al., 2012).  
 
1.1.3 The limitations of current available chemotherapeutics 
The clinical presentation of sleeping sickness may manifest from two separate stages 
of the disease. The first (early or S1) stage is haemolymphatic and the second (late or 
S2) stage occurs when the parasites cross the blood brain barrier (BBB) and enter the 
central nervous system (CNS) causing meningoencephalitis and sleep and 
behavioural disturbances. Human infections can lay latent for many years before any 
symptoms emerge (Barrett et al., 2003). S2, if left untreated may lead to coma and 
death (Malvy and Chappuis, 2011). The pathology of African trypanosomiasis is 
thought to arise from an uncontrolled type 1 cell response, acting via TNFα and the 
immune molecules actions upon macrophages (Magez et al., 1999). Another feature 
of the immune response is a great increase in the IgM levels, both specific and non-
specific to trypanosomes (Vincendeau and Bouteille, 2006). It was once thought that 
HAT was fatal in all cases, if not treated. However, more recent studies suggest that 
T. b. gambiense was not 100% fatal, and did not always follow the classical 
progression (S1 - S2) of HAT to neurological involvement. This suggests that either 
human hosts were able to clear infection, or could live as asymptomatic hosts 
(Jamonneau et al., 2012). Since no vaccine is available, it means that clear diagnosis 
of subspecies, prophylaxis of cattle hosts and chemotherapeutics are the only way to 
treat this disease. HAT diagnosis tends to be late, so chemotherapeutic treatment is 
reliant on the efficacy of S2 treatment (Wastling and Welburn, 2011). 
Drug efficacy, practicality and affordability remain great obstacles in the 
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control of sleeping sickness, since tsetse fly control through pesticide spraying, 
targets and traps will never be a long term solution. Only four drug combinations are 
available for treatment of HAT (as discussed by Steverding, 2010). All of these 
chemotherapeutics have to be administered intravenously under hospital stay, which 
is far from ideal, since many people in tsetse endemic regions do not have easy 
access to health facilities. Most of these treatments cause adverse effects in patients. 
For example, melarsoprol, given for S2 infection in T. b. rhodesiense, kills 5 - 10% 
of patients that receive it (Legros et al., 2002; Balasegaram et al., 2006). The safest 
S2 treatment is Eflornithine-Nifurtimox (NECT) combination therapy, but is only 
available for the treatment of T. b. gambiense (Priotto et al., 2009). 
Drug resistance is a continuing problem and is associated with a variety of 
parasitic responses to selection pressures. Resistance can be readily seen in the field 
and has two main themes; firstly, parasites show reduced drug uptake and secondly, 
parasites exhibit cross-resistance to arsenicals and diamidines (Williamson and 
Rollo, 1959; Damper and Patton, 1976; Frommel and Balber, 1987; Mäser et al., 
2003). For Melarsoprol and Pentamidine resistance, this is because both types of 
compounds are taken up by the same P2 adenosine transporter, which is deficient in 
resistant cell lines and so reduces uptake of these compounds into the cell (Carter and 
Fairlamb, 1993; Carter et al., 1995; de Koning et al., 2000). Recent studies have also 
identified the presence of an aquaporin (AQP) 2 that may ordinarily have a role in 
osmoregulation or glycerol transport, which is also responsible for conferring cross-
resistance to Pentamidine and Melarsoprol (Baker et al., 2013). 
The ideal solution to the problem of trypanosomiasis control would involve 
the systematic development of new oral therapeutics; however, drug discovery 
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remains limited due to low economic input (Croft et al., 2005).  
 
1.1.4 The lifecycle of T. brucei 
T. brucei is termed pleomorphic, as it exists in many morphological forms through 
the course of its lifecycle (see Figure 1.2). In the mammalian host there exists two 
main bloodstream forms (BSFs): a proliferative slender form and a quiescent stumpy 
form, named due to their diverse physical appearance under a microscope 
(Vickerman, 1965; Tasker et al., 2000). 
Slender forms proliferate to increase or establish parasitemia, but are 
removed by immune lysis. Thus infection is self limiting, and the parasite may 
actually exploit their host’s immune response to ensure a chronic infection and to 
increase the chances of being picked up by a tsetse vector (Pays et al., 2001). The 
formation of stumpy trypomastigotes is thought to be density dependent, and it has 
been suggested that stumpy induction factor (SIF), a molecule produced by the 
parasite, mediates cell density sensing in the blood stream via the cAMP pathway 
(Vassella et al., 1997). The differentiation of slender to stumpy cells is not due to the 
host’s immune response, as immunodepressed hosts may still generate stumpies 
(Matthews and Gull, 1994). Nonetheless, the density dependent (utilising positive 
feedback) control of stumpy cell differentiation and the arrest of cell cycle division at 
phases G0 and G2 of the cell cycle maintains the parasitemia below a threshold that 
would be otherwise fatal to their host (Vassella et al., 1997). As well as being a way 
of limiting parasite burden, the formation of stumpies prepares the trypanosome for 
passage into the tsetse fly midgut and for differentiation to procyclic forms (PCFs). 
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The additive effects of differentiation and AGV contribute to the infectiveness of the 
parasite (Vassella et al., 1997; Barry and McCulloch, 2001; Lythgoe et al., 2007; 
MacGregor et al., 2012). 
Once the stumpy parasites are taken up in a blood meal they are taken to the 
midgut. Here they develop into PCFs within 24 hours at the posterior of the midgut. 
This differentiation can be reproduced in vitro, and is apparent after 8 - 10 hours 
(Roberts et al., 2000; Fenn and Matthews, 2007). After approximately 10 days of 
midgut establishment PCFs escape through the peritotrophic membrane via the 
anterior of the midgut to the proventriculous and colonises this area as elongated 
proventricular PCFs. After subsequent cell cycle arrest the parasites then migrate to 
the salivary glands as non-dividing proventricular mesocyclics and proceed to attach 
themselves to the microvilli of the salivary glands via their flagellum, where they 
divide as epimastigotes. Once the parasites disengage from the salivary gland cells 
and change to metacyclic form, the tsetse fly becomes infective and can inject these 
parasites into their mammalian hosts upon their next blood meal. The whole process 
from ingested stumpy to injected metacyclic takes 15 to 35 days (as described by 
Roberts et al., 2000; Sharma et al., 2009). 
Chapter 1 
  13 
 
Figure 1.2. The lifecycle of T. brucei in the mammalian and insect hosts. 
The mammalian host is infected upon the bite of an infected tsetse fly, where 
infective metacyclic stage trypomastigotes are injected into the bite wound. 
Bloodstream form trypomastigotes (BSFs) divide as slender forms in the mammalian 
host and differentiate to stumpy forms at high density, which are subsequently picked 
up by a feeding tsetse fly. Once inside the midgut, procyclic cells (PCFs) escape the 
peritrophic membrane and colonise the salivary glands where they replicate as 
epimastigotes and differentiate to mammalian infective metacyclics. The cell cycle is 
closely linked to kinetoplast repositioning and mitochondrial remodelling.  
Reproduced from (Vickerman, 1985). 
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The different morphological forms illustrated in Keith Vickerman’s lifecycle 
diagram are brought about in part by kinetoplast repositioning in relation to the 
nucleus through the elongation of microtubules from the posterior end of the cell 
(Matthews et al., 1995). Central to the lifecycle of T. brucei is the process of 
metabolic and mitochondrial remodelling that equips the parasite for two very 
different host environments, which will be discussed in more detail in the next 
Section. 
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1.2 The unique mitochondrion of T. brucei 
Within the mammalian bloodstream, glucose is abundant, and so trypanosomes make 
use of this through glycolysis (see Michels et al., 2006). In T. brucei the first seven 
steps of glycolysis occur within a specialised peroxisome-like organelle, the 
glycosome. The last three steps, in the cytosol, produce pyruvate, which is excreted 
and transported to the mitochondrion (Opperdoes, 1987). 
In PCFs, the branched mitochondrion (see Figure 1.3 A) allows for the 
utilisation of more carbon sources than just glucose that are abundant in the tsetse fly 
midgut, such as threonine and proline (Cross et al., 1975; Coustou et al., 2003). Here 
glycolysis produces acetyl Co-enzyme A (acetyl-CoA) and subsequently acetate, via 
degradation of pyruvate, within the mitochondria (see Tielens and Van Hellemond, 
1998; Michels et al., 2006). Unusually, acetyl-CoA doesn’t feed the tri carboxylic 
acid (TCA) cycle, even though all TCA enzyme are present, rather this enzyme is 
utilised for de novo fatty acid synthesis via an unusual elongase system (Durieux et 
al., 1991; van Weelden et al., 2003; Lee et al., 2006). The TCA cycle is not active as 
a cycle, but is fed via glutamate (derived from scavenged L-proline) to produce 
succinate as its end product (see Besteiro et al., 2005). The phosphopyruvate 
generated from glycolysis can also re-enter the glycosome to create succinate directly 
(see Michels et al., 2006). PCFs display classical electron transport chains, similar to 
mammals, where glycerol-3-phosphate produced in the glycosome shuttles electron 
to the mitochondrion and respiratory complexes I and II provide electrons to 
ubiquinone, which can then be transferred to the complexes III and IV. Unusually, 
trypanosomes have a SHAM sensitive, plant like, trypanosome alternative oxidase 
(TAO), which is the only terminal oxidase that BSF T. brucei possess and is vital to 
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aerobic respiration in the parasite (Clarkson et al., 1989; McIntosh, 1994; Chaudhuri 
and Hill, 1996). In PCFs, an alternative branch leads to the TAO, the terminal 
oxidase. Complex V acts as an ATP synthase in the final step, exploiting the proton-
motif force (see Van Hellemond et al., 2005; Besteiro et al., 2005). 
The structure and function of the mitochondrion of bloodstream form 
trypanosomes (BSFs) is unique (see Figure 1.3 B). The much reduced organelle lacks 
the key components required for oxidative phosphorylation and TCA cycle, 
therefore, BSFs rely on glycolysis for ATP production, which indicates adaptation to 
a glucose rich environment (see Van Hellemond et al., 2005; Tielens and Van 
Hellemond, 2009). As with PCFs, oxygen is the final electron acceptor. To maintain 
a mitochondrial membrane potential BSFs must employ respiratory complex V, the 
ATP synthase, as an ATPase, where a proton gradient is generated from the 
hydrolysis of ATP (Schnaufer et al., 2005). 
Several studies have been undertaken to elucidate the differential expression 
of mitochondrial subunits between BSFs and PCFs. Although it had previously been 
thought that complex 1 (NDH1) was absent in T. brucei, both complex 1 and an 
alternative complex 1 (NDH2) are present in both lifecycle stages, although the 
formers' proton pumping activity is uncertain. This is why it was assumed complex 1 
was active but non-essential to cell metabolism and growth, since the two are most 
likely functionally redundant. In this scenario NADH reducing agents are shuttled 
from the glycosome to mitochondria by glycerol-3-phosphate, which shows the 
importance of this organelle in both lifecycle stages (Panigrahi et al., 2008; Panigrahi 
et al., 2009; Verner et al., 2011; Surve et al., 2012; Verner et al., 2013). 
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Figure 1.3. Expression and function of mitochondrial complexes in PCF and slender 
BSF T. brucei. 
Slender BSF (B) trypanosomes have a reduced, sack like mitochondrion, which has 
fewer cristae and respiratory chain subunits, in comparison to PCF cells (A). Slender 
BSFs lack electron transport chain components, and complex V works as an ATPase, 
generating a proton gradient through the hydrolysis of ATP. PCFs have a 
mitochondrion more similar to mammals than BSFs, in that they have a working 
electron transport chain, and their complex V works as an ATP synthase. Uncertain 
processes are indicated by a dashed line. Complex 1 (NDH1) contains the subunits 
encoded for by NADH dehydrogenase subunit 7 (ND7). This transcript is focussed 
upon in Chapter 3.  
Abbreviations: TAO - trypanosome alternative oxidase, Gly3p – glycerol-3-
phosphate, IMS - intermembrane space and Alt.I – Alternative complex 1(NDH2). 
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Figure 1.3 illustrates NDH2 facing the matrix, as postulated by Coustou et 
al., 2008; Tielens and Van Hellemond, 2009, however, it has also been suggested 
that this complex may face the intermembrane space (IMS). This more unlikely 
scenario was concluded indirectly, because the matrix is impermeable to NADH and 
addition of NADH to permeated mitochondria caused an increase in oxidative 
activities (Verner et al., 2013). Although the T. brucei mitochondrion is an obligate 
aerobic organelle, the parasite only partially oxidises its metabolic substrates, the 
reasons for this is not known (Tielens et al., 2002).  
Since different substrate environments dictate the type of energy metabolism 
employed by the parasite, it can be assumed that they have evolved a degree of 
metabolic flexibility, which has proven useful in establishing themselves in new host 
environments (Tielens and Van Hellemond, 2009).  
 
Chapter 1 
  19 
1.2.1 The kinetoplast and the kDNA network 
Trypanosomes contain a single mitochondrion per cell, and the mitochondrial DNA 
is organised as a structure called the kinetoplast. In T. brucei this mitochondrial (mt) 
or kinetoplast (k) DNA makes up to 20% of the total DNA content of the cell, and is 
arranged into thousands of concatenated, highly heterogeneous minicircles (of ~1 kb 
in length) and 40 to 50 homogeneous maxicircles (20 to 40 kb in length). Minicircles 
encode uniquely trans-acting guide (g)RNAs that bind through Watson-Crick base-
pairing to maxicircles that encode pre-edited and never edited mitochondrial 
transcripts (Englund and Marini, 1980; Hajduk et al., 1986; Benne et al., 1986; 
Simpson, 1987; Simpson et al., 1987; Simpson and Shaw, 1989; Stuart et al., 1989; 
Blum et al., 1990; Pollard et al., 1990; Sturm and Simpson, 1990a; Shapiro and 
Englund, 1995). The arrangement of maxicircles and minicircles, and the transcripts 
that they encode are summarised in Figure 1.4. This order of mitochondrial genes is 
present in all species of trypanosomatids investigated, but pre-mRNAs are edited to 
different degrees (Hajduk and Ochsenreiter, 2010). 
Both maxi- and minicircle DNA is transcribed through the action of 
mtRNAP, a polymerase that closely resembles at T7 phage RNA polymerase (Grams 
et al., 2002; Hashimi et al., 2009).  
For a single transcript, all corresponding gRNAs must be maintained lest the 
mature transcript be lost. To ensure that minicircle classes are not lost during random 
segregation events, they are catenated when not segregating and each of the smaller 
minicircles are interlocked (without being supercoiled) to an average of three  
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Figure 1.4. The kinetoplast network of mitochondrial DNA molecules. 
As with the rest of the T. brucei genome, mitochondrial transcripts are transcribed 
into polycistronic units before post-transcriptional cleavage and subsequent kDNA 
specific editing. A) Highlighted in red are a maxicircle (left) and minicircle (right) 
separated from the kDNA network. B) Schematics of the maxicircle and minicircle 
DNA. Maxicircles cryptogenes (i.e. genes the transcripts of which undergo editing) 
are highlighted in purple. The degree of editing in T. brucei for each mitochondrial 
transcript is summarised in Table 1.1. 
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neighbouring ones (Borst, 1991; Drew and Englund, 2001; Liu et al., 2005; Jensen 
and Englund, 2012). It should be stressed; however, that the exact manner in which 
minicircles and maxicircles entwine is not well understood (Shapiro, 1993). 
Minicircles exist in over 200 different classes, of which there are multiple minicircles 
each with 3 - 4 separate gRNA transcripts coexisting alongside. This presents the cell 
with approximately 10, 000 separate gRNAs (Steinert and Van Assel, 1980; Blum et 
al., 1990; Pollard et al., 1990; Sturm and Simpson, 1990a). The sequences of these 
gRNAs are especially heterogenous in T. brucei and are directly correlated with the 
extensiveness of RNA editing that takes place to produce mature mitochondrial 
transcripts (Stuart and Feagin, 1992). 
All minicircles have a conserved region, which also contain their origin(s) of 
replication (Birkenmeyer et al., 1987). Minicircle replication requires a number of 
proteins such as topoisomerase II, UMSBP, POLIB, p38, p93 and various 
mitochondrial DNA (mtDNA) polymerases to aid in the initiation of transcription, as 
well as maintenance of the kDNA network and subsequent segregation of catenated 
and daughter minicircles (Wang and Englund, 2001; Liu et al., 2006; Liu and 
Englund, 2007; Milman et al., 2007; Li et al., 2008; Liu et al., 2009; Bruhn et al., 
2010; Liu et al., 2010).  
In general gRNAs are transcribed from minicircles and pre-mRNAs from 
maxicircles. Unusually, COII gRNA required for its editing is contained within the 3' 
end of the primary transcript, and works in cis but not trans. Most gRNAs work in 
trans, since they are transcribed elsewhere and are shuttled to the editosome 
(Clement et al., 2004; Golden and Hajduk, 2005). 
Chapter 1 
  22 
1.2.2 Living without mitochondrial DNA 
Rather unusually, cells exist that have a reduced, or completely absent, kinetoplast 
and are termed dyskinetoplastic (Dk) or akinetoplastic (Ak) respectively. Ak (T. 
evansi) and Dk trypanosomes (T. equiperdum and T. evansi) can be found in the 
wild. These parasites have lost the ability to differentiate into insect stage PCFs and 
can only be transmitted through biting flies or venereally, which in turn has allowed 
them to leave the tsetse fly belt in sub-Saharan Africa (Hoare, 1937; Tobie, 1951; 
Riou and Saucier, 1979; Brun et al., 1998). Examples of naturally occurring T. 
evansi lack maxicircle DNA, and have only a single gRNA class (Borst et al., 1987; 
Songa et al., 1990). Ak T. brucei, which is lacking in all kDNA and associated 
mRNAs has been created through treatment with acriflavine, a DNA intercalator that 
chemically induces kDNA loss over passage history (Stuart, 1971; Stuart and Gelvin, 
1980).  
Detailed characterisation of a number of T. evansi and T. equiperdum isolates 
by Lai et al., 2008 confirmed various degrees of kDNA loss, including partial or 
complete maxicircle deletions and minicircle homogenisation. They proposed that 
the latter may have been the result of lack of genetic exchange within the tsetse fly 
vector, in turn a consequence of being locked within the mammalian host (Lai et al., 
2008).  
The loss of kDNA in trypanosomes will ultimately have downstream 
consequences on mitochondrial biogenesis. The A6 subunit of complex V appears to 
be the only editing product ultimately required in BSFs, and its loss can be 
compensated for by a mutation in the γ subunit of F1 (Bhat et al., 1990; Schnaufer et 
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al., 2005). In the case of T. brucei, a single L262P mutation within the C terminal of 
the γ-subunit of F1 complex V was sufficient to allow complete kDNA loss on 
treatment with acriflavine (Dean et al., 2013). This mutation caused the uncoupling 
of F1 and FO, rendering complex V an obligatory ATPase from a facultative ATP 
synthase. It was already known that petite-negative yeast can exist without mtDNA 
and still maintain a functioning mitochondrion, as long as they exhibited certain 
mutations in the F1 moiety of complex V. These allow the generation of a membrane 
potential by acting as an ATPase in conjunction with electrogenic exchange of ATP4- 
/ ATP3- by the ATP/ADP carrier (Clark-Walker et al., 2000) (see Figure 1.3).   
This aside, lab-induced Dk cells have maintained functional (in the presence 
of a gRNA substrate) editosomes, since editosome genes are nuclear encoded, even 
though the RNA editing process is redundant in these cells (Schnaufer et al., 2002; 
Domingo et al., 2003).  
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1.2.3 Complex editing in T. brucei 
RNA editing in T. brucei is an essential and extensive post-transcriptional process 
with 12 of the 18 mitochondrially encoded protein-coding transcripts being edited 
(Estévez and Simpson, 1999). For a list of these transcript and the subunits they 
encode for, see Table 1.1.  The process of editing (Figure 1.5) is essential since it 
creates a functional open reading frame from pre-mRNA maxicircle transcripts, 
through the use of gRNA templates, and in doing so produces a mature transcript 
suitable for translation (Estévez and Simpson, 1999). RNA editing was first 
described by Benne et al., (1986), as the process where 4 uridylyl (U) residues were 
added to the COII transcript of T. brucei and Crithidia fascilata.  
There have been three models of the editing process discussed in the 
literature. Firstly that of transesterification, put forward separately by Blum et al and 
Cech et al (1991). In this model the site of editing is determined by the 3' of the 
gRNA and the gRNA oligo-(U) tail is the source of uridylyls inserted in editing 
(Blum et al., 1991; Cech, 1991). This has since been dismissed as the number of 
added uridylyls does not seem to be dictated by the gRNA, although RNA cleavage 
appears to be gRNA directed (Seiwert and Stuart, 1994; Kable et al., 1996; Seiwert 
et al., 1996). Also, the discovery of other catalytic components involved in editing, 
as discussed in Section 1.3, has also undermined this model. A second model is that 
of cleavage-ligation, where by the editing site is predicted by the pre-mRNA, and is 
directed by gRNA templates throughout cleavage and addition and deletion of 
uridylyls, before the rejoining of the mature transcript by a ligase (Blum et al., 1990; 
Pollard et al., 1992).  The third model of editing involved cleavage and ligation 
through the formation of gRNA-mRNA chimeras (Sollner-Webb, 1991). As with the 
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cleavage ligation model, the editing site is determined by the pre-mRNA, however 
after the initial cleavage gRNA-mRNA chimeras are formed and the subsequent 
number of uridylyls added is determined after the subsequent cleavage of the 
chimera. The finding of gRNA-mRNA chimeras in vitro editing assays suggested 
that their formation uses the same cleavage-ligation activities as RNA editing itself, 
in a gRNA dependent manner since the 5' monophosphate born of endonucleolytic 
cleavage could be a substrate for the 3' end of the gRNAs (Blum and Simpson, 1992; 
Harris and Hajduk, 1992; Koslowsky, et al., 1992b; Read et al, 1992a; Seiwert et al., 
1994; Rusché et al., 1995; Piller et al., 1996; Seiwert et al., 1996) 
Although chimeras can be detected in vitro, which makes the last model 
appealing, chimeras are thought to be scarce in vivo and can detected only through 
PCR (Stuart et al., 1997). The first direct evidence for the involvement of a ligase in 
the production of editing intermediates was provided by Sabatini and Hajduk (1995), 
who also showed that chimera formation and ligase activity in vitro could be 
inhibited by addition of pyrophosphate, in a dose dependent manner. At present,  the 
nuclease-ligase model of RNA editing is the preferred one, as many other catalytic 
components involved in editing have since been discovered. These will be discussed 
in Section 1.3. 
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No. of U insertions/ 
U-deletions 
Length of edited 
mRNA (nt) 
ND1 Complex I 
 
Not edited  
ND3 210/13 452 
ND4 Not edited  
ND5 Not edited  
ND7 553/89  1,238 
 
ND8 259/46 574 
ND9 345/20 649 
Cyb Complex III 34/none 1,151 
COI Complex IV Not edited  
COII 4/none 663 
COIII 547/4 1 969 
A6 Complex V 447/28 811 
RPS12  Ribosomal protein S12 132/28 325 
MURF1 Unknown function Not edited  
MURF2 26/4 1,111 
MURF5 Not edited  
CR3 148/13 299 
CR4 325/40 567 
9S rRNA SSU ribosomal RNA 30 oligo 
uridylation 
 
12S rRNA LSU ribosomal RNA 30 oligo 
uridylation 
 
12 of the 18 mitochondrial transcripts are edited, some of these extensively so. 
ND NADH-ubiquinone oxidoreductase subunits 1-9; Cyb: apocytochrome b; CO: 
cytochrome oxidase subunits I–III; A6: ATP synthase subunit 6; S12: small subunit 
ribosomal protein 12; MURF: maxicircle unidentified reading frame; CR: G versus 
C-strand biased genes no. 3 and 4; SSU: small subunit; LSU: large subunit. 
Reproduced from Göringer, 2012. 
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Figure 1.5. The RNA editing process. 
In the editing process pre-mRNA mitochondrial transcripts (dark blue) and processed 
in a 3’ to 5’ direction by Watson-Crick (dashes) or G:U (colons) base pairing with 
gRNA templates (light blue). Endonucleolytic cleavage by an editing endonuclease 
occurs at the first mismatched base pair after the gRNA-pre-mRNA anchor duplex. 
Uridylyls are either added by a TUTase or deleted by an exoUase, in accordance to 
the gRNA sequence. All fragments are ligated by an RNA editing ligase (REL). 
Several rounds of editing and many gRNA templates are required to fully edit the 
pre-mRNA. 
Reproduced from Stuart et al., 2005. 
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The editing process itself, using the nuclease-ligation model (Figure 1.5) 
requires the following three steps: endonucleolytic cleavage at an internal editing 
site, addition or deletion of uridylyls via an RNA editing terminal uridylyl transferase 
(TUTase) or a U- Specific exonuclease (exoUase) respectively, and finally ligation 
of the edited transcript fragments by an RNA editing ligase (REL). Addition editing 
is a more common event that deletion editing (see Stuart et al., 2005). 
Editing occurs generally in a 3’ to 5’ direction, whereby the sequential 
annealing of gRNAs by Watson-Crick and G:U base pairing at a stretch of 10-15 
nucleotide long complementary anchor sequence generates the next available editing 
site. Endonucleolytic cleavage occurs at the first mismatched nucleotide pair. Editing 
occurs in different blocks, or domains throughout the transcript (Decker and Sollner-
Webb, 1990). It has been suggested that some kind of higher order structure is 
required for substrate recognition and anchoring of the gRNA-mRNA. This may 
suggest a proofreading step (Golden and Hajduk, 2006).  
The population of mtDNA transcripts in its steady state include fully, 
partially and unedited mRNAs (Simpson and Shaw, 1989). Of all these transcripts, 
partially edited ones are the most abundant (Koslowsky et al., 1991). Editing is not a 
perfect process, however, and misediting often occurs (Sturm and Simpson, 1990a; 
Sturm et al., 1992). For comprehensive reviews of RNA editing see Stuart et al., 
2005 and Aphasizhev and Aphasizheva, 2011. 
RNA editing is developmentally regulated independent of gRNA abundance 
(Koslowsky et al., 1992a). Complex 1 subunits and RPS12 are preferentially edited 
in BSFs , whereas Cyb and COII are only edited in PCFs (Feagin et al., 1985; Feagin 
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and Stuart, 1985; Jasmer et al., 1985; Feagin et al., 1986; Feagin et al., 1987; Feagin 
et al., 1988; Koslowsky et al., 1990; Read et al., 1992b; Souza et al., 1992). 
However, A6 was shown to be constitutively edited (Bhat et al., 1990). This tight 
regulation of mt transcripts is very different in the genus Leishmania, where kDNA 
is constitutively expressed across both its lifecycle stages (Nebohácová et al., 2009). 
The BSF mitochondrion, being the site of RNA editing, makes the organelle 
an attractive target for drug discovery and design. Several of the enzymes involved in 
RNA editing, including RNA editing ligase 1 (REL1) show promise as a potential 
drug targets, since their inhibition caused cell death in BSF T. brucei following a loss 
of detectable fully edited mRNA (Schnaufer et al., 2001; Wang et al., 2003a; Trotter 
et al., 2005; Carnes et al., 2005; Salavati et al., 2006; Law et al., 2007; Babbarwal et 
al., 2007; Tarun Jr. et al., 2008; Guo et al., 2008; Ernst et al., 2009; Guo et al., 2012; 
Lerch et al., 2012; Carnes, et al., 2012b). 
In particular, the essential REL1 has been the focus for structural analyses, 
and subsequent virtual and compound screening with the intention of discovering an 
inhibitor. To date, naphthalene- and azo-dye-based inhibitors have had a suboptimal 
effect on the active site of the ligase, but important screening pipelines have been 
established (Amaro et al., 2008a; Amaro et al., 2008b; Durrant et al., 2010). Such 
approaches in design of novel chemotherapeutics are important, since there are a 
limited number of drugs available and resistance has been described. To add to this, 
it is unclear how some readily available drugs act upon the parasite and there can be 
side effects to their administration (Williamson and Rollo, 1959; Damper and Patton, 
1976; Frommel and Balber, 1987; Carter and Fairlamb, 1993; Carter et al., 1995; de 
Koning et al., 2000; Legros et al., 2002; Matovu et al., 2003; Croft et al., 2005; 
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Balasegaram et al., 2006; Steverding, 2010). 
 
1.2.4 The evolution of RNA editing  
It is thought that the unique and extensive U addition/deletion editing first arose in 
the bodonids, which are a class paraphyletic with Trypanosomatida within the 
phylum Euglenozoa. This would suggest that RNA editing is an ancestral process 
within kinetoplastids (Deschamps et al., 2011). Since the bodonid, Trypanoplasma 
borreli, displays this same kind of deletion/insertion editing, this biological process 
was suggested to be between 500 and 700 million years old (Fernandes et al., 1993; 
Lukeš et al., 1994; Speijer, 2006). The need to modify mitochondrial transcripts 
post-transcriptionally can also be seen in diplonemids, which frequently use trans-
splicing (for a comprehensive comparison see Lukeš et al., 2005). 
A possible linkage to lifecycle complexity and selection pressures acting 
upon the parasite to produce and maintain RNA pan editing is being debated, with 
positive and purifying pressures and neutral evolution being implicated. These 
theories can be separated by three themes: (i) editing on the way out, (ii) 
maintenance of kDNA and mt gene expression and (iii) protein diversification. 
Theories ii and iii can also be thought of as editing “on the way in” since they 
suggest that pan-edited evolved from never edited transcripts. 
Editing on the way out (i) suggests that pan editing existed in the last 
common ancestor of the extant kinetoplastids, and over time during several instances 
pan edited genes were replaced with partially and never edited transcripts due to a 
selection pressure to reduce the numbers of mutations. In this model the never-edited 
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flanking regions of maxicircles facilitated homologous recombination in a manner 
that replaced sequences with reverse transcripts of more fully edited ones. This has 
been further linked to the loss of minicircle classes and dyskinetoplasty (Landweber 
and Gilbert, 1994; Maslov et al., 1994). However, in some lineages minicircle 
classes remain diverse, which suggests that RNA editing has remained an important 
process. To add to this, dozens of nuclearly encoded and essential editosome proteins 
are required just to edit 12 mitochondrial transcripts in T. brucei (Lukeš et al., 2009).  
Maintenance of kDNA and mt gene expression (ii) suggests that pan RNA 
editing evolved in parasites with two hosts from a limited process when a pre-
existing RNA machinery was already in place, to provide a proofreading system to 
counteract mutations and ensure mitochondrial gene expression when selection 
pressure is lax. In this way the more fragile mitochondrial kDNA is fragmented and 
tightly regulated, and thus its loss, when not in use for mt biogenesis, would be 
prevented. In this manner editing could either become fixed by genetic drift and 
subsequently become essential, or fragmentation of the kDNA genome could be a 
result of a positive selection pressure to prevent loss of mitochondrial subunit 
expression (Covello and Gray, 1993; Cavalier-Smith, 1997; Speijer, 2006). The 
presence of many overlapping gRNAs suggests that RNA editing may be prone to 
errors and a proofreading system is in place (Pollard et al., 1990). This would 
provide a mechanism (through the exploitation of an already existing RNA 
processing machinery) to prevent the loss of genes that are not essential in the 
bloodstream form and, are therefore not expressed highly or essential, which would 
be required for the parasite to become tsetse fly infective (Lukeš et al., 2009).  The 
role of neutral evolution in RNA editing has been discussed at length by Lukeš and 
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colleagues. They have postulated that the correct RNA editing machinery was 
already in place before and the editing process co evolved with the gRNA templates, 
which were produced from gene duplication events aimed to neutralise mutations 
accumulated over time. This editing system would be biased against gRNA loss, and 
so, contrary to what had been discussed before, editing site would evolve alongside 
their gRNA templates in a manner that produced no real selective advantage, in a 
“unidirectional ratchet-like expansion” (Lukeš et al., 2005; Lukeš et al., 2009; Gray, 
2012). This model constructive neutral evolution suggests that complexity in editing 
arises in the absence of positive selection (Gray, 2012).  
Protein diversification (iii) encompasses the idea that two proteins can be 
coded from a single gene. RNA editing is governed by guide RNA templates. The 
heterogeneity of T. brucei minicircles reflects the extent and complexity of RNA 
editing in this organism (Sturm and Simpson, 1990a). Indeed the number of unique 
gRNAs exceeds that of known editing sites (Corell et al., 1993; Hong and Simpson, 
2003; Ochsenreiter et al., 2007). In addition, alternative gRNAs for some mRNAs 
may result in alternative editing products, through the production of alternative 
reading frames, and potentially govern the diversity of proteins derived from RNA 
editing (Abraham et al., 1988; Decker and Sollner-Webb, 1990). The most well 
studied alternatively edited protein is one that is derived from the COIII transcript, 
called Alternatively Edited Protein 1 (AEP-1). This protein is truncated compared to 
the full length protein, at 214 amino acids long, and contains five transmembrane 
domains. It is thought that this protein is responsible for kDNA maintenance and has 
a particular role in segregation. This is because it localises to the Tripartite 
Attachment Complex (TAC) between basal body and kinetoplast, and its 
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construction of an AEP-1 dominant-negative cell line leads to kinetoplast mis-
segregation (Ochsenreiter and Hajduk, 2006; Ochsenreiter et al., 2008). This 
evidence, however, is indirect since the protein could not be detected by mass 
spectrometry (Hajduk and Ochsenreiter, 2010). The theory of alternative RNA 
editing evolving as a mechanism to create further genetic diversity is not a new one, 
however, the idea of two proteins from one gene remains controversial. This is 
because it is thought that the potential losses from production of alternative proteins 
may outweigh the benefits of producing the mitochondrial subunits intended for 
translation (Landweber et al., 1993; Ochsenreiter et al., 2008; Lukeš et al., 2009). 
Although RNA editing has been shown to be widespread if not ubiquitous 
among kinetoplastids (as reviewed by Roy et al., 2007; Lukes et al., 2009) this thesis 
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1.3 The structure and function of the 20S core editosome 
RNA editing is governed by nuclearly encoded and self-assembling multi-protein 
editing machines called editosomes of which there may be two distinct 
conformations, a stable 20S and a less stable 35-40S complex. In the trypanosome 
editing field, the S (Svedberg unit) typically refers to the sedimentation rate of 
editosome particles on a 10 – 30 % glycerol gradient (Pollard et al., 1992; Corell et 
al., 1996). A list of editosome components can be found in Table 1.2, and a protein 
interaction map can be found in Figure 1.6 A. Editosome components are nuclearly 
encoded, but enter the mitochondrion due to a targeting sequence on the protein, 
where they are assembled into functional complexes (Rusché et al., 2001; Panigrahi 
et al., 2001; Panigrahi et al., 2003). Functional 20S editosomes can assemble within 
the mitochondria in the absence of any RNA substrate, as concluded from the study 
of chemically induced T. brucei and naturally occurring T. evansi Dk cells (Domingo 
et al., 2003). 
The core 20S editosome complex can be further organised into a deletion and 
an insertion subcomplex (Schnaufer et al., 2003; Panigrahi et al., 2006; Golas et al., 
2009). RNA editing ligase 1 (REL1), a U-specific exonuclease (ExoUase, KREX2) 
and kinetoplast RNA protein A2 (KREPA2) make up the deletion subcomplex, and 
RNA editing ligase 2 (REL2), a 3′ terminal uridylyl transferase (TUTase, KRET2) 
and kinetoplast RNA protein A1 (KREPA1) make up the insertion subcomplex 
(Palazzo et al., 2003; Schnaufer et al., 2003).  The two subcomplexes were 
hypothesised to be joined by a substantial RNA substrate binding site, supposedly 
bridging the two complementary addition and deletion catalytic editing  
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Table 1.2. Protein Components of the 20S Editosome. 
Current name Former name(s) Function Motif 
KREPA1 TbMP81, LC-1, band II Interaction OB-fold zinc finger 
KREPA2 TbMP63, LC-4, band III Interaction OB-fold zinc finger 
KREPA3 TbMP42, LC-7b, band VI Interaction 
 
OB-fold zinc finger 
KREPA4 TbMP24, LC-10 Interaction OB fold? 
KREPA5 TbMP19 Interaction OB fold? 
KREPA6 TbMP18, LC-11, band VII Interaction OB fold 
KREN1 TbMP90, KREPB1 Deletion 
 
RNase III, dsRBM, U1-like 
KREPB1 TbMP67 Endonuclease RNase III, dsRBM, U1-like 
KREN2 TbMP61, LC-6a, KREPB3 Insertion 
 
RNase III, dsRBM, U1-like 
KREPB4 TbMP46, LC-5 Interaction RNase III, Pumilio, U1-like 
KREPB5 TbMP44, LC-8 Interaction RNase III, Pumilio, U1-like 
KREPB6 TbMP49, LC-7c Interaction U1-like 
KREPB7 TbMP47 Interaction U1-like 
KREPB8 TbMP41 Interaction U1-like 
KREL1 TbMP52, LC-7a, band IV Ligase Ligase, tau, K 
KREL2 TbMP48, LC-9, band V Ligase Ligase, tau, K 
KREX1 TbMP100, LC-2 ExoUase 5’3’ exo,endo/exo/phos 
KREX2 TbMP99, LC-3, band I ExoUase 5’3’ exo,endo/exo/phos 
KRET2 TbMP57, LC-6b TUTase (editing) NT, PAP-core, PAP-assoc 
KREH1 TbmHel61p Helicase Helicase 
 Editosomes consist of many catalytic and stabilising proteins, also important in the 
binding of ss and later dsRNA, endonucleolytic cleavage, U addition and deletion, 
and 5’ – 3’ ligation. 
Reproduced from Carnes and Stuart, (2008a). 
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activities (Göringer, 2012). The assembly of the editosome complex has revealed two 
distinct subcomplex positions of REL1 and REL2, inferring a differential role for 
these ligases (which will be discussed later in Section 1.3.5). The manner of 
organisation also allows certain catalytic activities to be confined to the editosome 
that would normally be detrimental to the cell if left unconstrained (Stuart et al., 
2005).  
It is likely that all components of the editosome machinery may have 
originated from RNA repair enzymes that existed in an RNA-protein world which 
predated a DNA world, since the protein machinery would be capable of 
proofreading and repairing RNA molecules (Ho et al., 2004). 
 
1.3.1 Core interactive proteins 
Kinetoplast RNA editing proteins (KREP)A proteins are key interactive proteins 
responsible for editosome integrity. Several studies have suggested that the 
disruption of KREPA proteins result in the loss of functioning editing complexes and 
disruption of editing through loss of editosome integrity. This was revealed through a 
shift in editosome size, or a repression of endonucleolytic cleavage and subsequent 
RNA editing events (Drozdz et al., 2002; Huang et al., 2002; Salavati et al., 2006; 
Law et al., 2007; Tarun Jr. et al., 2008; Law et al., 2008; Guo et al., 2008). Some 
KREPA proteins contain a zinc finger domain used for the binding and recognition 
of RNA and all contain an interactive oligonucleotide/oligosaccharide binding (OB 
fold) domain responsible for editosome integrity through protein-protein binding 
(Schnaufer et al., 2003; Schnaufer et al., 2010; Park et al., 2012b). If either of these 
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domains are interrupted in KREPA3 the editosome integrity is compromised, 
resulting in a loss of complexes and a complete disruption of editing in BSFs and 
partial loss of editosomes in PCF, although this may be a function of knock-down 
efficiency, rather than function  (Guo et al., 2008).  KREPA3 may also exhibit some 
catalytic activity, is involved in gRNA-mRNA processing and is capable of excising 
uridylyls in vitro, although this remains a controversial viewpoint as no recognisable 
catalytic motif has been found and regular deletion activity remains in its absence 
(Brecht et al., 2005; Law et al., 2008; Guo et al., 2008; Niemann et al., 2009). This 
capacity to trim uridylyls is useful, to allow for proofreading, as U-insertion editing 
involves the addition of more residues than necessary by the corresponding TUTase 
(Byrne et al., 1996).  
The interactions between stabilising and catalytic proteins, inferred from 
yeast two-hybrid data and co-expression data using tagged recombinant proteins in 
vitro, have been elucidated by Schnaufer et al in 2010, giving a more detailed 
structure of the editosome, see Figure 1.6. It has also been suggested that these 
editosome components interact due to their complementary electrostatic properties 
(Shaneh and Salavati, 2010). Since the study by Schnaufer et al., 2010, a KREPA3-
KREPA6 hetero-dimer has been visualised by crystallography. This trans-tetramer 
model adds further weight to the notion that the editosome contains a core made up 
of OB folds, which is important in maintaining the overall structure and for binding 
double stranded (ds) RNA substrates of editing (Park, et al., 2012a; Park et al., 
2012b). 
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Figure 1.6. Protein Interactions of the 20S Editosome, and the role in editing for 
different types of editosome. 
A) The 20S editosome contains an addition subcomplex (right), containing L2 ligase, 
A1 protein and T2 TUTase, and a deletion subcomplex (left), containing L1 ligase, 
A2 protein and X2 exoUase. Taken from Schnaufer et al., 2010. B) All 20S 
editosomes contain the same core set of proteins, but differ in composition by the B 
proteins (B4 -8), endonucleases (N1 – 3) and exoUases (X1 and X2) that associate 
with them, giving rise to 3 different types of editosomes. Each is responsible for 
governance of three different kinds of RNA editing. RECC1 (left), RECC2 (middle) 
and RECC3 (right) are involved in deletion, insertion and COII insertion editing 
respectively. COII insertion (by RECC3) differs from regular insertion editing as the 
gRNA acts in cis and not trans. Adapted from Ernst et al., 2009 and Ringpis et al., 
2010. 
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1.3.2 The endonucleases and KREPB accessory proteins 
Kinetoplastid RNA editing endonucleases (KRENs) and kinetoplastid RNA editing B 
proteins (KREPBs) associate in distinct pairs with a common set of core proteins to 
create three different kinds of editosomes, or RNA editing core complexes (RECC 1 
- 3). Each kind governs a different kind of editing event (see Figure 1.6 B). 
Repression of KREN1 (formerly known as KREPB1) caused a specific reduction in 
deletion editing, whilst KREN3 (formerly known as KREPB2) ablation caused a 
40% reduction in edited COII transcripts, indicating a specific role in editing of this 
transcript (Trotter et al., 2005; Carnes et al., 2008b; Ernst et al., 2009; Carnes et al, 
2012a). KREN2 (formerly known as KREPB3) knockdown causes a general growth 
phenotype affects insertion editing events and causes an accumulation of unedited 
and a reduction in edited transcripts (Carnes et al., 2005). KREPB6, KREPB7 and 
KREPB8 associate with KREN3, KREN2 and KREN1, respectively, and are thought 
of as accessory proteins since they associate with the core complex, to give different 
functional properties (Guo et al., 2012). The KRENs associate physically with the 
insertion subcomplex, whereas the KREPB proteins associate directly, or indirectly, 
with the deletion subcomplex components, as indicated by their weak involvement in 
precleaved addition based editing assays. The specificity of these three different 
editosomes drives substrate recognition (Guo et al., 2012). The KREPB6 - B10 
proteins may drive this specificity by allowing the adaptation of their associated 
endonucleases to particular substrates (Lerch et al., 2012).  
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1.3.3 The TUTases 
There are two distinct RNA editing TUTases (RET1 and RET2) within the T. brucei 
editosome that are involved in editing (Aphasizhev et al., 2002). Stability of the 
editosome is not affected by TUTase down regulation. RET2 is a 3’ uridylyl 
transferase, responsible for a single U base addition and exists within the addition 
subcomplex (Aphasizhev et al., 2003). RET1, on the other hand, is responsible for 
the addition of poly(U) tracts (or ladders) onto gRNA, and gives stability to the 
transcript. This was apparent as RET1 RNAi caused a decrease in steady state 
mRNAs without disrupting transcription (Aphasizhev et al., 2002). RET1 and RET2 
differ in their properties and essentiality. The down regulation of RET2 leads to the 
complete inhibition of addition editing in vitro, without affecting deletion editing, 
and also growth inhibition after 80 hours induction (Aphasizhev et al., 2002; 
Aphasizhev et al., 2003; Aphasizheva et al., 2009). RET1 RNAi, on the other hand, 
has no effect on gRNA U tail addition with respect to deletion editing and has little 
effect on in vitro U-insertion editing. This suggests there is a division of labour 
between RET1 and 2 (Aphasizhev et al., 2002; Ernst et al., 2003; Aphasizhev et al., 
2003; Ringpis et al., 2010). RET2 exists as a single copy in the editosome, and is 
bound by its middle region to KREPA1 (Fig. 1.6) (Schnaufer et al., 2010; Ringpis et 
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1.3.4 The exoUases 
Uridylyl-specific editing exonucleases (3’– 5’ ExoUases) catalyse the removal of a 
single non-base-paired uridylyl at a time and are inhibited by base paired uridylyls.  
Within the editosome there are two exoUases: KREX1 and KREX2, which have U-
specific excising activities (Kang et al., 2005; Rogers et al., 2007; Ernst et al., 2009). 
The knock-down of KREX1 and KREX2 has differential effects on the cell. Whilst 
KREX2 RNAi and ablation caused no discernible growth phenotype in BSFs and a 
slight growth impediment in PCFs, both deletion and addition editing activities were 
subtly reduced and there was a size decrease in functioning editosomes. KREX1 
RNAi, however, caused a sizable decrease in deletion editing activities and 
specifically caused the loss of KREN1 editosomes (Kang et al., 2005; Rogers et al., 
2007; Ernst et al., 2009; Carnes et al., 2012c). This may suggest that KREX1 and 2 
exhibit division of labour, where KREX1 serves to remove uridylyls during deletion 
editing, whilst KREX2 may remove the excess uridylyls at insertion editing sites, 
and in doing so functions as a proofreading enzyme (Ernst et al., 2009; Carnes et al., 
2012c). 
 
1.3.5 REL1 vs. REL2: a tale of two ligases 
The final process of editing in trypanosomes involves ligation of RNA substrates and 
is performed by two RNA editing ligases, REL1 and REL2 (Figures 1.6 and 1.7). 
Ligation itself is a multi-step process involving ATP hydrolysis with covalent 
binding of AMP to a lysine residue in the ligase active site, transfer of AMP to the 5’ 
phosphate of the 3’ substrate, and, finally, formation of a phosphodiester bond 
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between the 5’ phosphate and 3’ hydroxyl termini of the two RNA strands. RNA 
termini may be joined in the presence of a complementary gRNA template strand 
(Cruz-Reyes and Sollner-Webb, 1996; Blanc et al., 1999; Odell et al., 2000; Palazzo 
et al., 2003; Ho et al., 2004; Nandakumar et al., 2004).  
REL1 and REL2 are most closely related to the superfamily of covalent 
nucleotide transferases, and share their RNA joining properties (Ho et al., 2004). The 
most closely related enzyme to REL1 is T4 RNA Ligase 2 (T4Rnl2), which was 
established as a nucleotide transferase as it contained the motifs I, III, IIIa, IV and V; 
the latter two of these are essential to the activity of the ligase (Ho and Shuman, 
2002). T4Rnl2-like ligases are more widespread in other organisms than T4Rnl1-like 
ligases, and these seal dsRNA breaks in vitro (Ho and Shuman, 2002; Wang et al., 
2003b). The in vivo function of T4Rnl2 is unknown, but it has previously been 
suggested that it is involved in RNA editing, RNA repair and the capping of 
dephosphorylated RNA ends (Ho and Shuman, 2002; Yin et al., 2003).  
Ligases that seal dsRNA breaks, such as REL1, REL2 and T4Rnl2 most 
likely originated as general RNA repair enzymes in the presence of protein 
replicating machinery, before DNA existed, as RNA repair of this type is very 
uncommon in newly arising metabolic pathways (Ho et al., 2004; Chan et al., 2009). 
The proto-ligase in this scenario would be non-specific and would only require 
terminal phosphates for ligation. Selectivity for RNA substrates could have happened 
with a domain swap, or change to the C-terminal domain (Nandakumar and Shuman, 
2004). The presence of small gRNA-like molecules in a proto-editosome would have 
also allowed the evolution of more complex dsRNA molecules (Cheng and Unrau, 
2010). 
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In T. brucei REL1 and REL2 are embedded within the editosome, and occupy 
the same biological niche, which is unlike the scenario for T4Rnl1 and T4Rnl2 (Ho 
and Shuman, 2002; Schnaufer et al., 2003). REL1 and REL2 are 52 and 48 kDa in 
size, respectively, localise to the mitochondrion and contain a KXXG active site 
motif (McManus et al., 2001; Schnaufer et al., 2001). REL2 is structurally similar to 
REL1, (41% sequence identity and 61% similarity) and both ligases are more similar 
to T4RNL2 than to any other RNA ligase (Shaneh and Salavati, 2010).  Relevant 
sequence alignments and the crystal structures of REL1 and T4Rnl2, complete with 
their adenosine substrates are shown in Figure 1.7 overleaf.  The crystal structure of 
REL1 shows that at the active site the α-phosphate of ATP is stabilised within the 
binding pocket and that its adenylylation is dependent on the presence of divalent 
magnesium (Deng et al., 2004).  
The catalytic N-terminal catalytic domain (CD) is required for the RELs 
autoadenylylation activity. However, if the N-terminal CD is expressed 
recombinantly without its interaction domain (ID), it appears to be less active in vitro 
than full length REL1 (Deng et al., 2004). The C-terminal ID of REL1 is required for 
integration into native editing complexes, via direct interaction with KREPA2, and 
does not contain any catalytic sites (Schnaufer et al., 2003; Gao et al., 2005; 
Schnaufer et al., 2010). The C-terminal ID of T4Rnl2 is essential for strand sealing 
specificity, because it is required for substrate binding (Ho et al., 2004). Therefore, 
T4Rnl2 and the RELs consist of two domains: a C-terminal ID and an N-terminal 
CD. In the RELs these domains are responsible for protein-protein interaction and for 
strand sealing activities, respectively. Where T4Rnl2 and the RELs greatly differ is 
in their ID (Schnaufer et al., 2003). REL1 and REL2 differ from most other DNA or 
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RNA ligases as they do not have a separate OB-fold domain, rather this is provided 
in trans by the REL’s interaction partners within the editosome (Schnaufer et al., 
2003; Worthey et al., 2003; Deng et al., 2004). 
It is clear from  gene knockdown and knockout studies that REL1 is essential 
to the cell, whereas REL2 RNAi (despite an efficient knockdown) does not induce a 
growth phenotype (Huang et al., 2001; Rusché et al., 2001; Schnaufer et al., 2001; 
Drozdz et al., 2002; Gao and Simpson, 2003; O’Hearn et al., 2003). However, it 
should be noted that a subtle cell deformation was reported for one RNAi study 
(O’Hearn et al., 2003). Ablation of REL1 in BSFs causes loss of fully edited mt 
transcripts within 46 hours and cessation of cell division within 70 hours (Schnaufer 
et al., 2001). REL1 was also shown to be essential in PCFs as no null mutant could 
be created (Rusché et al., 2001). 
The reason why REL1 is essential, but REL2 appears not to be, is not clear, 
but differences in their RNA substrate specificity and ATP affinity may lend some 
ideas, since the REL’s appear to have distinct ligation activities. The adenylylation 
reaction governed by these ligases differs corresponding to their differences in 
affinity for phosphate and ATP, in that REL2 has a higher affinity for ATP than 
REL1 (Rusché et al., 2001; Cruz-Reyes et al., 2002; Palazzo et al., 2003).  
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Figure 1.7. Sequences and crystal structure of the RNA Editing Ligases. 
A) Sequence alignment of the T. brucei RELs, highlighting the important 5 motifs 
(lined) present in the nucleotidyl transferases. Arrows indicate the CD-ID fusions 
used in Chapter 2. Red lines indicate the mt targeting. B) The crystal structures of the 
ligases, highlighting the essential amino acid residues responsible for their catalytic 
properties. Left: REL1-ATP, right: T4Rnl2-AMP (Taken from Deng et al., 2004). 
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  REL1 is also less stringent about what substrates it will ligate, annealing 
RNA fragments with both overhangs and nicks. REL2, however, is more stringent in 
its activities and is restricted to the ligation of perfectly nicked duplexes, although it 
appears that both RELs, as with DNA ligases, have a preferential ligation for a 
perfect nicked duplex (Blanc et al., 1999; Igo et al., 2000; Rusché et al., 2001; 
Schnaufer et al., 2001; Cruz-Reyes et al., 2002; Palazzo et al., 2003).   
In the aforementioned scenarios REL1 can compensate for the loss of REL2, 
but REL2 cannot compensate for the loss of REL1 (Huang et al., 2001; Schnaufer et 
al., 2001; Gao and Simpson, 2003). This questions the need for two ligases.  Tandem 
Affinity Purification (TAP) tag purification and yeast-2-hybrid analysis of the two 
ligases put them into two separate subcomplexes of the editosome (as mentioned 
previously in Section 1.3), with REL1 in the deletion subcomplex and REL2 in the 
addition subcomplex (Schnaufer et al., 2003). Due to this subcomplex positioning, it 
could be assumed that REL1 and REL2 are involved in ligation of deletion and 
addition editing substrates, respectively. Gao and Simpson addressed this question by 
monitoring the state of edited RNA after REL1 and REL2 RNAi knockdown. Down-
regulation of REL2 had little effect on the abundance of any of the edited transcripts 
studied, including COII, which only contains 4 addition, and no deletion editing 
sites. In contrast, down regulation of REL1 greatly affected transcripts involved in 
addition (Cyb, ND7) deletion editing (ND7), but had little or no effect on COII 
editing. This led to the conclusion that REL2 may be less active, or inactive in vivo, 
and that the two ligases have different biological roles (Gao and Simpson, 2003).  
Knockdown or knockout of REL1 to determine function and specificity is 
further complicated by the observation that in some cases the editosome becomes 
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less stable in this absence (Huang et al., 2001; Cruz-Reyes et al., 2002). However, 
this is contradictory to some other findings, although residual REL1 from genetic 
manipulation may confound the true effects of its loss on editosome integrity (Stuart 
et al., 2002). Expression of a catalytically dead REL1 enzyme suggests division of 
labour between the two RELs, and their separate involvement in deletion and 
insertion editing (Huang et al., 2001). The most attractive hypothesis to the 
essentially of REL1 does not pertain to its roles in deletion or addition editing, but 
instead suggests that this ligase has a role in the repair of erroneous cleaved 
substrates (Huang et al., 2001). 
 
1.3.6 Accessory complexes in T. brucei 
For RNA editing to occur, there must be simultaneous processing for gRNAs and 
pre-mRNAs (since maxicircles and minicircles are transcribed as monocistrons), 
suggesting a role for accessory factors in allowing efficient editing of the transcripts 
(Reifur et al., 2010). Mitochondrial RNA precursor processing endonuclease 
(mRPN) is involved in the maturation of polycistronic pre-gRNAs to monocistronic 
gRNAs (Grams et al., 2000; Madina et al., 2011). The presence of RNA editing 
helicase 1 (REH1) increases editing efficiency in the presence of multiple gRNAs, by 
aiding 3' - 5' gRNA detachment (Li et al., 2011). 
There are a number of proteins involved in editing outside the core editosome 
complex, responsible for stabilising the gRNA-mRNA duplexes and shuttling 
gRNAs and mRNAs to the RECC to undergo editing. TbRGG1 (which is named as 
such because it contains the RGG RNA binding domain) is equally present in both 
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PCFs and BSFs, sedimenting at 35 - 40S. Its ablation causes disruption in the 
regulation of mRNA editing, but does not affect never edited transcripts (Vanhamme 
et al., 1998; Hashimi et al., 2008). TbRGG2 contains a C-terminal RNA recognition 
motif, and its knockdown affects pan edited transcripts only (Fisk et al., 2008; 
Ammerman et al., 2012; Foda et al., 2012).  
Both the Mitochondrial RNA binding protein (MRP1/2) heterodimer and Y 
box RNA binding protein of 16 KDa (RBP16) are essential to editing and have 
RNA-RNA annealing properties. Simultaneous knock down of MRP1/2 and RBP16 
causes a growth phenotype in PCFs, but not BSFs, without affecting gRNA 
abundance. This may be reflected in the quantity of transcripts that are required to be 
edited at each lifecycle stage for mitochondrial biogenesis. It is thought that RBP16 
helps reveal the mRNA anchor sequence, and at the same time the MRP1/2 
heterodimer exposes the gRNA anchor sequence. Both are essential for editing 
specific mRNAs as they promote RNA-RNA annealing activities (Hayman and 
Read, 1999; Schumacher et al., 2006; Ammerman et al., 2008; Fisk et al., 2009). 
RBP16 binds the poly U tails of gRNAs, acting to stabilise mRNA and promote 
gRNA-mRNA interactions (Pelletier and Read, 2003).  
The mitochondrial RNA binding complex (MRB1) is not stably associated 
with the 20S editosome, rather it associates with the RECC in vivo via dynamic RNA 
interactions, and has an indirect effect on editing (Domingo et al., 2003; Ammerman 
et al., 2012). Down regulation of one of its sentential components, TbRGGm, leads 
to smaller editosome complexes (through loss of components), abnormal kDNA 
division and a skewing of mt RNA populations  (Acestor et al., 2009). This is an 
interesting observation, since Dk cells possess smaller MRB1 complexes, which is 
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caused by a loss of maxicircle DNA (Schnaufer et al., 2002; Acestor et al., 2009). 
This MRB1 complex binds gRNA through the stabilising actions of gRNA 
associated proteins 1 and 2 (GAP1/2) and is involved in extensive or pan editing 
(Fisk et al., 2008; Acestor et al., 2009; Ammerman et al., 2010; Ammerman et al., 
2012). RNA stability is governed by a number of other factors like mitochondrial 
editing mRNA stability factor 1 (MERS1) and RNA editing helicase 2 (REH2) 
(Weng et al., 2008; Hashimi et al., 2009; Hernandez et al., 2010). 
There are many examples listed here and elsewhere of accessory complexes 
having an indirect effect on RNA editing on ablation, and sedimenting at 35 - 40S on 
glycerol gradients. Altogether (see Figure 1.8) this suggests the presence of a large 
and dynamic complex responsible for processing and shuttling gRNAs and pre-
mRNAs to the 20S catalytic core complex for editing (Göringer, 2012). 
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Figure 1.8. Proposed interactions between accessory complexes. 
In this model, which focuses closely on the MRB1 complex, the gRNAs are brought 
in toward MRB1. At the same time TbRGG2 promotes gRNA-mRNA annealing. 
The RECC, or editosome, associates with these complexes via the RNA it edits. The 
finished transcripts are them deemed to be translational competent after the addition 
of a long A/U tail by the KPAP1 complex, and can be shuttled to the mitoribosome. 
Abbreviations: RECC – RNA editing core complex (20S editosome), TbRGG2 – 
protein 2 with RNA RGG binding motif, KPAP1 - kinetoplast poly(A) polymerase 1, 
GAPs – gRNA accessory proteins, MRB1 - mitochondrial RNA binding complex 1 
Reproduced from Hashimi et al., 2013. 
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1.4 RNA maturation and translation 
There is a strong association between RNA editing, stability, maturation and 
translation (Figure 1.9). Poly(A) tails have been shown to be developmentally 
regulated cis-elements that stabilise mRNA or promote its decay (Bhat et al., 1992; 
Read et al., 1992b; Read et al., 1994a; Militello and Read, 1999). Further 
investigation of RNA populations revealed that transcripts with short poly(A) tails 
were unedited transcripts, whereas populations with a mixed A tail length were 
editing intermediates. It was also suggested from the same study that long A tails 
were required for stability (Militello and Read, 1999). 
Short poly(A) tails are added onto mt transcripts through the actions of a 
kinetoplast ploy(A) polymerase (KPAP1), which allows the transcripts to maintain 
cis-stability in all stages of editing. KPAP1 is localised to the two antipodal regions 
of the kDNA disc and is essential to both BSF and PCF parasites (Etheridge et al., 
2008). In addition, the kinetoplast polyadenylation and uridylylation factor hetero-
dimer (containing KPAF1 and 2) promotes the addition of long poly(A/U) tails 
through the actions of KPAP1 and RET1. KPAF proteins contain pentatricopeptide 
(PPR) repeat sequence motifs, which are also responsible for stabilising 12S and 9S 
rRNAs. These long A/U tracts were not found flanking COI or Cyb transcripts in 
BSFs, which are not edited in this lifecycle stage. Furthermore, transcripts with long 
A/U tails and proteins with PPR repeats localise to the mitoribosomes, indicating that 
such transcripts are translation competent (Pusnik et al., 2007; Aphasizheva et al., 
2011).  
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Figure 1.9. Schematic of mitochondrial RNA processing in trypanosomes. 
Guide RNA and mt RNA maturation and processing are closely linked. This diagram 
highlights the complexes associated with RNA maturation and indicates the fate of 
never edited and edited transcripts. 
Abbreviations: RET1 - RNA editing TUTase, KPAP1 - kinetoplast poly(A) 
polymerase 1, KPAF1/2 - kinetoplast polyadenylation and uridylylation factor 1/2, 
GRBC - gRNA binding complex (referred to in the text as MRB1 - mitochondrial 
RNA binding complex). 
Reproduced from Aphasizhev and Aphasizheva, 2011. 
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It is not currently known how these PPRs recruit tRNAs or mitoribosomes, or 
how they aid AU tail formation, or any other aspect of translation. Degradation of 
transcripts is independent of this long A/U tract (Ryan et al., 2003). However, little is 
known about the degradation products in trypanosomes. It is thought that this process 
is also inhibited by the secondary and tertiary structures of the transcripts, as well as 
their stage specific regulation (Ryan et al., 2003). 
The mitochondrial genomes of kinetoplastids lack tRNA genes, so all are 
imported from the cytosol after they are nuclearly expressed (Hancock and Hajduk, 
1990). Trypanosomatids lack a bacterial tRNAmet initiator of translation, and instead 
utilise a tRNA formyltransferase after import to formylate tRNAmet allowing the 
recognition of initiation factor 2. A single RNA editing event (CCA – UCA) then 
allows the imported tRNA to decode mitochondrial transcripts. The large number of 
proteins in mitochondrial ribosomes in kinetoplastids is thought to compensate for 
the relatively short rRNAs they have in comparison to other eukaryotes (as reviewed 
by Schneider, 2011; Niemann et al., 2011). 
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1.5 Context of the PhD objectives 
We wished to discern why REL1 is essential to cell growth and viability, but REL2 
appears not to be. We hypothesised that in addition to its function in resealing fully 
edited mRNA after U deletion, and perhaps U addition, REL1 is required for repair 
of erroneously cleaved mRNAs. Due to its more constrained substrate requirements, 
REL2 would not be able to compensate for loss of this activity, pinning any RNA 
repair function solely on REL1.  
To help determine this, we wanted to determine whether it was the catalytic 
properties, or its position within the deletion subcomplex that made REL1 essential. 
Either REL1 is essential because of a particular catalytic functionality, i.e. in 
repairing miscleaved RNAs during editing, or REL1 is essential because of its 
physical location in the editosome. These hypotheses are not mutually exclusive, and 
REL1 may be essential for both of these reasons.  
Preliminary studies by Matthew Spencer had indicated that only ectopic 
expression of an additional copy of REL1, but not of REL2 or of chimeric REL 
proteins, can fully rescue the growth phenotype produced upon REL1 ablation in 
conditional knockout (cKO) lines. 
Sequencing the 5’ ends of RNA editing intermediates after genetic ablation of 
REL1 would give information on whether the RNA fragments produced would be 
products of addition, deletion or misediting.  
To address the conundrum of REL2’s apparent redundancy, even though it is 
catalytically active, we carried out an evolutionary analysis. If REL2 has no essential 
role in editing, or to the cell in general, we would expect the ligase to be neutrally 
Chapter 1 
  55 
evolving. Due to the known essentiality of REL1 we would expect this enzyme to be 
under strong purifying selection, which would reduce the number of deleterious 
mutations acquired over evolutionary time. 
 
1.5.1 Research Objectives 
Firstly, we used a molecular biology approach to generate and purify editing 
complexes via tagged chimeric ligases in order to dissect the respective contributions 
of position within the editosome versus substrate specificity to the essential role of 
REL1 in editing. This experiment was also expected to shed light on how REL1 
compensates for the loss of REL2 in insertion editing. REL1 and REL2 have distinct 
domains for catalysis and interaction with their associated partner proteins in the 
editosome respectively. The ectopically expressed copies of REL1, REL2 and 
chimeric REL proteins were TAP-tagged, allowing purification and analysis of the 
complexes these proteins associate with. These experiments also allowed 
investigation into whether the chimeric proteins can associate with the predicted 
subcomplexes and, if so, how position and catalytic properties affected function (see 
Figure 2.2 for schematics of the TAP tagged “rescue” ligases). 
Secondly, another related aim was to undertake a comprehensive 
identification of in vivo REL1 substrates by determining 5’ ends of mitochondrially 
derived transcripts before and after REL1 inactivation, taking advantage of the 
existing REL1 conditional knock-out cell line. Through the development of a novel 
5’ end mapping and RNA sequencing approach, we hoped to reveal those transcripts 
that remain unligated after endonucleolytic cleavage, to identify the precise cleavage 
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sites, and to determine downstream editing events quantitatively. 
Thirdly, RNAi studies have shown that knockdown of REL2 does not cause 
any growth effects in BSF T. brucei (Drozdz et al., 2002; Gao and Simpson, 2003; 
O’Hearn et al., 2003). However, given the uncertainties associated with the 
incomplete gene inactivation in RNAi, one of the aims of this study was to attempt to 
create a null mutant of REL2. In addition to clarifying whether REL2 function is 
indeed completely redundant, generation of such a cell line will also allow the 
complementation study outlined above to be conducted in a more definitive manner.  
The final aim was to investigate essentiality of REL1 and REL2 by means of 
an evolutionary analysis. This involved separate comparison of REL1, REL2 and an 
interactive KREPA protein from different species of closely related trypanosomatids, 
with a means to determine whether the proteins are under positive or purifying 
selection, or whether they are neutrally evolving. The relative type and strength of 
selective pressures were expected to indicate whether REL2 may still have a function 
within – or independent of - the editosome that RNAi has not revealed.  
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1.5.2 Research Questions 
This research project aimed to answer the following separate questions pertaining to 
RNA editing, focusing on the specific role of REL1 ligase, within trypanosome 
mitochondrial biology: 
1 Why is REL1 essential in editing, and REL2 is not? In particular, is it the 
catalytic properties and/or physical positioning within the deletion 
subcomplex of the editosome that makes it essential to editing? 
2 What are the substrates of REL1? Can identification of those RNA substrates 
that remain unligated when REL1 is ablated help determine its precise 
function? 
3 Can the essentiality of REL1 and suggested redundancy of REL2 be 








A genetic complementation approach to 
understand why REL1 is essential 
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2.1 Introduction to project 
It is not fully understood why REL1 is essential and REL2 is not, since both insertion 
and deletion of uridylyls are required for accurate editing of pan edited transcripts, 
and both enzymes are closely related to each other and the RNA repair enzyme, 
T4Rnl2 (Ho and Shuman, 2002; Ho et al., 2004; Deng et al., 2004). Unpublished 
studies by Achim Schnaufer have indicated through the overexpression of 
catalytically inactive ligases that REL1 is essential to the cell, but REL2 does not 
appear to be. This adds weight to the published literature (as discussed in Chapter 1) 
that REL1 is essential, but REL2 appears to be dispensable to the cell (Huang et al., 
2001; Rusché et al., 2001; Schnaufer et al., 2001; Drozdz, et al., 2002; O’Hearn et 
al., 2003). 
The apparent non-essentiality of REL2 in the cell, has been taken as evidence 
that either the ligase is not active in vivo, or that REL1 may also function in addition 
editing reactions, collectively suggesting that REL2 is non-essential to the RNA 
editing process (Drozdz et al., 2002; Gao and Simpson, 2003; O’Hearn et al., 2003).  
Other studies have suggested that both REL1 and REL2 have their distinct 
roles in editing. The subcomplex division of the ligases may suggest that they have 
division of labour within editing, and indeed REL1 and REL2 display distinct 
catalytic properties in vitro, pertaining to deletion or insertion editing, respectively 
(Cruz-Reyes et al., 2002; Schnaufer et al., 2003). Even though both ligases prefer 
perfectly nicked duplexes, biochemically, REL1 and REL2 have distinct properties, 
and perform differential roles in deletion and addition editing ligation, respectively 
(Blanc et al., 1999; Igo et al., 2000; Cruz-Reyes et al., 2002; Palazzo et al., 2003; 
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Schnaufer et al., 2003). It is known that the substrate requirements of REL1 are less 
specific and more relaxed than those of REL2, which has strong preference for fully 
base paired RNA duplexes (Cruz-Reyes et al, 2002; Palazzo et al, 2003; Rusché et 
al., 2001). Indeed, REL1 is not required for insertion editing to occur in vitro (Huang 
et al., 2001). However, it has also been suggested that REL1 may be able to 
compensate for REL2, in its absence, by also functioning in addition, as well as 
deletion, editing and this would certainly explain why REL1 is an essential ligase 
(Cruz-Reyes et al., 2002). However, the study by Huang et al, which inferred that 
REL2 is still required for addition editing, may suggest that REL1 has another very 
important cellular function in RNA repair (Huang et al., 2001). 
Miscleavage and misediting are known to occur in vivo. For example, 
truncated cDNA sequences of pan edited A6 and ND7, which are products of 
cleavage during editing, have been reported (Koslowsky et al., 1991). Such events 
would lead to the loss of transcripts, unless there was a method to rescue them via re-
ligation or cleavage-re-ligation, respectively. 
Therefore, one objective of this thesis is, through genetic complementation 
methods, to determine why REL1 is essential in editing when REL2 is not, as this 
matter requires resolution. This current study looks to discern whether it is REL1's 
position in the deletion subcomplex, or its specific catalytic properties, or both, that 
makes it indispensable for RNA editing. 
To ascertain the catalytic roles of the two ligases in editing, chimeric ligases 
were constructed and expressed in a REL1 conditional knock-out (cKO) cell line. 
Rescue copies of full length REL1 and REL2 were used as positive and negative 
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controls, respectively, to determine if the approach worked correctly. Endogenous 
REL2 still remains in this cKO REL1 cell line. This manner of approach allowed the 
involvement of the REL1 catalytic domain in addition editing and a REL2 catalytic 
domain in deletion editing to test if this structural dichotomy reflects a biological 
one. Figure 2.1, overleaf, shows the four possible outcomes from each cell line 
constructed in the absence of tetracycline inducible REL1. It also outlines the two 
possible scenarios tested in explanation of REL1's essentiality through expression of 
chimeric ligases. 
Firstly (1), if REL1's catalytic properties are the reason that it is essential, 
then placing a REL1CD into the insertion subcomplex should compensate for the 
knock-out of the regulatable REL1 in this system. Secondly (2), if a ligase is required 
in the deletion subcomplex, but not necessarily REL1, then placing a REL2CD into 
this subcomplex should compensate for the loss of REL1. 
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Figure 2.1. Outcomes of genetic complementation approach. 
REL1-TAP and REL2-TAP, as controls, are expected to caused cell survival and 
death respectively. The outcome of tagged chimeric ligase integration is unknown, 
but will test whether REL1 can function from the addition subcomplex (1), or if 
REL2 can replace REL1 in the deletion subcomplex (2). 
Abreviations:  L2- REL2 ligase, A1 – KREPA1 protein, T2 - TUTase, L1 - REL1 
ligase, A2 – KREPA2 protein and X2 - exoUase. 
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2.2 Methods 
2.2.1 Cell lines used: cKO REL1 – TAP 
REL1 cKO BSF cell lines, constitutively expressing TAP-tagged ectopic versions of 
either REL1, REL2, or chimeric proteins with recombined catalytic (CD) and 
interaction domains (ID); i.e. REL2CD:REL1ID and REL1CD: REL2ID, were 
constructed prior to this study by Matthew Spencer using pHD1344-derived vector, 
pHD1344t-TAP (Alibu et al., 2004; Carnes, et al., 2012a). The interaction domains 
of REL1 and REL2 mediate binding to the deletion and insertion subcomplex, 
respectively (See figure 1.6). Relevant schematics are illustrated in Figure 2.2 
overleaf. Cells were passaged in 5-ml cultures with HMI9 medium containing 10% 
foetal calf serum (FCS) and selective drugs (2.5 μg/ml G418, 5 μg/ml hygromycin, 
2.5 μg/ml phleomycin, 2.5 μg/ml puromycin and 1 μg/ml tetracycline to induce the 
ectopic REL1 allele). 
To ensure cells were correctly expressing constitutive TAP tagged and 
endogenous REL1 (in the presence of tetracycline in the media) proteins at a 
comparable level, crude lysates were made for Western blot analysis. Cells were 
pelleted, and resuspended in 2 × SDS sample buffer, (4% SDS, 20% glycerol, 120 
mM Tris-HCL, pH 6.8, 0.2% bromophenol blue, 200 mM DTT) to give 1 × 106 cells 
in 10 μl.  
For subsequent miniTAP, glycerol gradient and auto-adenylylation 
experiments cell lines were grown for 48 hours in the absence of REL1 before 
pelleting, so allow for good ablation of ectopically expressed REL1. 
Chapter 2 
  64 
 
 
Figure 2.2. cKO constructs and strategy used. 
Left: In the established cKO cell line (Schnaufer et al., 2001) the first and second 
endogenous REL1 alleles have been replaced by T7RNAP/NEO and TETR/HYG 
cassettes, respectively, and the ectopic rescue copy is regulated by tetracycline. The 
cell lines used in this study also expressed constitutively expressed TAP tagged 
proteins (selection of transfectants with puromycin). Right: A schematic 
representation of recombinant and chimeric proteins expressed within the four cKO 
REL1 cell lines used. The TAP tag is located on the C terminus and CD and ID 
refers to the catalytic (adenylylation) domains and protein-interaction domains of 
these ligases, respectively.  
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2.2.2 Creation of new REL1CD/2ID-TAP fusion constructs 
To make chimeric sequences with 2 different fusion points (referred to as fusion 333 
and 322), two different REL1 fragments corresponding to slightly different versions 
of the CD were amplified from genomic DNA of 427 strain T. b. brucei (Wirtz et al., 
1999) using the primer combinations A and B or A and C (tabulated in Figure 2.3). 
Next, to allow the subsequent insertion of the chimera into the available restriction 
sites in the pHD1344t-TAP plasmid (Alibu et al., 2004; Carnes et al., 2012a), the 
protein-protein interaction domain (ID) of REL2 had been mutagenised by Matthew 
Spencer to remove the HindIII site, using site-directed mutagenesis and primer sets 
(see Appendix 1 for primers and strategy) . This product was then subject to PCR 
reaction with primer sets D and F or E and F, respectively, to create the two different 
fusion points within the REL2 protein-protein ID. A standard Phusion 50 μl PCR 
reaction was set up (10 ng 427 gDNA, 0.5 µl Phusion high fidelity DNA Polymerase 
(Finnzymes) and 10 µl corresponding buffer, 200 µM dNTPs and 0.5 µM primers) 
with the following temperature programme: 98°C 2 minutes [98°C 10 s, 70°C 30 s, 
72°C 30s] for 35 cycles, followed a five-minute incubation at 72°C. PCR reactions 
were analysed on a 1% TBE agarose gel, and amplicons were gel excised and 
cleaned up as per manufacturers’ instruction using Nucleospin® Extract II 
(Macherey-Nagel). The corresponding REL1 CDs and REL2 IDs amplified were 
mixed in an equimolar ratio and subjected to a PCR reaction under the 
aforementioned conditions with primer set A and F. These primers simultaneously 
removed the STOP codon from the REL2 ID and added a HindIII and a BamHI site 
to the 5’ and 3’ end of the chimera, respectively. PCR products were run on a 1% 
agarose gel, excised and cleaned using Nucleospin® Extract II.  
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Name Sequence Details 
A 5' ATAAAGCTTATGCAACTCCAAAGGTTGGG F'' 5' REL1CD 
B 5' GATTGATGGAGTCTCTTCGTACCGTGTCGATAAATGTC R' fusion 333 REL1CD 
C 5' CATCTACGCGAGGCCCTTGCTTACCGGGGTGCTTCAAC  R' fusion 322 REL1CD 
D 5' GACATTTATCGACACGGTACGAAGAGACTCCATCAATC F' fusion 333 REL2ID 
E 5' GTTGAAGCACCCCGGTAAGCAAGGGCCTCGCGTAGATG F' fusion 322 REL2ID 
F 5'  ATAGGATCCTTCGCTAAAGTCAGGAGACT R' REL2 ID 
 
Figure 2.3. Plasmid constructs for expression of TAP-tagged chimeric ligases. 
The in silico map was constructed using Lasergene software (DNASTAR). The Not1 
linearization of this plasmid allowed integration and constitutive expression of the 
TAP tagged protein from a β tubulin locus. 
The fusion points used to create chimeras REL1CD333REL2ID and  
REL1CD322REL2ID and the fusion point of the chimera that did not integrate, 
(REL1CD324REL2ID ) are shown in Figure 1.7 (Chapter 1). 
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PCR products were ligated into Zero BLUNT® TOPO® vector (Invitrogen), as per 
manufacturers' instruction. Ligation products were used to transform 50 μl of 
competent XL1-Blue cells (Stratagene), which were spread on plates containing 50 
μg/ml kanamycin. Three random colonies were picked and grown up in 2 ml of LB 
medium and 50 μg/ml kanamycin. Plasmid DNA was isolated using the peqGOLD 
kit (PEQLAB). Diagnostic restriction digests using EcoRI were set up using 100 ng 
of miniprep DNA and analysed on a 1% agarose gel to check for the presence of 
inserts, before sending DNA for big dye reaction sequencing (Genepool, Edinburgh). 
Correct inserts and pHD1344t-TAP (Alibu et al., 2004; Carnes, et al., 2012a) 
backbone were gel purified from plasmids doubly digested HindIII and BglII and 
HindIII and BamHI, respectively. The two fragments were ligated in an equimolar 
ratio using T4 DNA ligase (NEB). XL1-blue cells wre transformed with ligation 
product and colonies were picked to grow midiprep cultures. DNA was isolated as 
per manufacturer’s instruction (Machery-Nagel). 10 μg of NotI linearised plasmid 
was used to nucleofect 4 × 107 cKO REL1 cells using methods detailed by Burkard 
et al., 2007. Briefly, cells were pelleted at 1,300 rpm, resuspended in 100 μl of 
transfection buffer (90 mM sodium phosphate, 5 mM potassium chloride, 0.15 M 
calcium chloride, 50 mM HEPES, pH 7.3), and mixed with 10 μg of linearised 
plasmid before nucleofection (Amaxa program Z-001). Cells were resuspended in 
media with G4.15, hygromycin and phleomycin (as detailed in Section 2.2.1), 
subjected to 10-fold dilutions, and allowed to recover for 6 hours in 24 well plates 
before drug selection with 0.1 μg/ml puromycin antibiotic.  Clones were selected 
after 7 days. Clones A4 (fusion 333) and B4 (fusion 322) were used in subsequent 
analysis. 
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2.2.3 Growth analysis of cKO REL1 – TAP cell lines 
The aforementioned cell lines were subjected them to growth analysis by Matthew 
Spencer (with and without tetracycline) over a 5 to 6 day period to ascertain which 
RELs could rescue the cKO REL1 growth phenotype. Briefly, cells were grown in 5 
ml cultures containing selective drugs (2.5 μg/ml G418, 5 μg/ml hygromycin, 2.5 
μg/ml phleomycin and 2.5 μg/ml puromycin) without the presence of tetracycline 
and were diluted to 100,000 cells/ml each day after counting. Fresh tetracycline (1 
μg/ml) was added daily. 
 
2.2.4 TAP purification of tagged proteins 
All proteins were TAP-tagged to allow their purification (and that of associated 
protein complexes) via a tandem affinity purification protocol (TAP) (Rigaut et al., 
1999). For small scale purifications, a protocol modified from the full trypanosome 
TAP protocol (Schnaufer et al., 2003), here called miniTAP was used (Figure 2.4).  
Before the miniTAP could be established magnetic beads (Dynabeads® M-
270 epoxy - Invitrogen) were covalently linked to IgG, as described by Oeffinger et 
al., 2007, and modified by Achim Schnaufer. Briefly, 4 × 109 beads were 
resuspended in 4 ml of 0.1 M NaPO4, pH 7.4, through vortexing and were aliquotted 
into four separate 1.5-ml Eppendorf tubes. Each tube of beads was treated separately 
as follows. The bead suspension was gently shaken for 10 minutes before tubes were 
placed into a magnetic rack and buffer was aspirated. Beads were washed once with 
1 ml NaPO4 and incubated with 1 ml of antibody mix (2.5 mg rabbit IgG (Sigma), 50 
mM NaPO4, 1 M ammonium sulphate) for ~20 hours at 30°C, with gentle agitation. 
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Beads were subsequently washed, quickly, with 600 μl 100 mM Glycine-HCL, pH 
2.5, once with 600 μl  10 mM Tris, pH 8.8 and once, quickly, with 600 μl  opf fresh 
100 mM triethylamine. Coated beads were then subjected to four 5-minute washes 
with 1 ml PBS, one wash with 1 ml PBS with 0.5% Triton-X 100 for 5 minutes and a 
final 15-minute wash with PBS with Triton-X 100. Beads were finally resuspended 
in 1 ml PBS with 0.02% sodium azide.  
For each miniTAP procedure, 1 × 108 cells were, washed once with ice cold 1 
M phosphate buffered saline with 6 mM glucose (PBS-G), pelleted again, and either 
stored at -80°C or directly processed as follows. In short, 100 μl of IPP150 (10 mM 
Tris-HCL pH8, 50 mM NaCl, 0.5 mM EDTA, 0.1% NP40, 1 mM DTT), containing 
mini EDTA – free protease inhibitor (Roche), 1 tablet/10 ml) was added to a fresh or 
frozen pellet of 1 × 108 cells. Cells were lysed by adding Triton X-100 to a final 
concentration of 1% (where frozen cells were used, these were allowed to thaw on 
ice first). The lysate was incubated on ice for 20 minutes before centrifugation at 
10,000 g for 15 minutes at 4°C (Fresco 21, Thermoscientific). The supernatant (i.e. 
cleared cell lysate) was added to 10 μl of 2 × BSA-preincubated magnetic beads and 
were left rotating at 4°C for two hours. The supernatant was removed and the beads 
washed three times with 250 μl of IPP150 and once with 100 μl of TEV cleavage 
buffer (10 mM Tris-HCL pH8.0, 150 mM NaCl, 0.1% NP40 before the addition of 
10 U AcTEV protease (Invitrogen) in 30 μl of TEV cleavage buffer and two hours 
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Figure 2.4. The MiniTAP procedure.  
This method was used throughout all experiments in the thesis. TAP tagged ligases 
were constitutively expressed in the conditional REL1 KO environment and affinity 
purification used to isolate the ligases and their associated proteins. Since eluates 
were not sent for mass spectrometry, a single step of purification was sufficient for 
analysis.  
TAP tagged proteins were purified using magnetic beads covalently linked to IgG, 
and were eluted through cleavage with AcTEV protease. After elution, TAP tagged 
ligases contained the CBP (Calmodulin Binding Peptide) part of the tag and so could 
be detected using an antibody raised to this part of the tag.  
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 Eluates and samples from each intermediate step of the protocol were 
collected for Western blot analysis to optimise the procedure. 
 
2.2.5 Glycerol gradient sedimentation of native editosome 
subcomplexes 
Cells were grown to a density of approximately 1-2 × 106 cells /ml with 1L HMI9 
containing selective drugs, washed in PBS-G, and pelleted. Flashfrozen pellets were 
stored at -80ºC prior to glycerol gradient sedimentation.  The total number of cells 
present in each pellet is tabulated below in Table 2.1. 
 
Table 2.1 Number of cells used in glycerol gradients and subsequent TAP. 
TAP tagged construct # cells in pellet 
rREL1 7.15 × 10 8 
rREL2 1.05 × 109 
REL2CD/1ID 9.96 × 10 8 
REL1CD/2ID 1 1.27 × 109 
REL1CD/2ID Q 1.31 × 109 
 
Pellets were thawed and cellular matter was lysed in 500 μl of IPP150 and 
1% Triton X-100. After a 20-minute incubation on ice, debris was pelleted by 
centrifugation at 10,000g for 15 minutes at 4ºC. Cleared cell lysate was then directly 
loaded onto 10-ml glycerol gradients and subjected to a 9-hour centrifugation at 
38,000 rpm using a Beckman SW40Ti rotor and a Beckman L-60 Ultracentrifuge. 10 
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– 30% glycerol gradients were poured using a Hoefman SG15 gradient mixer, and 
were stored for a maximum of 1 hour on ice before use. Briefly, 5 ml of buffer A (10 
mM Tris HCL pH 7.2, 10 mM MgCl2, 100 mM KCl, 1 mM DTT, 10% glycerol) and 
buffer B (10 mM Tris HCL pH 7.2, 10 mM MgCl2, 100 mM KCl, 1 mM DTT, 30% 
glycerol) was added to compartments 1 and 2, respectively. Both buffers contained 
freshly added protease inhibitors (1 mM Pefabloc, 2 μg/ml Leucopeptin and 1 μg/ml 
Pepstatin A in a total 11 ml). The two buffers were mixed gradually as per 
manufacturers' instruction and poured into Beckman thick-walled centrifuge tubes 
(331374).  One to two gradients were run at a time, and 500 μl fractions were 
collected from the top and kept on ice prior to miniTAP analysis. 
Freshly collected fractions were pooled ready for analysis into the following 
4 pools: 1-3, 6-8, 9-11 and 12-14, based on published information (Schnaufer et al., 
2003) and from optimised 10-ml, 9- hour glycerol gradients on wild type (wt) 427 
cells. These fractions represent non-incorporated ligases, ligase integration into 
subcomplexes, ligase integration into the 20S editosome and ligase integration into 
larger complexes, respectively. The composition of these fractions was confirmed in 
pilot experiments using wt 427 cells and antibodies available for editosome 
components KREPA1, A2, A3 and REL1 (Panigrahi et al., 2001). 40 μl aliquots 
were taken from each of the pools for western analysis and the remainder was 
subjected to a TAP analysis, using 50 μl IgG-coupled, BSA-blocked magnetic beads. 
TAP was performed as in Section 2.2.4, and scaled up accordingly to accommodate 
for starting cell number. TAP tagged proteins were eluted in 150 μl of TEVCB and 
were concentrated using StrataClean resin (Stratagene). Briefly 5 μl of resuspended 
beads were added to the TEV eluate in 1.5-ml Eppendorf tubes, vortexed thoroughly 
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and subjected to centrifugation at 2,000 g for 1 minute. The supernatant was removed 
and the resin was resuspended in 10 μl of distilled water and 5 μl of 4 × SDS sample 
buffer. Samples were boiled for 5 minutes, fractionated by SDS-PAGE, and 
transferred to a PVDF membrane by Western blotting (see Section 2.2.7). 
 
2.2.6 Ascertaining the activity of TAP tagged ligases through 
radioactive adenylylation 
200 ml of culture of each cell line was grown and pelleted, then subjected to 
miniTAP purification. Aliquots of whole cell lysates and eluate samples were kept 
for Western blot analysis. TEV eluates were subjected to adenylylation and 
deadenylylation reactions as described by Cruz-Reyes et al., 2002 and Sollner-Webb 
et al, 2001.  
Half the TEV eluates, containing 5% glycerol, (6 µl) were first fully 
deadenylylated with 16 mM freshly made tetra pyrophosphate solution (pH 8.0) 
through pre-incubation for two minutes on ice. Excess phosphate was then removed 
through the addition of one unit of pyrophosphatase (Sigma) and reactions were 
incubated on ice for a further five minutes before adenylylation. To all reactions 12 
µl adenylylation master mix was added, creating reaction conditions with 25 mM 
KCl, 12.5 mM HEPES, pH 7.9, 5mM Mg acetate, 0.25 mM DTT and 10 µCi/µl (3.3 
µM) [α-32P] ATP. After a five-minute incubation at room temperature, reactions 
were stopped through addition of 20 µl 2 × SDS sample buffer (with 1% BSA) and 
denatured at 70°C for 10 minutes. Samples were run on a precast 10 % Bis-Tris Midi 
gel (Invitrogen) in 1 × MOPS, with ‘NuPage antioxidant (Invitrogen) in the upper 
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chamber, for 45 minutes at 200 V. 
After the removal of gel from its casing, the bottom of the gel, below the 40 
kDa marker, contianing free [α-32P] ATP, was excised and disposed of. The 
remaining gel was transferred to a Perspex box and incubated in 200 ml fixing 
solution (50% methanol/10% acetic acid) with gentle agitation for 30 minutes. The 
gel was then incubated with 200 ml equilibration buffer (7% methanol/7% acetic 
acid/1% glycerol) for another 30 minutes with agitation. The gel was then removed, 
placed onto two pieces of 3MM Whatman paper, covered with parafilm and dried for 
1 hour at 80 °C in a 583 vacuum gel dryer (Biorad). Once completely dried, the gel 
was exposed for 20 hours to a phosphor-imaging screen (Molecular Dynamics), 
before scanning on a Typhoon Trio variable mode imager (GE Healthcare). A 50 μm 
resolution image was taken, using the phosphor setting, and was analysed using 
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2.2.7 Western Blotting 
Equivalent amounts of protein (pertaining to 1 × 106 cells starting material) were 
assessed by Western blotting. All samples were boiled  in 2 × SDS sample buffer, 
(4% SDS, 20% glycerol, 120 mM Tris-HCL, pH 6.8, 0.2% bromophenol blue, 200  
mM DTT) for 10 minutes before 10μl of sample was run per gel lane. SDS-PAGE 
was carried out for 90 minutes at 150 V, using the Nupage® (Invitrogen) system 
(Novex® 10% BisTris gels with 1 × MOPS running buffer). Gels were blotted onto 
pre-equilibrated Immobilon-P (Millipore) PVDF membranes, using a Biorad® 
apparatus at 90 V for 45 minutes, before blocking overnight in TBST buffer (10 mM 
Tris-HCl, 150 mM NaCl and 0.05% Tween-20) with 10-20% dry milk as blocking 
agent.  All washes were carried out with TBST and all antibody blocking steps 
involve a one hour incubation with antibodies in TBST / 5% dry milk.  
Blots were stripped after exposure using stripping solution (0.1 M DTT, 0.05 
M Tris HCL, 2% SDS, pH 7) and incubation at 50 ºC for 1 hour. Blots were then 
washed for 30 minutes in TBST before repetition of the Western procedure from the 
initial blocking step.  
Bands were detected using ECL or ECL plus (Amersham), which visualised 
signals given from horseradish peroxidase (HRP)-coupled goat secondary antibodies 
(Bio-Rad).and were developed using Kodak MBX films and an SRX-101A X ray 
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Table 2.2 Antibodies and respective concentrations used in Chapter 2. 
Name Protein  Concentration Secondary Ab 
(Biorad) 
Reference 




Gift Stuart Lab 
(Panigrahi et 
al., 2001) α-KREPA1 (P4D8) KREPA1 1/50 1/1000 α-mouse 
α-KREPA2 (P1H3) KREPA2 1/100 1/1000 α-mouse 
α-KREPA3  (P3C12) KREPA3 1/50 1/1000 α-mouse 
α-CBP CBP 
(TAP-tag) 
1/1000 1/2000 α-rabbit Millipore 
PAP Protein A 
(TAP-tag) 
1/5000 N/A Sigma 
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2.3 Results 
2.3.1 Growth analysis of REL1 cKO -TAP cell lines 
Matthew Spencer’s results (Figure 2.5) indicated that only ectopically expressed 
REL1 (dashed purple line), but not REL2 or either of the two chimeric forms (other 
dashed lines), can rescue the growth phenotype caused by shutting down expression 
of REL1 in the cKO cell line. The parental REL1 cKO cell line (black) was used for 
comparison. All REL1 expressing cells grew exponentially. All other cells exhibited 
growth arrest by 70 hours, followed by death. All tagged chimeras are expressed, 
comparably (Figure 2.6). 
 
2.3.2 TAP analysis of tagged proteins and their integration 
into the editosome 
In order to test whether these TAP tagged proteins associated with the expected 
subcomplexes within the editosome, a suitable purification procedure had to be 
established. Optimisation of the miniTAP using IgG covalently linked to magnetic 
beads (single stage of purification) allowed efficient purification of TAP-tagged 
complexes from trypanosome lysates (results not shown). Relatively small numbers 
of cells were sufficient to reveal tagged and associated proteins by Western blotting 
from whole cells lysates (Figure 2.7). The four cell lines (expressing each of REL1, 
REL2, REL1CD/2ID and REL2CD/1ID-TAP) were then subjected to the miniTAP 
protocol, followed by Western analysis using antibodies against CBP, REL1 and 
KREPA2 to test whether the TAP-tagged REL proteins integrated into the editosome 
and could be pulled down efficiently.  
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Figure 2.5. Growth Curve of cKO Cell Lines. 
Matthew Spencer’s growth curve clearly shows that only an additional copy of REL1 
(dashed purple line) can rescue the growth phenotype caused by REL1 cKO 
conditions (i.e. in the absence of the tetracycline inducer).  
Solid and dashed lines correspond to cells grown in the presence and absence 
tetracycline, respectively. 
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The expression and integration data before and after TAP analysis is shown 
in Figure 2.7.  These results indicate that all proteins could be purified by miniTAP, 
as indicated by the presence of a CBP band of the correct size in whole cell lysates 
(WCL) at ~60 kDa and in eluates (E(10) at ~50 kDa (Figure 2.7A). The size shift 
from whole cell lysates to eluates is indicative of the loss of protein-A from the TAP 
tag upon TEV cleavage. REL1 and REL2CD/1ID tagged ligases could be visualised 
by Western using α-REL1, as this antibody is indicative of the ID only. Figure 2.7B 
shows the presence of inducible REL1 at ~50 kDa in all cell lines grown in the 
presence of tetracycline, as expected. Tagged REL1 can be detected in -tet samples 
only in REL1 and REL2CD/1ID whole cell lysate and eluate samples. The inducible 
copy of REL1 is also visible in eluates (+tet) from cell lines constitutively expressing 
REL1, REL2 and REL2CD/1ID, but not REL1CD/2ID. To add to this KREPA2 
(which is consistently masked in whole cell lysates) cannot be detected in eluates 
from REL1CD/2ID (Figure 2.7C). This shows all save the REL1CD/2ID chimeric 
protein could integrated properly into the editosome, since KREPA2 was present in 
the eluates of the other three cell lines. This indicates that 20S editosomes can 
successfully be pulled down by miniTAP via tagged REL1, REL2 and REL2CD/1ID 
proteins. This finding further indicated that the REL1CD/2ID chimeric protein 
created, perhaps because it was not folded correctly, was not able to integrate into the 
editosome efficiently.  This motivated us to construct new REL1CD/2ID-TAP 
chimeric protein for expression within the cKO REL1 environment.  
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Figure 2.6. Initial confirmation of expression of TAP-tagged ligase proteins. 
Western analyses were conducted with whole cell lysates (1 × 106 cells per lane) of 
REL1 cKO cells constitutively expressing TAP-tagged REL1, REL2, or chimeric 
proteins. Uninduced REL1 cKO cells and purified REL1-TAP fractions were used as 
negative and positive controls, respectively.  
A) Detection with 1/1000 P3Cl (REL1), which is specific for the C-terminal protein-
protein ID, clearly indicating the presence of endogenous REL1 across the cell lines 
as well as the REL1 ID present in the TAP-tagged REL1 and REL1ID/2CD 
constructs. The size increase from induced ectopic REL1 is consistent with the size 
of the TAP tag. B) Detection of the protein-A part of the TAP tag with a 1/5,000 
dilution of PAP indicates comparable expression of tagged proteins across all cell 
lines, and gives no signal for the control REL1 cKO cells, as expected. Image 
courtesy of Matthew Spencer.  
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Figure 2.7. TAP purification of tagged REL1, REL2 and chimeric proteins. 
Tagged proteins and associated complexes were purified from whole cell lysates 
using IgG-coated magnetic beads (which bind the protein A part of the TAP tag) 
followed by TEV protease cleavage. TEV eluates were analysed by immunoblot 
using antibodies against A) calmodulin binding protein (CBP part of the tag), B) 
REL1ID, C) RECC component KREPA2, or D) Tubulin. The data suggest all tagged 
proteins except for the REL1CD/REL2ID chimera successfully integrated into 
editosomes.  
Abbreviations: WCL – whole cell lysate, E(10) – eluate. 
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2.3.3 Creation of a new REL1CD/2ID tagged chimeric ligase  
The initial integration analysis in Figure 2.7 indicated that the tagged 
REL1CD324/2ID can not integrate into the editosome, even though the TAP tagged 
proteins, are comparable to the tubulin control. The newly created REL1CD/2ID 
constructs were based on two different fusion points (see Figure 1.7 and 2.3) 
designated as REL1CD333/REL2ID and REL1CD322/REL2ID. Figure 2.8A (overleaf) 
clearly shows that the four clones analysed express the new TAP tagged 
REL1CD/2ID fusions at a level comparable to REL1-TAP (as the CBP blot indicated 
a comparable amount of tagged protein throughout each miniTAP purification), but 
indicates a less efficient integration into native editosomes, as indicated by a weaker 
signal on the KREPA2 immunoblot (Figure 2.8B).  For subsequent experiments 
clones A4 (REL1CD333/REL2ID) and QB5 (REL1CD322/REL2ID) were used, since 
integration into editosomes was more efficient in these cell lines than in the others 
analysed. 
It is clear that in the absence of tetracycline in the media (and hence down-
regulated REL1) these cell lines exhibit the same growth arrest (typically after ~60 
hours) as the parental cKO REL1 cell line (Figure 2.8B). To dissect this finding 
further, the integration of the tagged ligases into the correct RECC subcomplex had 
to be ascertained, through the isolation of specific deletion and addition 
subcomplexes on glycerol gradients. 
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Figure 2.8. REL1CD/2ID growth curve and integration into the editosome. 
A) TEV eluates were analysed by immunoblot using α-CBP and α-KREPA2 to 
ascertain expression levels and integration into 20S editosomes. The data suggest 
both clones of the two new REL1CD/REL2ID chimera fusions (322 and 333, Figures 
1.7 and 2.3) are expressed comparably to the REL1-TAP protein and successfully 
integrate into editosomes, albeit not as efficiently.  B) Growth of REL1 cKO lines 
shows only an additional copy of REL1 (dashed purple line) can rescue the growth 
phenotype caused by REL1 cKO conditions (i.e. in the absence of the tetracycline 
inducer), as can also be seen in Figure 2.5.  
Abbreviations: WL – whole cell lysate, CL – cleared lysate, P – pellet, FT – flow 
through, E– eluate. 
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2.3.4 Isolation of subcomplexes using glycerol gradients 
To establish conditions for subsequent analysis, cleared T. brucei wt 427 lysates were 
fractionated on 10-ml glycerol gradients. Two separate gradients gave similar results 
when concentrated samples were immunoblotted with monoclonal antibodies 
(MAbs) for REL1, KREPA1 KREPA2 and KREPA3 (Figure 2.9 A). From this, it 
was decided to pool fractions 9, 10 and 11 for the 20S editosome, as these fractions 
showed co-integration of all four editosome components. This was consistent with 
data from the literature (Schnaufer et al., 2003).  
TAP-expressing ligase cell lines were grown in the absence of tetracycline (in 
the absence of untagged REL1) before glycerol gradient fractionation and subsequent 
miniTAP. It is clear from the concentrated eluate samples subjected to Western 
blotting analysis (Figure 2.9 B) that TAP tagged ligases were able to integrate into 
the subcomplexes, for which they were intended. REL2CD/1ID-TAP and REL1-TAP 
ligases integrate into the deletion subcomplex, since immunoblotting detects 
KREPA2 in the TEV eluates of the subcomplex and 20S fractions. KREPA1 is 
detected in the 20S eluates, from which REL1-TAP indicates that the whole 
editosome is pulled down. Likewise, REL2-TAP, REL1CD333/2ID-TAP and 
REL1CD322/2ID-TAP fusions integrate into the addition subcomplex as KREPA1 
can be detected in the subcomplex and 20S editosome fractions.  
CBP antibodies indicate the expression of a TAP tagged ligase in fractions 
pertaining to unincorporated, subcomplex, RECC and post editosome fractions 
across all 5 cell lines.  A schematic diagram of the editosome components detected in 
TAP eluates, and inferred integration position of tagged ligases within the editosome 
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is shown in Figure 2.9 C. Nonetheless, detection of editosome proteins in 20S 
fractions was inconsistent from  REL2-TAP, REL1CD333/2ID-TAP and 
REL1CD322/2ID-TAP eluates, in that only KREPA1 could be detected, and not 
KREPA2 as would be expected. KREPA3 could not be detected in any samples, after 
glycerol gradient and miniTAP even though it can be clearly detected in 
mitochondrial extract (mitoprep) controls (Figure 2.9B). 
 
2.3.5 Discerning the activity of TAP tagged ligases 
Prior to undertaking the adenylylation assays with the TAP tagged ligases, a control 
experiment was set up to determine if the TEVCB (containing DTT) would interfere 
with activity. Here, rREL1 expressed in E. coli and T4Rnl2 were subjected to 
adenylylation reaction, in respective storage and adenylylation buffers, with and 
without the presence of TEVCB. The presence of TEVCB did not affect the 
efficiency of adenylylation (results not shown).  
The activity of the isolated TAP tagged ligases was determined using 
adenylylation and deadenylylation assays, with radiolabelled ATP in conjunction 
with phosphorimaging analysis, so that this could be related to the growth curves. 
Deadenylylation through addition of free phosphate was attempted, because REL2 
has a high affinity for ATP and so is already adenylylated within the cell, and we 
wanted to measure this adenylylation activity. Auto-adenylylation was used as a 
proxy for TAP-tagged ligases, and had advantages over a full ligase activity assay, 
since different ligases in a sample can be distinguished (Cruz-Reyes et al., 2002). 
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Figure 2.9. Integration of TAP tagged ligases into editosome. 
(A) Glycerol gradients and subsequent Western blots were performed first with wt 
427 BSF cells to determine reproducibility and the fractions to be pooled for 
subsequent TAP. (B) Western blots of TAP purified pooled glycerol gradient 
fractions after fractionation of lysates from REL1-ablated cells. Eluates were probed 
using antibodies against CBP, REL1, or RECC components KREPA1, A2 and A3. 
(C) A schematic of TAP tagged ligases into the editosome. Sites of tagged ligase 
integration are indicated in blue and protein components detected by Western 
blotting are indicated in black. KREP A3 could not be detected in (B), even though 
mitochondrial extract controls (mitoprep) indicated all antibodies were working 
correctly. Abbreviations:  MP - mitoprep control, S/C – subcomplex, WL – wild type 
whole cell lysate. 
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 The most active ligase, by far, was REL1-TAP, present as a band at ~60 
kDa.  A small band at ~48 kDa indicates the presence of a small amount of 
regulatable REL1 after ablation. Endogenous REL2 could also be detected in these 
lanes (Figure 2.10A, lanes 1 and 6) as well as in the lanes containing REL2CD/1ID-
TAP ligase indicative of integration into the deletion subcomplex (Figure 2.10A, 
lanes 3 and 8), at 47 kDa. The strength of the endogenous REL2 adenylylation signal 
is comparable in lanes 1, 3, 6 and 8. Phosphate treatment did not significantly 
improve the detectable activities of ligases possessing the REL2 catalytic N-terminal 
domain, in the absence of endogenous REL1 suggested that the attempted 
deadenylylation had not been successful (Figure 2.10A, lanes 2, 4, 5, 7, 9 and 10). 
These reactions did not reveal the presence of endogenous REL2, suggesting that 
REL2-TAP, REL1CD333/2ID-TAP and REL1CD322/2ID-TAP integrated correctly at 
REL2’s site in the addition subcomplex. However, since the deadenylylation reaction 
did not work, even after multiple attempts, the activities of the REL1CD and 
REL2CD cannot be reliably compared. 
Western blotting was carried out on whole cell lysate and eluate fractions 
collected from each TAP purification, using CBP antibody to determine amount of 
TAP tagged protein present, and KREPA2 to determine the integration efficiency 
into the editosome (Figure 2.10B). Results indicate that neither the amount of 
isolated ligase used in each radioactive assay nor the integration efficiency into 
native editosomes was equal across the five cell lines. 
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Figure 2.10.  Activity of TAP tagged ligase determined through radioactive auto-
adenylylation. 
A) Auto-adenylylation gel and quantification of gel using phospho-imaging. Assay 
conditions were as follows: 1-5 without prior adenylylation; 6-10 deadenylylation 
prior to adenylylation.  1,6 REL1-TAP, 2,7 REL2-TAP, 3,8 REL2CD/1ID-TAP, 4,9 
REL1CD333/2ID-TAP, 5,10 REL1CD322/2ID-TAP. B) Western blot of cell equivalent 
whole cell lysates and eluates used in each assay. Each lane was loaded with 
approximately 0.5 × 106 cells and probed with 1/500 α-CBP and 1/2000 α-rabbit 
antibodies. Blots were then stripped and reprobed with 1/50 A2 and 1/1000 α- mouse 
antibodies. Abbreviations: WCL – whole cell lysate, E(10)– eluate. 
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 Indeed, full length REL1-TAP and REL2CD/1ID-TAP were the most 
abundant in the TEV eluate and all whole cell lysates contained a comparable 
amount of tagged ligases (CBP) (Figure 2.10B). Figure 2.10, in sum, clearly 
indicates that the REL2CD/1ID-TAP is not as active as REL1-TAP. Although the 
amounts of REL2-TAP, REL1CD333/2ID-TAP and REL1CD322/2ID-TAP ligases 
(CBP) and of KREPA2 were comparable in the TEV eluates, suggesting integration 
into editosomes with similar efficiency, it is clear that there was both lower recovery 
and integration of the tagged ligases, in comparison to the remaining two cell lines. 
This complicates the interpretation of activity of the REL1CD/2ID chimeric ligases, 
since the amount of these recovered ligases used in each activity assay is less in 
comparison to REL1-TAP or REL2CD/1ID-TAP. 
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2.4 General Discussion 
Results gained from this Chapter suggest a more complicated scenario than originally 
anticipated (see Figure 2.1). REL1-TAP was the only ligase expressed that restored 
the growth phenotype, caused by loss of regulatable REL1. This was as hoped, and 
provided a positive control to the study, demonstrating that this approach could be 
pursued. As expected the REL2-TAP ligase could not rescue the growth phenotype 
caused by REL1 ablation, and provided a negative control to this study. The chimeric 
ligases provided a means to involve REL1 in the addition editing subcomplex and 
REL2 in the deletion editing subcomplex 
Once two new REL1CD:2ID chimeras were constructed and were shown to 
integrate correctly in RECCs, the repeated growth curve for four separate clones also 
revealed no rescue of the growth phenotype on ablation of regulatable REL1. All 
growth curves were constructed using the parental cKO as a comparison and to 
validate the growth curves. This indicated that all growth phenotypes, typically 
appearing around 60 hours, were caused by the loss of REL1. Although a 
constitutively expressed epitope tag may in theory cause cytotoxicity, the highly 
expressed REL1-TAP protein fully rescued the growth defect of the parental cKO 
cell line, demonstrating that it did not affect REL1 function significantly (Medina et 
al., 2000). 
REL2-TAP, REL1CD333/2ID-TAP and REL1CD322/2ID-TAP did not 
integrate as efficiently as the TAP ligases containing the REL1 interactive domain. 
This is most likely due to the presence of endogenous REL2. However, knowing that 
REL2CD/1ID-TAP can integrate as efficiently as REL1-TAP provides further 
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evidence that REL1 is essential at its deletion subcomplex position. In this scenario 
the REL2 CD, when present in the deletion subcomplex, cannot rescue the growth 
phenotype caused by REL1 ablation. Taken at face-value (from growth curves and 
miniTAP Western blots) a REL1CD is required at the deletion subcomplex for 
normal functioning of RNA editing and growth. 
Glycerol gradient sedimentation of cleared cell lysate, and subsequent 
miniTAP and Western analysis confirmed TAP tagged ligases were correctly 
integrated into the subcomplexes for which they were intended. Although the 
KREPA3 interacting protein could not be detected in each of these pooled glycerol 
gradient fractions, it could be detected in the mitoprep positive control run alongside 
these samples (see MP in Figure 2.9). Although its absence could reflect the TAP tag 
masking the core of the 20S editosome, KREPA3 could be detected in REL1-TAP 
expressing cell fractions in previous studies (Schnaufer et al., 2003). The 
components of the adjacent deletion subcomplex, however, could be detected from 
pooled TAP eluates from glycerol gradients (Figure 2.7 and 2.8) using REL1 and 
chimeric REL2CD/1ID cell lines. In the remaining cell lines expressing a ligase with 
a REL2 ID, only the subcomplex where integration occurred could be detected in the 
affinity purified fractions. This may indicate instability of the 20S editosome in the 
absence of a ligase integrating into REL1s position in the deletion subcomplex. This 
has also been reported by some groups  (Huang et al., 2001; Cruz-Reyes et al., 
2002), but not others (Stuart et al., 2002; Gao and Simpson, 2003). This discrepancy 
may be explained in terms of editosome stability (which may be due to the absence 
of REL1) and the length of experimental procedure, comprising of 9-hour glycerol 
gradient sedimentation, followed by fractionation and subsequent miniTAP. If there 
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were any destabilisation effects caused by REL1 loss then they would be more 
apparent after glycerol gradient and subsequent TAP than after TAP only. 
Next, the activities of the ligases needed to be taken into consideration. 
Unusually the pyrophosphate treatment did not increase the auto-adenylylation 
activity of REL2-TAP, or the REL2CD:1ID-TAP, to levels comparable with REL1-
TAP, even though in the literature auto-adenylylation activity of REL2 exceeds that 
of REL1 after deadenylylation (Cruz-Reyes et al., 2002). The conditions of the 
deadenylylation assay used were as described by (Cruz-Reyes and Sollner-Webb, 
1996; Cruz-Reyes et al., 2002) and fresh pyrophosphate was used for each 
experiment (as suggested by Jorge Cruz-Reyes, personal communication). Together, 
this indicates that deadenylylation did not work as expected.  
The activity measured for the isolated tagged ligases in the TEV eluates 
needs to be normalised for the amount of ligase present in these samples. 
Unfortunately, due to technical constraints, these blots could not be quantified. 
However, it was obvious that more TAP tagged ligase was present in the eluates 
from the cell lines expressing the REL1 ID. REL1CD333/2ID-TAP and 
REL1CD322/2ID-TAP ligases are also recovered more efficiently in the presence of 
endogenous REL1, suggesting that its presence improves integration into the 
editosome and pull down, possibly through a stabilising effect on the whole of the 
editosome, at least under purification conditions (results not shown). All chimeric 
ligases were much less adept at auto-adenylylation in comparison to REL1, so strong 
conclusions cannot be made, since the growth phenotype, at least in part, may reflect 
their relative catalytic activites. 
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Most studies to date have focused more on the essential motifs of the RNA 
ligases, and have not addressed the role of the interactive domain in governing 
catalytic activity, through a stabilisation effect for example. It is conceivable that the 
recombination of catalytic and protein-protein interaction domains (N- and C-
terminal parts of the protein, respectively) in the chimeric ligases interfered with 
activity. This would in itself explain the lower activity of these ligases in auto-
adenylylation reactions. A study of REL1, directly assessing the activity of this 
catalytic domain, revealed that the N-terminal domain was not as catalytically active 
as the full length ligase in auto-adenylylation and complete ligation assays (Deng et 
al, 2004). However, it appears from mutational studies that the closest relative of 
REL1, T4Rnl2, has a C-terminal domain that is dispensable for catalytic activity 
when the adenylylation step is bypassed, but has an N-terminal domain which retains 
activity after its isolation, albeit with a different pH optimum  (Ho et al, 2004). The 
primary structure of this C-terminal domain is partially conserved between T4Rnl2 
and the RELs, which do not possess the OB fold domain, present in DNA ligases (Ho 
et al., 2004; Nandakumar et al., 2004). Further investigation into T4Rnl2 has 
revealed that this C-terminal domain is required for RNA substrate specific activities, 
whereas the N-terminal domain has been implicated in the first (adenylylation) and 
last (strand sealing) steps of ligation (Nandakumar and Shuman, 2004; Nandakumar 
and Shuman, 2005; Nandakumar et al., 2006). This may explain why the chimeric 
ligases were not as active as their full length counterparts, since the domain swap 
may have interfered with their catalytic function. It is not assumed that the tag itself 
reduced ligase activity, since REL1-TAP was able to restore growth phenotype in the 
absence of ectopically expressed REL1. 
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2.5 Conclusions and Outlook 
The results for this part of the project are not as clear cut as hoped. Because of the 
reduced catalytic activity of the chimeric ligases, it can only be concluded that REL1 
is essential at its position in the deletion subcomplex. However, the negative data 
produced from the chimeric ligases constructed has provided interesting information 
regarding the apparent cross talk between the CD and IDs of the RELs.  
These cell lines may still be used in the future. To alleviate the potential 
fragility of the editosome, when no ligase is expressed in place of ectopic REL1 in 
the deletion subcomplex (as with REL2, REL1CD333/2ID-TAP and REL1CD322/2ID-
TAP expressing cell lines), an inducible and catalytically dead copy of REL1 could 
be expressed in its place. With added stabilisation, the glycerol gradients and 
subsequent TAP and Westerns may reveal more components of the editosome. It 
may also improve integration and recovery for the auto-adenylylation assays, but it 
would not address the activity of the ligases. The Schnaufer laboratory also has a 
FRET-based fluorescent assay for measuring REL1 activity, which could be 
employed as a measure of full round ligase activity. The equivalent amount of REL1-
TAP ligase eluate used in the adenylylation assays could be detected (results not 
shown) and not only would this approach be more sensitive, but it would also 
measure more than the first step of the ligation activity. However, the limitation of 
this approach is that the activity ascertained would be additive of multiple ligases 
within a complex. Although auto-adenylylation involves the first part of the editing 
reaction only, it is useful in assigning activity to separate ligases. First, however, 
deadenylylation and adenylylation assays must be properly established.  It would 
also be important to isolate subcomplexes and subject them to in vitro addition and 
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deletion editing specific assays. This approach would use pre cleaved RNA 
substrates to discern chimeric ligase involvement in the restoration of editing, which 
may be very slight due to low activity.  Another approach would be to discern the in 
vitro roles of chimeric ligases in editing at their respective subcomplex position  
through the titration of ATP and  PPi (as used by Cruz-Reyes et al., 2002). This 
method would comprehensively determine whether the catalytic function or 
subcomplex positioning is key to REL1's essentiality. 
This study also provided indirect evidence for the cross-talking of REL CDs 
and protein-protein ID, which has not been extensively studied, and illustrates an 









Identifying the substrates of REL1 using 
limited and deep sequencing 
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3.1 Introduction to project 
The identification of REL1 substrates may provide clues to its precise role, and 
therefore the basis for its essentiality to the process of RNA editing. In this Chapter 
we used cKO REL1 cell lines (the parental cell line, Chapter 2) to grow cultures of 
trypanosomes with normal and substantially reduced levels of REL1, with the aim to 
isolate and analyse RNA. Specific mitochondrial transcript substrates were 
sequenced, by the use of a 5’ RNA linker ligated post isolation, which took 
advantage of the 5’ monophosphate produced as a result of endonucleolytic cleavage. 
These substrates are readily ligatable to such a linker by an enzyme that can join 
single stranded RNA, like T4Rnl1 (Romaniuk and Uhlenbeck, 1983; Tessier et al., 
1986). By mapping the 5' ends of these ligation substrates it is possible to see what 
cleavage products remain unligated, and from this deduce the specificity of REL1. A 
similar 5’ trapping approach was successful in other studies (Bruderer et al, 2003; 
Granneman et al, 2009).  
One of the aims of this part of the study was to infer whether REL1 could be 
functioning as a general RNA repair enzyme (5’ PO4 to 3’ OH) for erroneously 
cleaved RNA substrates, in addition to its role in sealing correctly edited sites. Such 
an idea is not a new one; indeed there have been several comparisons of REL1 to 
T4Rnl2, which was proposed to have general RNA repair activity (Ho and Shuman, 
2002; Palazzo et al., 2003; Yin et al., 2003; Ho et al., 2004; Nandakumar et al., 
2004; Deng et al., 2004). Central to the experimental design for the capture of editing 
intermediates was also the removal of abundant ribosomal RNA, degradation 
products of which may also have 5’ monophosphates (Ryan et al., 2003). The 
approach described here, however, selectively amplified mitochondrial transcripts by 
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use of specific reverse primers, and in doing so, eliminated the chances of 
sequencing undesirable RT-PCR products. Whilst a global approach was not 
achieved in the time frame given with this PhD study, this approach still allowed 
specific questions pertaining to REL1 substrates, such as: what particular editing 
events does REL1 govern? And how frequently do these occur? 
The outline of the sequencing strategy is shown schematically overleaf in Figure 3.1. 
Chapter 3 
  99 
 
 
Figure 3.1. Sequencing workflow 
Approximately 5 × 10 8 cells (equating to 500 ml cultures in logarithmic growth) were cultured for 
each of the RNA preps. RNA was isolated using TRI reagent ® solution instead of a column based 
RNA isolation kit, since columns incur a size bias to the RNA population extracted. 5’ ends were 
mapped with the use of an RNA linker, which was ligated to the 5’ monophosphate product of 
endonucleolytic cleavage during the processing of polycistons, or editing substrates. 
Colour scheme: red – 5' RNA linker, purple – unedited region of transcript, blue – edited region of 
transcript, green – DNA generated from RT and PCR. 
The reaction condition for 5’ linking and subsequent RT using tagged hexamer primers were adapted 
from Granneman et al., 2009 and Matsumoto et al., 2010. 
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3.2 Methods 
3.2.1 Cell culture 
CKO REL1 cell lines (used as a parental cell line in Chapter 2, Figure 2.2, Schnaufer 
et al., 2001) were maintained in HMI-9 media containing 10% (v/v) FCS and 
selective drugs (2.5 μg/ml G418, 5 μg/ml hygromycin, 2.5 μg/ml phleomycin and 1 
μg/ml tetracycline). Log phase cells were cultured to 500 ml, both in the presence 
and absence of tetracycline, and counted and harvested after 48 hours. Pellets were 
kept on ice prior to the addition of 1 ml of TRI reagent ® (Ambion) per 1 × 108 cells 
grown in the presence and absence of tetracycline (+tet and –tet). TRI lysates were 
left at -80°C until required for RNA extraction. Aliquots of whole cell lysates at 48 
hours, for cells grown in the presence and absence of tetracycline, were kept for 
Western blot analysis. 
 
3.2.2 RNA extraction  
For all RNA work, benches were cleaned thoroughly with 70% ethanol and 
RNaseZap® (Ambion), and filter tips were used throughout to reduce chances of 
RNase contamination. Phenol-chloroform clean up and TRI Reagent extractions 
were performed in the fume hood, and a double layer of gloves were worn as a 
precaution. Autoclaved DEPC water was used instead of distilled or Milli Q water 
with all of the RNA work up to the final PCR reactions involved in generating 
sequencing material. 
RNA from approximately 6 × 108 pelleted trypanosome cells was isolated 
using TRI reagent ® solution and its associated standard protocol (Applied 
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Biosiences). Briefly; cells suspended in TRI reagent were left to thaw and incubate at 
room temperature for 5 minutes before the addition of 130 μl and 630 μl of Bromo-
chloro-3-propanol (BCP) for +tet and –tet samples respectively. Lysates were left to 
incubate at room temperature for 15 minutes before centrifugation at 12,000 g for 15 
minutes at 4ºC. The aqueous phase was transferred to a fresh tube and 650 μl and 
3.15 ml of isopropanol was added for + tet and –tet samples, respectively. The 
mixtures were briefly vortexed and left to incubate for 10 minutes at room 
temperature before the RNA was pelleted by centrifugation at 12,000 g for 10 
minutes at 4°C. The RNA pellets were washed in 10 ml 75% ethanol by 
centrifugation at 12,000 g for 10 minutes. The pellets were allowed to air dry before 
their resuspension in 100 μl DEPC water. 
 
3.2.3 DNA clean up of total RNA 
RNA was treated with DNA-free DNase (Ambion), as specified by the kit before the 
lysate was subjected to two rounds of poly(A)+ RNA selection using the standard 
protocol of MicroPoly(A)Purist™ kit (Ambion). Two parallel reactions were set up 
for Ambion® DNA-free™ (Life) DNase Treatment with 40 μl total RNA, 4 μl 10 x 
DNase I Buffer and 0.5 μl rDNase I. After gentle mixing, the reactions were 
incubated at 37°C for 30 minutes, before the addition of a further 0.5 μl rDNase I and 
subsequent incubation at 37°C for 30 minutes. After the DNase Inactivation Reagent 
was resuspended by vortexing, 4 μl was added to the RNA reactions to stop the 
reaction and this was subjected to continual mixing by pipetting for 2 minutes at 
room temperature. To finish, reactions were centrifuged at 10,000 × g for 1.5 min 
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and transferred to a clean tube to await poly(A)+ RNA purification on oligo(dT) 
beads. 
 
3.2.4 Purification of poly(A)+ RNA using Poly(A) PuristTM kit 
To minimise loss of RNA throughout this process the DNA free cleaned RNA was 
added directly to the oligo(dT)  column without prior ethanol precipitation. Aside 
from this, the protocol was carried out as per manufacturer’s instruction. Briefly, an 
equal volume 2 × Binding Solution was added and mixed thoroughly and each RNA 
sample was added to 1 tube oligo(dT) cellulose and mixed well by inversion and 
pipetting. The tubes were incubated for 5 min at 65 °C to denature secondary RNA 
structures, before leaving them for 1 hour at room temperature rotating. 
The oligo(dT) cellulose was pelleted by centrifugation at 3,000 × g for 3 min 
at room temperature, and the flow through was collected and kept on ice until the end 
of the procedure to ensure good poly(A)+ RNA recovery.  The cellulose was initially 
resuspended by vortexing in 500 μl Wash Solution 1, before transferring to a spin 
column to aid removal of non-specifically bound material by centrifugation at 3,000 
× g for 3 min at room temperature. The flow through was discarded. The beads were 
washed once more with 500 μl Wash Solution 1 and three times with Wash Solution 
2 in the same manner. Spin Columns containing the bound poly(A)+ RNA were 
placed into new microfuge tubes and 200 μl of warm (70°C) RNA Storage Solution 
was added to the Oligo(dT) Cellulose. Tubes were briefly vortexed and immediately 
centrifuged at 5000 × g for 2 min to elute the RNA. This process of elution was 
repeated. This was immediately followed by a second round of oligo(dT) selection 
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using the cellulose present in the spin column. The 350 μl of the 400 μl eluted RNA 
was added to 350 μl of 2 × Binding Solution and the denaturation, rotating 
incubation, washes and elution were carried out as before. All aforementioned 
solutions were provided by the kit. RNA was then ethanol precipitated by the 
addition of 1 μl glycogen, 0.1 volumes 3 M sodium acetate pH 5 and 2.5 volumes 
100 % ethanol. Reactions were vortexed briefly before incubation in a –80°C freezer 
for 30 min. After this time, poly(A)+ RNA was washed in 200 μl of 75% ethanol and 
pellets were left to air dry before being resuspended in 20 μl DEPC water. Both total 
and poly(A)+ RNA were quantified and assessed for purity using the Agilent 
Bioanalyzer system. Simultaneous removal of ribosomal RNA and enrichment of 
mRNA transcripts was assessed by Northern blotting, using a riboprobe for actin 
mRNA (a kind gift from the Matthews lab). The Northern blotting protocol described 
below was modified from one described in Chapter 7 of Maniatis et al., 1982 and 
used more recently in (Mayho et al., 2006). 
 
3.2.5 Northern Blotting 
For this procedure all containers were washed thoroughly with detergent, rinsed with 
distilled water, sprayed with 70% ethanol and left to air dry before use. All base 
solutions used in the Northern blotting procedure, which were not provided with the 
corresponding kit, may be found in Appendix 2. 
A 1.2% 3-(N-morpholino)propanesulfonic acid (MOPS)-based agarose gel 
containing 1% formaldehyde was poured and allowed to set in a fume hood. The gel 
was loaded onto the gel with 1 µg and 300 ng of total and poly(A)+ RNA, 
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respectively, in 5 µl DEPC along with the following: 9 µl formaldehyde, 3 µl 37% 
formamide, 2 µl MOPS and 2 µl RNA loading buffer . Samples were denatured at 
65°C for 5 minutes, before running for 90 minutes on the RNA Agarose gel at 150 V 
in 1 × MOPS running buffer. The gel was post-stained with 0.5 µg/ml EtBr for 15 
minutes, destained twice for 30 minutes with distilled water, all at room temperature, 
and visualised using a UV transilluminator (Syngene) to determine loss of ribosomal 
bands in the poly(A)+ RNA when loaded in an equivalent concentration alongside 
total RNA. 
RNA was transferred onto a positively charged membrane (Roche) through 
capillary action overnight. The blot was assembled in the following manner and time 
was taken to ensure bubbles were removed at each stage by rolling a 10 ml pipette 
over the layer in question. A large tray was filled with 10 × saline-sodium citrate 
(SSC), and a wide sheet of Perspex was placed over the tray, leaving a gap either 
side for the pre-wetted Whatman chromatography paper (Fischer Brand) wick which 
was subsequently placed on top of the Perspex. The gel was next laid down, with 
parafilm surrounding it, to prevent drying overnight, followed by the membrane (pre-
wetted in 10 × SSC) and 2 gel sized Whatman filter papers (pre-wetted in 2 × SSC). 
Finally a 6 inch layer of tissues were added on top, followed by a hard backed text 
book and the RNA was allowed to transfer overnight. The following day the nylon 
membrane was allowed to dry and then UV cross linked in the Stratalinker for 1200 
counts or 0.12 joules.  
After cross linking the RNA to the membrane, the blot was transferred to a 
hybridisation tube and subjected to pre-hybridisation incubation with 10 ml of DIG 
hybridization buffer (Roche). After this time, the 10 ml of hybridization buffer was 
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poured away and replaced with 7 ml fresh buffer and 1 µl actin riboprobe, prepared 
by DIG RNA Labelling Kit (SP6/T7) (Roche) (kind gift from the Matthews lab) and 
was left to incubate overnight at 68 ˚C. The blot was then subjected to two 30 minute 
washes with 2 × SSC/0.1% SDS and one 30 minute wash with 0.5 × SSC/0.1% SDS, 
all at hybridization temperature. The blot was transferred from a hybridisation tube to 
a tub and washed for 1 minute at room temperature with wash buffer (Maleic acid 
buffer + 0.03% Tween 20), before a 1 hour incubation at room temperature with 
Maleic acid buffer with 1% DIG Block in a new tub. After blocking the membrane, 
to prevent any non-specific binding, it was transferred to a new tub and incubated for 
30 minutes with 50 ml of Maleic Acid buffer with 1% DIG Block and Anti-DIG*. 
Subsequently, the blot was washed 6 times for 5 minutes with wash buffer on a 
rocker, before soaking for 2 min in detection buffer. After excess detection buffer 
was removed, the membrane was placed in a heat sealable bag (Jencons) and 1 ml of 
CDP-star detection agent (10 µl of substrate in 1 ml Detection Buffer) was added. 
After a two-minute incubation, excess liquid was removed and the bag was heat 
sealed and left at 37˚C for 15 minutes. The blots were visualised using X-ray film. 
  
3.2.6 Nano Agilent Chip analysis of total and poly(A)+ RNA 
To prepare for running a nano chip one of the wells of an electrode cleaner chip was 
slowly filled with 350 µl RNaseZAP (Ambion), which was then subsequently placed 
into the Agilent 2100 bioanalyzer, and left with the lid closed for 1 minute. This 
action was repeated with another electrode cleaner containing 350 µl of RNase-free 
DEPC water, which was left for 10 seconds with the lid closed and another 10 
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seconds with the lid open for the water on the electrodes to evaporate before closing 
the lid. 
The gel matrix was prepared as follows. All reagents in the Agilent RNA 
nano kit were left to equilibrate to room temperature in the dark for 30 minutes 
before use. The RNA 6000 Nano dye concentrate was vortexed briefly and spun 
down, and 1 µl of this was added to a 65 µl aliquot of pre-filtered Agilent RNA 6000 
Nano gel matrix and the mixture was centrifuged for 10 minutes at room temperature 
at 13000 × g. The Nano chip was then inserted into the chip priming station, with the 
base of the plate of the station set to position (C), in preparation of sample loading. 
Once the matrix-dye mixture had equilibrated at room temperature 9 µl of it was 
added at the bottom of the well marked (G). Making sure that the plunger was 
positioned at 1 ml, the chip priming station was closed until the latch clicked and the 
plunger of the syringe was pressed down until it was securely held by the clip. After 
30 seconds the plunger was released with the clip release mechanism. After 5 
seconds, the plunger was slowly pulled back to the 1 ml position. On opening the 
priming station 9 µl of the gel-dye mix was pipetted slowly into each of the wells 
marked G, and 5 µl of the RNA 6000 Nano marker was pipetted into the well marked 
with the ladder symbol and into each of the 12 sample wells. Wells due to be empty 
were filled with 5 µl of the RNA 6000 Nano marker plus 1 µl of DEPC water. 
Ladders were thawed and kept on ice prior to analysis. To minimize secondary 
structure, samples were heat denatured (70°C, 2 minutes) before loading on the chip. 
The chip containing 1 µl of each sample in each of four sample wells was 
horizontally placed in the adapter of the IKA vortex mixer and vortexed for 1 minute 
at 2000 rpm. The chip was then immediately inserted in the Agilent 2100 
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Bioanalyzer, which had the chip selector in position (1), the lid was closed and the 
analysis run using the Expert software. 
 
3.2.7 5’ linkage of poly(A)+ transcripts  
100 pmol of a 5’ RNA linker (5-
/InvddT/GTTCAGAGUUCUACAGUCCGACGAUC-3, a kind gift from the Tollervey 
lab - Granneman et al, 2009) was ligated over night at 16°C to 100 ng poly(A)+ 
RNA in an 80 μl reaction with ligase buffer (50 mM Tris-HCl, 10 mM MgCl2, 10 
mM DTT, 1 mM ATP, pH 7.0), 80 u RNasin (Promega) and 40 u T4 RNA ligase 1 
(NEB). Italicised nucleotides refer to RNA bases in the 5’ linker. RNA was 
precipitated as follows: 20 μg glycogen, 1/10 volume 3 M Na acetate and 2 volumes 
100% EtOH were added and the mixture incubated at -20°C for 30 minutes, before 
centrifugation for 15 minutes at 11,000 × g  in a bench top centrifuge (Technico 
Maxi). Supernatant was discarded and the pellet washed in 200 μl 70% EtOH before 
resuspension in 20 μl of DEPC-treated water. 
 
3.2.8 First strand synthesis 
RNA was subject to incubation at 65°C for five minutes with 125 ng of random 
hexamer primer (5'-CCTCTGAAGGTTCACGGATCCACATCTAGANNNNNN), 
to maximise hybridisation. The tag had been introduced to facilitate global mtRNA 
analysis, which was unsuccessful. This was used in a 20 μl reaction mixture 
containing 1st strand buffer (50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2), 
20 U RNase OUT, 0.2 mM DTT, 200 U Superscript II (Invitrogen) and 10 mM 
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dNTPs was subjected to the following temperature programme: 25°C 15 minutes, 
42°C 50 minutes and 70°C for 15 minutes. 1 μl of RNaseH was added to this, and the 
reaction was subjected to two further incubations; 37°C for 20 minutes and 90°C for 
10 minutes. RT reactions were cleaned using phenol-chloroform extraction. Briefly, 
RT reactions were made up to 100 μl with DEPC and an equal volume of phenol-
chloroform was added in Eppendorf tubes. Tubes were vortexed briefly and spun at 
10, 000 g for 1 minute and the aqueous layers were transferred to new tubes. A 
further 100 μl of DEPC was added to each phenol-chloroform mixture and the 
aqueous layer extracted as previously described. Extracts in DEPC were precipitated 
in the presence of glycogen, as described previously, and cDNA pellets were 
resuspended in 20 μl DEPC-treated water.  
 
3.2.9 Second strand synthesis  
Second strand cDNA synthesis was performed in a 25 µl reaction with 200 pmol of 
5’ linker-specific primer (5’-GTTCAGAGTTCTACAGTCCGACGATC), 200 pmol 
of either a non-discriminating ND7 primer (ND71) (5’-
CGGAAGACATTGTTCTACAC), a primer designed to amplify ND7 transcripts 
that had already entered the editing cycle (ND72) (5’-
GTACCACGATGCAAATAAC) or an RPS12 specific primer (5’- 
AAAAACATATCTTATATCTAAA). PCR reactions also included 1 U GoTaq® 
DNA polymerase (Promega), 200nM dNTPs, 1.5 mM MgCl2 and 1 × flexi buffer 
(pH 8.5). PCR reactions were subjected to the following temperature program: 94°C 
2 minutes, 35 cycles of 94°C 30 seconds, 50°C 1 minute, 72°C 2 minutes, and 72°C 
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7 minutes. The regions of ND7 where primer sets anneal are illustrated in Figure 3.5. 
 
3.2.10 Cloning of sequences for limited sequence analysis 
PCR reactions were run out on a 2% agarose gel at 100 V for 2 hours. Discrete bands 
or smears were excised (see Figure 3.6) using Gene Catcher disposable gel excision 
tips. DNA was purified using Nucleospin II kit (Macherey-Nagel). These sequences 
were cloned into pGEM®-T Easy (Promega), as per manufacturer’s instructions and 
sent for Sanger sequencing (big dye reaction) at the GenePool faculty of Edinburgh 
University.  
Sequences were aligned manually in Microsoft Word. 
 
3.2.11 Preparation of 5’ linked RT-PCR products for Ion 
TorrentTM and MiSeqTM Illumina based sequencing 
RT-PCR products were generated as described in Sections 3.2.7 to 3.2.9. Two lots of 
25 µl RT-PCR reactions were set up for each of the three primer sets described above 
and 1/5th of the reactions were analysed on a 2% agarose gel and purified using the 
Nucleospin II kit before being sent to the Western General Hospital for analysis 
using Ion Torrent (ND71- non discriminating) or the GenePool (University of 
Edinburgh) for MiSeqTM sequencing (RPS12 and ND72 - intermediates).  Before Ion 
TorrentTM sequencing, the RT-PCR library prep was cleaned using an AMPure® XP 
kit (Beckman Coulter. Inc). This kit purified sequencing material with a cut-off of 
100 bp, as an upper cut-off of 300 bp would not have been desirable. The 100 bp cut-
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off allowed the removal of sequences lacking ND7 transcripts. The Ion Torrent P1 
and A adapter sequences were  
5'-CCACTACGCCTCCGCTTTCCTCTCTATGGGCAGTCGGTGAT-3' and 5'-
CCATCTCATCCCTGCGTGTCTCCGACTCAG-3', respectively. Since +tet and –
tet samples were processed on the same chip, they were differentially barcoded with 
IonXpress11 (TCCTCGAATC) and IonXpress12 (TAGGTGGTTC), respectively. 
The process of Ion Torrent is shown in Figure 3.2. Ion torrent sequencing 
provided 300 bp single (non-paired) end reads, which had either forward (category 1) 
or reverse orientation (Category 2). MiSeq produced 250 bp paired-end reads, that 
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Figure 3.2. The process of Ion Torrent sequencing 
This method works on the principle that a nucleotide match against a stretch of 
complementary sequence causes a release of a hydrogen atom and a subsequent drop 
in pH, which can be measured.  From the peaks measured the sequence can be 
deciphered. The 5’ linked RT-PCR products used in this study were subjected to a 
100 bp cut off clean up and barcoding. Taken from Wikimedia Commons.  
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3.2.12 Analysis of editing intermediates from Ion TorrentTM 
and MiSeqTM sequencing 
Sequences were subject to bioinformatics sorting using an R-based pipeline devised 
by Al Ivens (CIIE). The workflow for this is shown in Figure 3.3. Tables that were 
finally generated consisted of the number of T-stripped sequences. Since we wanted 
to determine the number of uridylyls added or deleted during the editing process as 
well as define the type of editing sites captured by 5’ linker at a particular position in 
the sequence, we first had to align reads from RT-PCR to a sequence without T 
reads. Read data was separated into category 1 and 2 (Ion Torrent analysis) or A and 
B (MiSeq), depending on how they were processed (see Figure 3.3 for more details). 
Ion Torrent category 1 and 2 data were analysed separately for analysis of percentage 
of editing type at each nucleotide site, and the former was used to map the true 5’ 
ends of the transcripts captured by RNA linker. Since paired end data was retrieved 
from MiSeq analysis both categories A and B were combined where applicable for 
mapping the 5’ ends of transcripts and for determining the percentage of editing at 
each nucleotide site. 
Firstly, the number of sequences pertaining to the position of the 5' linker (i.e. 
the most 5' end) for category 1 were mapped. Secondly, the average number of 
uridylyls added before the position on the T-stripped ND7 sequence was plotted. 
These graphs were constructed using Graphpad Prism (version 6). Finally, the 
percentages of unedited, partially edited and correctly edited sequences were 
calculated for each position of the stretch of ND7 sequence in excel. From this data 
graphs were plotted using R. 
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3.2.13 Quantitative real-time PCR (Q-PCR) to ascertain RT 
efficiency of amplification in +REL1 and -REL1 samples 
RT cDNA products (made as described in Sections 3.2.2 - 3.2.5) were subjected to a 
1/10 dilution, before setting up 25 µl PCR reaction with 15 µl SYBR® green 
(Applied Biosciences) and 2.5 µl cDNA mix and 12.5 µl  of a 1.5 mM β-tubulin 
primer mix (F’-TTCCGCACCCTGAAACTG, R’-TGACGCCGGACACAACAG). 
Reactions +REL1/+RT, +REL1/-RT, -REL1/+RT and –REL1/-RT were set up in 
triplicate alongside a cDNA control amplified using an 18S primer mix (F’- 
CGGAATGGCACCACAAGAC, R’- TGGTAAAGTTCCCCGTGTTGA) to 
determine is the Q-PCR reaction worked as efficiently. Reactions were subjected to 
the following thermal conditions: 50ºC 120 s followed by 95ºC 10 minutes, followed 
by 40 cycles of 95ºC 15 s and 60ºC 60 s on an ABI prism PCR machine.  ΔΔCT was 
calculated for +REL1 and -REL1 RT from samples run in triplicate, using 
StepOnePlus Real-time PCR system software. 
Chapter 3 
  114 
 
3.3. Bioinformatics workflow to sort sequences 
Ion Torrent sequencing reads were filtered for the presence of the 5’ linker (Category 
1, Cat 1) or reverse primer only (Cat 2), which were analysed separately. Category 1 
reads were used for 5' end mapping and both Category 1 and 2 were used to visualise 
percentage editing type at each nucleotide site. MiSeq produced paired end reads that 
either spanned the entirety of transcripts individually (Cat A) or could be joined to 
produce full-length sequences (Cat B). Category A and B reads were either analysed 
together, or category A only reads were analysed and were used to devise graphs for 
5' end mapping and to visualise percentage editing type at each nucleotide site. 
Here is also indicated the programs used to write corresponding part of the pipeline, 
and a brief description of what each pipeline step entailed. 
The work flow was devised by Al Ivens (CIIE) 
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3.3 Results 
3.3.1 Analysis of RNA for sequencing  
Briefly, cells were grown to logarithmic 50 ml cultures in the presence of 
tetracycline, before washing tetracycline from the media and using 1 × 104 cells to 
inoculate 500 ml  HMI-9 media containing 10% (v/v) FCS and selective drugs (2.5 
μg/ml G418, 5 μg/ml hygromycin, 2.5 μg/ml phleomycin and 1 μg/ml tetracycline). 
500 ml cultures were grown in the absence or presence of tetracycline for 48 hours 
before cells were harvested and used for RNA extraction. A small culture flask of 
cells was kept to ensure cells died off as expected in the absence of REL1. No live 
cells were seen microscopically after 6 days.  
The Northern blot (Figure 3.4, A) shows the enrichment of mRNA transcripts 
exemplified by actin after poly(A)+ selection. The Western blot (Figure 3.4, B) 
reveals strong knock-down of REL1 (in the absence of tetracycline) after 48 hours, 
due to the absence of the ectopically expressed protein at 50 kDa. 
The quality of the poly(A)+ RNA was assessed by Agilent chip. The traces 
(shown overleaf in Figure 3.4, C-F) show great reduction in the amount of ribosomal 
RNA in the poly(A)+ samples. This can be seen from the loss of the three peaks 
pertaining to rRNA (Figure 3.4 C and D) the Agilent chip trace in the range between 
200 and 4000 nucleotides. Agilent chip analysis suggested total RNA was not badly 
degraded from the smooth baselines to the left of the ribosomal peaks, indicated on 
the traces. A peak around 100 bp perhaps indicates a corresponding increase in SSU 
RNAs and tRNAs. 
The same biological replicate of RNA was used for all sequencing reactions. 
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Figure 3.4. Northern blot and Agilent chip analysis for the RNA used in limited and 
Ion Torrent sequencing  
A) 1 µg total RNA was run alongside an equivalent 300 ng poly (A)+ selected RNA 
and analysed by Northern blot. The increased signal from the actin probe confirms 
enrichment of mRNA transcripts. B) Western blot using 1000 α-REL1 and 1/2000 α- 
mouse antibodies indicates that REL1 protein is absent after 48 hours. C-F) Agilent 
electropherographs clearly show the diminution of rRNA specific peaks from total 
RNA (C and D) after two rounds of poly (A)+ selection (E and F). 
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Figure 3.5. ND7 and RPS12 primers used in sequencing strategy 
Above is indicated where primers P2 (5’-GTACCACGATGCAAATAAC), P3 (5’-
CGGAAGACATTGTTCTACAC), P4 (5’- AAAAACATATCTTATATCTAAA) 
and P5 (5’ CTAATACACTTTTGATAACAAAC) anneal on ND7 and RPS12 
transcripts. 
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Figure 3.6. ND7 and RPS12 RT-PCRs visualised on a 2% agarose gel 
A and B) E, PE and U indicate fully edited, partially edited and unedited (bar 1st 
editing site) transcripts of RPS12 respectively. Areas of ND7 and RPS12 picked up 
by specific primer are indicated in Figure 3.5. %’ refers to a forward primer based on 
the 5’ RNA linker. In the case of ND7, the reverse primer either selected for editing 
at the first two sites (P2) or there was no bias in the stage of editing in the transcript 
(P3). For RPS12 the reverse primer used (P4) contains the first editing site and hence 
selected for transcripts undergoing editing. Smaller fragments of interest are 
indicated with an X and may represent products of endonucleolytic cleavage which 
have not been relegated by REL1.  
C and D) Red rectangles indicate bands which were excised, cloned and sent for 
Sanger big dye reaction sequencing. All manually aligned transcripts can be found in 
Appendix 3 All small fragments of interest are listed in Table 3.1.  
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3.3.2 Shallow sequencing: effect of REL1 ablation on ND7 
and RPS12 mRNAs 
PCR products obtained from Section 3.2.5 were resolved on a 0.8% agarose gel (see 
Figure 3.6). Bands produced a similar pattern to those in Schnaufer et al., 2001, 
indicating the presence of partially, fully and unedited transcripts (as indicated by 
PE, FE, UE). Bands enclosed with a rectangle (right panel) were excised, gel 
purified, cloned into pGEM®-T Easy and sequenced. The full length sequence data, 
for sequences cloned from +REL1 and –REL1 RT-PCR products are shown in 
Appendix 3. Fragments of interest in the -REL1 samples are collated alongside those 
of RPS12 in Table 3.1. 
From these sequences it can be seen that editing occurs generally from a 3’ to 
5’ direction, although this was not exact (as demonstrated previously Decker and 
Sollner-Webb, 1990; Koslowsky et al., 1991). Regardless of the presence or absence 
of REL1, sequences revealed extraneous uridylyls along the length of the sequence, 
even at non-editing sites. Within the ND7 edited region, linker ligation at deletion, 
addition and non-canonical editing sites was detected. The same substrates were 
detected up to three times. Within the RPS12 edited region only one example of a 
deletion editing event was detected, in comparison to eight misediting events. No 
examples of addition editing substrates were found on ablation of REL1, however, 
the 5’ linker was found at insertion sites, where addition editing had already 
occurred. Of the fragments (see Table 3.1), there were three examples of sequence 
mutation within the ND7 and one example for RPS12. In the presence of REL1 
(Appendix 3) the 18 ND7 cloned transcripts revealed two examples of correctly, 
fully edited sequences and 16 examples of partially, or misedited sequences.  
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Table 3.1. 5’ linked RNA fragments from ND7 and RPS12 specific RT-PCRs 
on RNA from cells grown in the absence of REL1 
ND7 DNA TA   A   G      ATTTA   TTG   A  TG    A   A  ATTTGTG   A 




Deletion                   -UA   UUG   A uUG   uA uuA uA   G G uuA  ×1 




                   -A   UUG  uA   G   uA   G  A   G G uuA  ×1            
                        -UG uuA  ..    AuuuAuuA UAG G uuA  ×1 
                             -A uUG   uA uuA uA   G G uuA  ×1 
                                        -uuA uA   G G uuA  ×2 
                                         -uAuuA  UG GGuuA  ×1 
                                         -uA uA   G G uuA  ×1 
Insertion 
DNA C A  C C C G  TTTC A   G   C  A  C    A     G     TTG   G       
RNA C A uC C C G     C A   G   C  A  C    A    uG       G  uG   
Mis           -G     C A  uG   C  A  C    A    uG       G  uG  ×1 
                      -G   C  A  C    A    uG       G  uG  ×1 
                                                  -UG  uG  ×1 
RPS12 DNA TGTTTTG   GTT  A A  A  G A  A   A  CA TCGTTTA  G AAG  AGA 
RNA  G    G  uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA 
Editing 
type 
Deletion  -G  UUG   GUU uAuA uA  GuA uA uuA  CA  CG  UAuuGuAAGuuAGA  ×1 
Mis         -ACUC uAuA uA  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA  ×1 
                                  -CA  CG  UAuuGuAAGuuAGA  ×1 
        -uG U  A A  A  GuA uA  uA  CA  CG  UAuuGuAAGuuAGA  ×1 
        -uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA  ×1 
                          -uAuuuA  CA  CG  UAuuGuAAGuuAGA  ×1 
                              -uA  CA  CG  UAuuGuAAGuuAGA  ×2 
                          -uGuuuA  CA  CG  UAuuGuAAGuuAGA  ×1 
Insertion 
 
Sequences were grouped into endonucleolytic products at deletion, addition and non-
canonical editing sites and aligned against DNA and edited RNA sequences. No 
addition editing events were observed. Dashes indicate 5’ linker position. Correctly 
and incorrectly inserted uridylyl bases (Us) are highlighted in blue and red 
respectively. Underlined bases indicate areas where deletion editing should occur and 
bases highlighted in purple indicate unexpected non-U residues. The frequencies that 
the transcripts were encountered at are shown on the right. 
Sequences with 5’ linkers attached addition sites had unexpected Us between linker 
and mRNA. Full length sequences can be seen in Appendix 3. 
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Interestingly, extra uridylyls (indicated in red) were clustered more tightly around the 
5th and 6th deletion editing site (from the 3’ end). For RPS12, no examples of 
correctly and fully edited sequences were found, in the six cloned examples, even 
though all had entered the editing process. 
The obvious differences between the sequences obtained from +REL1 and –
REL1 samples is the lengths of the transcripts obtained (See Appendix 3) and the 
state of editing that they were in. All +REL1 transcripts cloned and sequenced 
contained the most 5’ and 3’ end of ND7 and RPS12 at various states of editing. Full 
length –REL1 derived sequences remained unedited. The fragments presented in 
Table 3.1 were mostly at editing sites, although did not reflect cases of expected 
insertion editing substrates at addition sites and it was apparent that uridylyls were 
added and the transcript was cleaved subsequently in a misediting event. 
 
3.3.3 Deep sequencing analysis of REL1 substrates through 
Ion Torrent TM sequencing 
Shallow sequencing revealed an interesting accumulation of unligated editing 
intermediates in the absence of REL1 produced by cleavage at non-canonical sites 
(misediting) and deletion sites. However, this approach provided a limited number of 
examples of editing events governed by REL1, so deep sequencing approaches were 
pursued to obtain a clearer picture. Cleaned RT-PCR products were visualised on a 
0.8% agarose gel (Figure 3.7 A) revealing fully, partially and unedited transcripts 
(labelled E, PE, U and X respectively). RT-PCR products for +REL1 and –REL1 
samples were cleaned up further after library prep to remove unincorporated adapters 
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(see Agilent electropherographs, Figure 3.7 B). Agilent traces here reveal a 
population of smaller transcripts on both samples under 100 bp. These peaks may 
correspond to the adapter and 5’ linker. Transcripts totalling more than 100 bp were 
more abundant in –REL1 samples in comparison to +REL1 samples, indicative of 
smaller fragmented transcripts. Transcripts above 150 bp were diminished in the –
REL1 sample, indicating a reduction of partially and fully edited ND7. Two separate 
runs of Ion Torrent were performed on each sample. The sequencing read outs for 
ND7 specific samples after two separate runs are tabulated in (Appendix 4). 
The adapter trimmed reads were analysed from FASTQ files using the 
pipeline in Figure 3.3. Data tables produced from this are collated in Appendix 5. 
The positions of the most 5' ends of these substrates were graphically represented 
(Figure 3.9) and as was the percentage of unedited, correctly edited and misedited 
sequence at each ND7 position , separately for Category 1 and 2 reads (Figures 3.10 
and 3.11).  
Q-PCR results (Figure 3.8) indicated that the -REL1 sample was more 
efficiently reverse transcribed than the +REL1 sample, which was reflected in the 
ΔΔCt of 3.338, which was calculated using the difference of Ct between these two 
samples. Samples were run alongside an 18S positive control to check the overall Q-
PCR performance, since this RT sample (from RNA of wt 427 cells with γ 
replacement, amplified with random hexamers) and primer set (5’- 
CGGAATGGCACCACAAGAC, 5’- TGGTAAAGTTCCCCGTGTTGA) gave good 
results previously (provided by Caroline Dewar). Results also indicate that β-tubulin 
was specifically amplified, and so the ΔΔCt was used to adjust the number of read 
starts in Figure 3.9 and later on in Figure 3.13. 
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Figure 3.7. ND71 RT-PCR products for Ion Torrent sequencing 
A) Gel visualisation of cleaned ND71 RT-PCR products. +T and –T correspond to 
cells growth in the presence and absence of REL1 respectively. E, PE and U indicate 
fully edited, partially edited and unedited transcripts, respectively. X corresponds to 
unligated fragments in the –T sample. 
D) Agilent electropherographs for the corresponding gel in B. L - Ladder, +TND71 - 
+tet ND71 RT-PCR, -T ND71 - -tet ND71 RT-PCR. Repeats were run in duplicate 
(above and below) [bp] corresponds to transcript size in base pairs. 
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Figure 3.8. Q-PCR of +REL1 and -REL1 RT samples 
A) Amplification curve of β-tubulin, complete with the 18S cDNA control (RNA 
from single marker cells, with wild type replacement gamma, reverse transcribed 
with random hexamers) for Q-PCR efficiency. The ΔΔCt for the +RT samples was 
calculated using the threshold line, intended to capture the reaction in logarithmic 
phase, indicated by a blue dashed line B) Melt curves for β-tubulin primers, which 
overlap as expected when a single product is amplified. C) Gel visualisation of Q-
PCR after 40 cycles also indicates the presence of a specific band for β-tubulin.  Q-




Figure 3.9. Marking the 5’ ends of transcripts (5’ linker/ND7P3 RT-PCR) from cells with REL1 induced/uninduced 
The position of the 5’ linker indicates the start of the sequenced transcripts in Category 1 reads. The number of starts (adjusted to the ΔΔCt derived from Q-PCR 
results) was plotted against a T-stripped ND7 sequence. Starts had a heterogenous number of Us, expressed as percentages of the total within call-outs, for the 
peaks indicated. Black Line and numbering: +REL1 (+tet growth), grey line and numbering: -REL1 (-tet growth). The T- stripped sequence is given below. 
Underlined and bold/italic nucleotides refer to nucleotides immediately downstream of deletion and addition editing sites respectively.  
Sites are marked as addition (A), deletion (D) or misediting (i.e. non canonical-editing sites) (M) editing sites and the relative position along the sequence is 
indicated. For the complete sequence, pre- and post-editing, see Figure 3.5. 
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The graph illustrating the 5’ end of the ND7 transcripts retrieved from Ion 
Torrent sequencing (Figure 3.9) highlights the most prominent peaks (corresponding 
to read start position) in +REL1 and –REL1 samples. These peaks relate to the 5’ 
ends after processing of the polycistronic pre-cursor and a total of four deletion sites, 
three addition sites and two misediting sites. The highest peaks coincide with the 
previously reported 5’ end (Koslowsky et al., 1990) and with the next two nucleotide 
positions downstream on the T-stripped sequence after for both the +REL1 and –
REL1 samples.  Although, it was clear that the 5’ ends of ND7 were heterogenous 
from the linking at the first three nucleotide positions, the fact that we were able to 
map the most 5’ site validates the sequencing approach and suggests that published 
results suggesting 5’ homogeneity. The addition editing sites that have been flagged 
for both +REL1 and -REL1 samples contain adjacent deletion editing sites. The most 
common attachment sites for –REL1 are the deletion sites at positions 84, 91 and 92 
(157, 172 and 173 on edited sequence, Figure 3.5) and the addition sites at positions 
88, 89 and 93 (positions 165, 168 and 175 on edited sequence, Figure 3.5). For the 
+REL1 sample, the most common 5’ attachment sites are the misediting site at 
position 112 and the addition sites at 88 and 93. In the absence of REL1 the 
percentage of expected addition editing sites linked markedly decreased. At positions 
88 and 93 the greatest percentage of 5’ linked sites were directly at the A bases, the 
expected site of attachment for a product of endonucleolytic cleavage destined for 
uridylyl addition. However, in the absence of REL1 at sites 88, 89 and 93 the 
greatest percentage of linked sequences contain one or two extra uridylyls, indicative 
of potential miscleavage events occurring after addition editing. In the absence of 
REL1, deletion sites at positions 67, 84, 89 and 92 the greatest percentage of linked 
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transcripts represented transcripts that had been cleaved ready for deletion editing 
(i.e. they contained the expected pre-edited number of uridylyls) or had the expected 
number of uridylyls removed from deletion editing. It should also be noted that the 
RT-PCR product responsible for the peak produced at position 112 (edited position 
205, Figure 3.5) could not be identified on the gel as a physical product (Figure 3.7) 
and was treated as a technical anomaly of the sequencing process.  
Figures 3.10 and 3.11 illustrate that Category 1 and 2 reads produce similar 
graphs. There are a number of unexpected uridylyl bases present within the first ten 
(Category 1) and 20 (Category 2) nucleotides of the 5’ end of the T-stripped ND7 
sequence, and these are likely to reflect the heterogeneity of the ND7 5’ end. 
Misediting occurs throughout the entirety of the transcript, and can make up to 10% 
of the total editing events. It is of importance to note that on the percentage editing 
graphs dark grey bars correspond to editing at a non-editing site or the wrong number 
of uridylyls added at an editing site. The extent of correctly edited sequence within 
the editing blocks (areas of near consecutive editing) for Category 1 and 2 sets 
decreased from 3’ to 5’. For –REL1 Category 1 data, correct editing events per site 
decreases from 3' to 5' at a greater rate than with REL1, and there are fewer correctly 
edited sites upstream from site 66 (T-stripped sequence).  Since Category 1 data 
originated from the most 5’ end (containing the 5’linker) and spanned the length of 
the transcript to the 3’ end it may be more reliable for interpretation than Category 2 
data. Category 2 reads follow a similar pattern to that of Category 1, however the 
percentage of misedited and correctly, fully edited transcripts in the absence of REL1 
is diminished overall in comparison. This reduction of correctly edited sequence may 




Figure 3.10. Percentage of each type of editing, Category 1 reads for 5’ linker/ND7P3 RT-PCR 
Percentages of editing were calculated from total reads and from the number of reads involved in observed and expected editing events. White – non-edited at non-
editing site, light grey - non-edited at editing site, dark grey – edited at non-edited site/misedited, black – fully/correctly edited at editing site. The T- stripped 




Figure 3.11. Percentage of each type of editing, Category 2 reads for 5’ linker/ND7P3 RT-PCR 
Percentages of editing were calculated from total reads and from the number of reads involved in observed and expected editing events. White – non-edited at non-
editing site, light grey - non-edited at editing site, dark grey – edited at non-edited site/misedited, black – fully/correctly edited at editing site. 
The T- stripped sequence is aligned below. Underlined and bold/italic nucleotides refer to deletion and addition editing sites respectively.  
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are more apparent in the –REL1 sample.  
 
3.3.4 Deep sequencing analysis of REL1 substrates through 
MiSeqTM sequencing 
The sequences used in this analysis (tabulated in Appendix 6) were first subjected to 
the same pipeline as outlined in Figure 3.3. The MiSeq data was based upon RT-
PCRs that selected for editing intermediates only (i.e ES1 for RPS12 and ES1 ND7) 
and therefore all sequences linked and analysed had entered into the RNA editing 
reaction. Due to the short length of the ND7 sequences there were no separate A and 
B Categories, as reads covered the whole length of the sequences from the most 5’ 
end, to the reverse primer.  Before sending to the Genepool for MiSeq analysis, 
cleaned RT-PCR products were visualised on a gel (below in Figure 3.12). 
 
Figure 3.12. RT-PCR product for MiSeq 
The RT-PCR product was generated using primers that selected for ND7 and RPS12 
editing intermediates, and no non-edited transcripts. +T and –T correspond to cells 
growth in the presence and absence of REL1 respectively. E, PE and U X indicate 
fully edited sequence, partially edited sequence and un-edited sequence and unligated 
fragments, respectively.  
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The analysis of 5’ read starts (Figure 3.13) reveals the accumulation of 5' 
linked transcripts at deletion editing positions 67, 84 and 91 (positions 110, 157 and 
172 on edited sequence, see Figure 3.5), which also correspond to some of the most 
prominent peaks in the Ion Torrent data for this transcript in the absence of REL1.  
Position 91 produced the highest peak, corresponding to editing site 2, the first 
deletion editing site. This indicates that the greatest number of small fragments 
accumulated in the absence of REL1 corresponds to this editing site, and of these 
fragments over 90% of transcripts have not had the uridylyl removed by the 
ExoUase. The first three most 5’ bases are the most commonly linked, and these full 
length transcripts are more abundant in the presence of REL1, indicating full length 
transcripts at various stages of editing.  This echoes the results of the Ion Torrent 
sequencing and indicates that both deletion editing and misediting products are 
substrates for ligation by REL1. To determine whether more peaks could be 
visualised, the percentage of 5’ starts of the total reads were calculated and used to 
construct Figure 3.14. This method yielded a greater number of peaks and showed a 
clearer difference between + and – REL1 samples, which may have been occluded 
by adjusting for RT-PCR efficiency. As expected, the peaks pertain to the first three 
bases and deletion editing sites 67, 84 and 91 (positions 110, 157 and 172 on edited 
sequence, see Figure 3.5). Peaks were also apparent at positions 69 (addition editing 
site, position 117 edited sequence) and 74 (addition editing site, position 131 edited 
sequence) which are not apparent from the Ion Torrent data. At position 74, 65.52% 
and 96.91% of linked reads could be assigned to a fragment containing one terminal 
uridylyl, for +REL1 and –REL1 samples, respectively, indicative of potential 
miscleavage events occurring after addition editing.  
 
   
 
Figure 3.13. Marking the 5’ ends of transcripts (5’ linker/ND72 RT-PCR) from cells with REL1 induced/uninduced 
The position of the 5’ linker indicates the start of the sequenced transcripts in Category 1 reads. The number of starts (adjusted to the ΔΔCt derived from Q-PCR 
results) was plotted against a T-stripped ND7 sequence. Starts had a heterogenous number of Us, expressed as percentages of the total within call-outs, for the 
peaks indicated. Black Line and numbering: +REL1 (+tet growth), grey line and numbering: -REL1 (-tet growth). The T- stripped sequence is given below. 
Underlined and bold/italic nucleotides refer to nucleotides immediately downstream of deletion and addition editing sites respectively.  
Sites are marked as addition (A), deletion (D) or misediting (i.e. non canonical-editing sites) (M) editing sites and the relative position along the sequence is 
indicated. For the complete sequence, pre- and post-editing, see Figure 3.5. 
 
   
 
Figure 3.14. Percentage of 5’ ends of transcripts (5’ linker/ND7P2 RT-PCR) from cells with REL1 induced/uninduced 
The position of the 5’ linker indicates the start of the sequenced transcripts in Category 1 reads. The number of percentage starts of the total reads was calculated 
and plotted against a T-stripped ND7 sequence. Starts had a heterogenous number of Us, expressed as percentages of the total within call outs, which correspond to 
designated peaks. Black line and numbering: +REL1 (+tet growth), grey line and numbering: -REL1 (-tet growth).The T-stripped sequence is aligned below. 
Underlined and bold/italic nucleotides refer to deletion and addition editing sites respectively.  
Sites are marked as addition (A), deletion (D) or incorrect (M) editing sites and the relative position along the sequence is indicated. 
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Position 69, in the +REL1 sample, was linked via a highly variable number of 
uridylyls, whereas in the absence of REL1, 84.79% of 5’ linked transcripts contained 
a single terminal uridylyl. 
Analysis of the percentage editing of ND7 from MiSeq sequencing (Figure 
3.15) revealed misediting events fluctuating between 0% and 30% at sites throughout 
the rest of the length of the transcript. The most 5’ end reveals heterogeneity in the 
number of Ts present in the stretch of never-edited sequence, as previous described 
from Ion Torrent data. The percentage of total fully and partially edited sequence 
fluctuates between 100% (due to the primer selecting for transcripts that have already 
entered the editing process) and 10% at each position from the most 3’ and 5’ editing 
site of the edited region.  The rate of decline is reduced for 3’ to 5’ in the presence of 
REL1, in comparison to the absence of REL1, as seen for the Category 1 Ion Torrent 
sequencing data, which may indicate editing bottle necks.  
RPS12 transcripts were also analysed by MiSeq sequencing. Since no 
discernable 5’ linked peaks from +REL1 or –REL1 samples could be visualised 
using the Q-PCR adjusted  starts (save the most 5’ end), a graph was constructed for 
the percentage of 5’ starts within the total reads (Figure 3.16). This method of 
visualisation revealed heterogenous 5’ linking of transcripts at the most 5’ positions, 
as with ND7. The other sites that were linked were at positions 131 (misedited, 
position 164 of edited sequence, Figure 3.5), 132 (deletion editing site, position 168 
edited sequence), 140 (addition editing site, position 182 edited sequence), 141 and 
143 (addition editing sites at positions 183 and 185 edited sequence), and 145 




Figure 3.15. Percentage of each type of editing for 5’ linker/ND7P2 RT-PCR 
Percentages of editing were calculated from total reads and from the number of reads involved in observed and expected editing events. White – non-
edited at non-editing site, light grey - non-edited at editing site, dark grey – edited at non-edited site/misedited, black – fully/correctly edited at editing 
site. 




Figure 3.16. Percentage of 5’ ends of transcripts (5’ linker/RPS12 RT-PCR) from cells with REL1 induced/uninduced 
The position of the 5’ linker indicates the start of the sequenced transcripts in Category 1 reads. The number of percentage starts of the total reads was 
calculated and plotted against a T-stripped ND7 sequence. Starts had a heterogenous number of Us, expressed as percentages of the total within call 
outs, which correspond to designated peaks. Black line and numbering: +REL1 (+tet growth), grey line and numbering: -REL1 (-tet growth).The T-
stripped sequence is aligned below. Underlined and bold/italic nucleotides refer to deletion and addition editing sites respectively.  
Sites are marked as addition (A), deletion (D) or incorrect (M) editing sites and the relative position along the sequence is indicated. 
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Linked transcripts at position 132 were representative of deletion editing 
substrates, with the greatest percentage of +REL1 and –REL1 derived transcripts 
having a terminal G-base. Misedited sites were products of mis-directed 
endonucleolytic cleavage, and contained either an expected non-edited uridylyl 
(position 131) or no terminal uridylyl (position 145). Transcripts linked at addition 
editing site 140 in the presence and absence of REL1 could be attributed to 
production of true addition editing substrates lacking a terminal uridylyl (43.44% and 
25.02%, respectively) and of miscleaved substrates (39.34% and 65.85%, for +REL1 
and –REL1 samples, respectively). The addition editing site linked, at position 141, 
revealed two thirds of +REL1 and –REL1 derived transcripts that contained a single 
terminal uridylyl, suggestive of miscleavage events occurring after addition editing. 
Contrary to this, 98.91% of transcript fragments produced in the absence of REL1 at 
position 142 could be considered addition editing substrates, since they contained no 
terminal uridylyl. 
Figure 3.17 illustrates the percentage of editing type for RPS12 along the 
transcript. In the presence of REL1, fully edited transcripts decrease from 100% at 
the most 3’ end to less than 5% at the most 5’ editing site. This decrease is more 
gradual than with ND7. Misediting events at editing and non-editing sites does not 
exceed 25%, save at the most 5’ site, which may be indicative of a heterogenous 5’ 
end. In the absence of REL1 the presence of fully edited sites is drastically reduced 
below 5% throughout the length of the transcript, and examples of misediting 
increase proportionally from 5% (at most 5’ editing site) to 100% (most 3’ editing 
site). This clearly indicates that the absence of REL1 abolishes normal RNA editing 





Figure 3.17. Percentage of each type of editing for RPS12 
Percentages of editing were calculated from total reads and from the number of reads involved in observed and expected editing events. White – non-edited at non-
editing site, light grey - non-edited at editing site, dark grey – edited at non-edited site/misedited, black – fully/correctly edited at editing site. 
The T- stripped sequence is aligned below. Underlined and bold/italic nucleotides refer to deletion and addition editing sites respectively.  
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3.4 Discussion 
This study has indicated potential substrates for REL1 ligation throughout ND7 and 
RPS12 using a novel sequencing approach. Full length fully, partially and unedited 
5’ linked transcripts could be cloned and sequenced in the presence of REL1. 
However, shallow sequencing of 5’ linked transcripts revealed shorter fragments, 
which had failed to be re-ligated by REL1. These fragments represented substrates of 
typical deletion and erroneous, and unexpected addition, editing events. However, it 
was clear that the 5’ linker attached to addition editing sites, albeit not to typical 
substrates of addition editing, but rather to products of unexpected endonucleolytic 
cleavage. Of these misedited products, most started with one or two uridylyl 
residues, indicating that addition editing has occurred and the transcripts later had 
been cleaved by an endonuclease. Interestingly, there were no examples of 5’ linked 
transcripts indicative of true insertion editing. But, since only few sequences were 
available from limited cloning to describe this finding, deeper sequencing was 
undertaken. The cloned sequences reflect the gel patterns obtained from RT-PCR 
(also previously observed by Schnaufer et al., 2001) and clearly indicate that REL1 
ablation causes a reduction in fully edited mRNA populations to those of unedited or 
partially edited ones. 
The ND7 RT-PCR samples sent for Ion Torrent and MiSeq revealed the same 
5’ linked deletion editing sites at positions 67, 84 and 91 in the absence of REL1. 
The 5’ linker in this sample also adhered to addition editing sites (differing in 
position for Ion Torrent and MiSeq sequencing results), but few examples of 
expected addition editing products could be found at these sites, in comparison to 
products with terminal uridylyls. A key difference between the two RT-PCR samples 
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generated for Ion Torrent and MiSeq was the selection for transcripts that have 
entered into the editing cycle only in the latter sample. This was reflected by the 
greater percentage of overall correctly and fully edited sequences at the most 3’ end 
of ND7 in both +REL1 and –REL1 samples. 
The RPS12 RT-PCR samples sent for MiSeq analysis did not reveal any 
particular peaks relating to REL1 substrates when starts were initially analysed, even 
though clear bands corresponding to fully, partially and unedited transcripts were 
observed on the agarose gel. However, it was obvious that the preferred attachment 
site of the 5' linker was the previously reported 5' end of the transcript for +REL1 
(Read et al., 1992). To gain further insight into the sites of 5’ linkage, the percentage 
of read starts of the total number of reads obtained was plotted, which revealed 
further addition and non-editing sites. The results here suggest that, whilst a small 
percentage of 5' ends reflect true, or expected, products of addition editing, most are 
indicative of deletion editing and misediting (or miscleavage) events. 
Consistently, between all three separate runs of sequencing, the percentage of 
expected addition substrates at editing site positions was greater in the +REL1, in 
comparison to the –REL1 samples. This may be indicative of dual function of REL1 
and REL2, since REL1 had not re-ligated these addition editing substrates. A number 
of previous studies have suggested that REL1 and REL2 have distinct, but not 
mutually exclusive functions in editing (Huang et al., 2001; Schnaufer et al., 2001; 
Drozdz et al., 2002; Schnaufer et al., 2003; Gao and Simpson, 2003). Whilst this 
suggests distinct functions of the ligases in deletion and addition editing, 
respectively, it also suggests that the essentiality of REL1 is linked to its function in 
ligating erroneously cleaved transcripts (Huang et al., 2001).  
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Misediting, or erroneous cleavage of RNA substrates happens frequently in 
vitro (Kable et al., 1996; S D Seiwert et al., 1996; Rusché et al., 1997). It has 
previously been suggested that REL1 may have had a key role as an RNA repair 
enzyme, as its closest relative is T4Rnl2, and may be involved in the repair of 
erroneously cleaved substrates born of misguiding by the incorrect gRNA 
(Koslowsky et al., 1991; Huang et al., 2001; Ho and Shuman, 2002; Palazzo et al., 
2003; Yin et al., 2003; Ho et al., 2004; Nandakumar et al., 2004; Deng et al., 2004). 
These fragments are not re-ligated by REL2 in this scenario, since endogenous REL2 
is present in the REL1 cKO cell lines. This is likely due to the substrate requirements 
of REL2, since this ligase requires a perfectly nicked duplex produce from addition 
editing directed cleavage and cannot ligate overhangs like REL1 (Blanc et al., 1999; 
Igo et al., 2000; Schnaufer et al., 2001; Cruz-Reyes et al., 2002; Palazzo et al., 
2003). This study provides evidence of this, through the identification of unligated 
RNA substrates. This curious observation is frequently linked to the presence of 
additional uridylyls at an addition editing site that may suggest endonucleolytic 
cleavage occurred after the addition editing event, and as a result the transcript was 
cleaved erroneously. It cannot be ruled out that these observed bases are due to the in 
vivo formation of gRNA-mRNA chimeras through the action of an endonuclease and 
subsequently a ligase, or through transesterification (Blum et al., 1991; Rusché et al., 
1995).  However, it was previously observed that this chimera formation was 
decreased in conditions that also decreased ligase activity, it would be expected that 
such instances would decrease in the absence of REL1, and this is not shown here 
(Rusché et al., 1995). These chimeras formed of truncated mRNAs and gRNAs 
would be a dead end process formed of RNA editing, and would initiate some form 
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of editing block (Sturm and Simpson, 1990b).  It is known that addition uridylyls are 
added to an editing transcript by a TUTase, before potential excision by a 3’ exoUase 
(Byrne et al., 1996; McManus et al., 2000; Igo Jr. et al., 2002; Zhelonkina et al., 
2006). Additional uridylyls present at deletion editing sites may be a product of 
multi-cycle RNA editing and reflect the addition of extra uridylyls by a TUTase, 
independent of gRNA interaction (Feagin, Abraham, et al., 1988; Alatortsev et al., 
2008) 
Taken together, results of limited, Ion Torrent and MiSeq sequencing reveal 
that the most frequently linked sequences, for both +REL1 and –REL1 samples, (as 
indicated by the number of read starts) correspond to the first three nucleotides 
starting from the 5’ end of ND7. This may reflect a naturally occurring "micro" 
heterogeneity of the 5’ end, which has not been described before in ND7 (Koslowsky 
et al., 1990), but has been described before in cloned DNA sequences from CR6 
(RPS12) (Read et al., 1992b). This linkage does not provide information on the 
editing state that these transcripts are in, however, which would differ greatly 
between +REL1 and –REL1 samples, taking into consideration the results of shallow 
sequencing (see Appendix 3). It is clear from the ND7 data that there is an 
accumulation of transcript fragments starting at editing sites 1 (position 91), 2 
(position 84) and 3 (position 67) after REL1 ablation, which may suggest REL1 has a 
preference for these deletion editing substrates, over the products of misediting and 
addition editing. The same cannot be said for RPS12 in the absence of REL1, since 
the favoured sites for 5’ linking were at addition editing sites, and contained a mix of 
expected addition editing substrates and potential products of miscleavage. This, 
together with the percentage editing graph, indicates that REL1 has an important role 
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in the processing of miscleaved mRNAs and perhaps have a more active role in re-
ligation of addition editing products in RPS12. 
The most unexpected peaks were those seen in +REL1 which were most 
apparent in the MiSeq data. These peaks were omitted from the ND7 5' linked graph 
generated (due to peak intensity), but shown for RPS12 (Figure 3.16) as a peak at 
position 141. These peaks were probably not genuine, however, as they could not be 
correlated with bands on the gel. Studies have ascertained that the greatest biases 
have been introduced by the addition of 5’ and 3’ adapters to the transcripts, through 
the preferences of T4 RNA ligases to certain substrates and the secondary and 
tertiary structure of the RNAs sequenced (Amitsur et al., 1987; Hafner et al., 2011; 
Jayaprakash et al., 2011). This is important to note since it could have introduced 
linking biases, and given rise to unexplained peaks in the sequence data, although the 
reasons behind this discrepancy between +REL1 and –REL1 samples is unknown.   
The percentage editing graphs illustrate a general 3’ to 5’ progression of 
editing, which has previously been reported in the literature. Prior studies have 
revealed the most abundant mRNAs in the population were partially edited 
transcripts (Abraham et al., 1988; Decker and Sollner-Webb, 1990; Sturm et al., 
1992). Sequencing also revealed apparent junctions between these blocks of editing, 
suggesting that editing does not strictly occur from 3’ to 5’, with unexpected gRNAs 
often found along the stretch of pre-mRNAs (Feagin, Abraham, et al., 1988; Decker 
and Sollner-Webb, 1990; Koslowsky et al., 1990; Sturm and Simpson, 1990a; Sturm 
and Simpson, 1990b; Koslowsky et al., 1991; Read, Corell, et al., 1992; Sturm et al., 
1992). However, the in-depth analysis of percentage type of editing at each site 
present here confirms that editing does progress generally in a 3' to 5' direction. This 
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3’ to 5’ editing efficiency (equated to the percentage of fully edited transcripts per T-
stripped nucleotide site), however, is diminished in the absence of REL1. REL1 
knock-down abolishes normal RNA editing in RPS12, and instead proportionally 
increases the number of misediting or miscleavage events, throughout the length of 
the transcript. The discrepancy between Category 1 and 2 Ion Torrent data has most 
likely arisen from the lower quality score of the Category 2 data, since these reads 
were compiled from short fragments of potentially overlapping sequence originated 
from the most 3’ end of the ND7 transcript. Category 1 Ion Torrent and MiSeq 
sequence analysis illustrates a sharper diminution of fully edited transcripts from 3’ 
to 5’ in the absence of REL1, in comparison to +REL1 samples. The effect of REL1 
knock-down on RNA editing was more pronounced for RPS12, although the reason 
for this is unclear, as both proteins would be required for the cells function and are 
preferentially edited in BSFs (Koslowsky et al., 1990; Read, et al., 1992b).  
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3.5 Conclusions and Outlook 
The main findings of this Chapter were (i) REL1 is involved in the ligation of 
products born of deletion editing, more frequently in misediting, and rarely in 
addition editing events, (ii) the 5’ ends of pan-edited transcripts exhibit 
heterogeneity, (iii) the efficiency of 3’ to 5’ editing is reduced, or diminished in the 
absence of REL1, (iv) the 5' monophosphate born from endonucleolytic cleavage can 
be used to capture REL1 substrates using an RNA linker, which provides a basis for 
the sequencing of ligation substrates. This study is the first deep sequencing analysis 
of RNA editing intermediates to date, and provides an interesting insight into REL1 
substrates. There however, remains much potential to expand on these results.  
For example, the material used to generate RT-PCR products used all three 
sequencing approaches was limited to a single biological replicate, due to time 
constraints. It would be important to future studies to repeat the approaches with 
RNA extracted from separate biological samples.   
To dissect the potential RNA repair function of REL1, a novel assay could be 
derived from existing addition and deletion editing assays (Igo Jr. et al., 2002). This 
method would utilise pre-cleaved mRNAs (representative of miscleaved substrates) 
bridged to gRNAs as the substrates of interest. 
Further to this it would be important to verify that the absence of REL1 
would not be causing any secondary defects to editing, by for example by 
destabilising other editosome components (Huang et al., 2001; Cruz-Reyes et al., 
2002). This has not been reported in other studies, however (Stuart et al., 2002). This 
potential influence could be tested by utilising RNA isolated from cell lines 
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expressing a catalytically dead REL1 in its stead (such as used by Huang et al., 
2001).  
Since results here indicate that REL1 is involved primarily in misediting and 
deletion editing, it would be interesting to ascertain if REL2 is involved solely in 
addition editing. This could be achieved by extracting poly(A)+ RNA from an 
available REL2 RNAi line (Huang et al., 2001; Schnaufer et al., 2001; Cruz-Reyes et 
al., 2002; O’Hearn et al., 2003). Since few instances of expected addition editing 
substrates were observed here, we would expect the editing fragments produced from 
REL2 knock-down to represent these specific ligation substrates. Further 
investigation here is required to validate our working hypothesis that REL2 may be 
functioning as a proofreading ligase, along side REL1 that ligates productions of 
deletion editing and erroneous cleavage.  
The scope of this PhD study only permitted the analysis of ND7 and RPS12 
transcripts, but this approach could be applied to the other nine mitochondrial 
transcripts that are edited in BSFs, which in turn would reveal the extent of REL1 
involvement in the final step of RNA editing. This would be interesting to follow up 
since the data presented here suggest that they are transcript-specific effects of REL1 
knock-down.  
Further more, since the 5’ linking of cleaved transcripts with the Solexa-
based RNA linker was robust enough, a more global approach could be pursued. This 
was the original intention of this study, and the reason why a tagged hexamer primer 
was initially used to generate the RT material used in subsequent sequencing 
reactions. The tagged hexamer could subsequently be used to select for all 5’ linked 
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mitochondrial transcript in an enrichment PCR reaction containing a primer based 
upon the hexamer tag and the 5’ linker sequence. From the data presented here, Ion 
Torrent may produce more meaningful data. Whilst the long poly-U stretches may 
introduce biases during genome sequencing and increase error in the raw dataset, the 
ND7 sequencing results presented here suggest reproducibility of MiSeq to that of 
Ion Torrent sequencing results (Quail et al., 2012).   
To date, much information regarding the transcript specific effects of RNA 
editing has relied on the generation of large clone libraries (Benne et al., 1986; 
Feagin et al., 1987; Feagin, Abraham, et al., 1988; Bhat et al., 1990; Koslowsky et 
al., 1990; Read, Myler, et al., 1992; Souza et al., 1992; Read, Wilson, et al., 1994; 
Ochsenreiter and Hajduk, 2006; Ochsenreiter et al., 2008). This global approach 
would allow the direct investigation into the transcripts involved in REL-based 
ligation, and may allow the quantification of the involvement of REL1 in RNA 








Discerning the importance of REL1 and 
REL2 through evolutionary analysis  
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4.1 Introduction to project 
As discussed in Chapters 1 and 2, it has been ascertained that REL1 is essential to 
cell viability and the editing process, where as REL2 is not. The assumption that 
REL2 is non-essential to the cell is based on RNAi data, and specifically through 
analysis of growth phenotypes (Huang et al., 2001; Schnaufer et al., 2001; Drozdz et 
al., 2002; Gao and Simpson, 2003); however, microscopic images of REL2 RNAi 
cell lines reveal subtle cell deformation (O’Hearn et al., 2003).  If REL2 is not 
essential, then what is its purpose at its position within the addition subcomplex?  
Initially, we wanted to create a REL2 null mutant within a cKO REL1 environment 
to aid the integration of a tagged chimeric ligase (with a REL2 ID) into the 
editosome (Chapter 2). However, we also wanted to create a null mutant within a 
wild type environment, since RNAi is never fully complete and only a small amount 
of REL2 may be required for editing to function as normal.  
Aside from the direct genetic manipulation of T. brucei to ascertain if a 
residual amount of REL2 within the cell allows editing to function, we also wanted 
to determine if REL2’s presence within the cell could be explained evolutionarily. It 
is known that proteins are subject to strong purifying selective forces when they have 
stringent substrate or structural requirements, and so amino acid changes can be 
directly correlated to catalytic importance. A classic measure of the type of selective 
forces acting upon a protein is the calculated ratio of the number of synonymous and 
non-synonymous substitutions per site (dN/dS) (Hurst, 2002). Catalytically important 
proteins evolve more slowly than would be expected under neutrality. For example 
bacterial proteins which are essential and mammalian house keeping genes are more 
conserved over evolutionary time than non-essential, or tissue specific proteins 
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(Jordan et al., 2002; Zhang and Li, 2004).  These observations can be applied to the 
editing ligases of T. brucei to determine whether REL1 and REL2 have been 
subjected to the same kind of evolutionary forces. For example, do selective forces 
acting upon the ligases promote diversification or conservation of the sequence, in 
relation to protein function? This Chapter addresses these questions through 
evolutionary analysis of REL1 and REL2 using an open source program for 
Molecular Evolutionary Genetic Analysis (MEGA).  
It has been suggested that the components of the editosome have been 
subjected to the forces of constructive neutral evolution, where the absence of 
positive selection allowed the evolution of the protein machinery under neutral 
conditions (Lukes et al., 2005;  Lukes et al., 2009; Gray, 2012). Under this neutrality 
the editing process established itself and subsequently became essential and from this 
theory it could be expected that proteins are now under purifying selection to 
maintain protein sequence. Although the evolutionary forces acting upon the RNA 
editing machinery as a whole have been discussed at length, selection upon 
individual components has not yet been addressed. Sequences from KREPA3 have 
also been used in the following analysis, since this protein main role in editing is 
providing stability and not catalysis to the editing process. This protein connects the 
two subcomplexes of the editosome and is essential to the integrity of the whole 
complex (Brecht et al., 2005; Guo et al., 2008; Niemann et al., 2009; Gao et al., 
2010). Although this approach cannot clearly distinguish whether a protein is 
essential or non-essential, since the latter may still confer a selective advantage to the 
cell, we can still ascertain a proteins importance to the cell evolutionarily.  
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4.2 Methods 
4.2.1 Identification of REL1, REL2 and KREPA3 genes 
REL1 and REL2 genes present in the genomes of T. brucei, T. vivax, T. congolense 
and T. cruzi were successfully identified using the TriTryp online database 
(http://www.tritrypdb.org). Sequences for T. evansi (Chinese strain: STIB805) REL1 
and 2 were provided by Achim Schnaufer (unpublished data). BLAST analyses for 
RELs for Leishmania tarentolae were performed using the NCBI website 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Genes and their annotations used in the 
following analyses are summarised below in Table 4.1. Sequences used in 
subsequent analyses can be found in Appendix 7. The number of nucleotide sites 
analysed were as follows: REL1, 1404 bp, REL2, 1244 bp and KREPA3 1331 bp. 
Table 4.1. ORFs used in this study 
Species Systematic ID REL1 Systematic ID REL2 Systematic ID A3 
T. brucei 927 Tb09.1.60.2970 Tb927.1.3030 Tb927.08.620 
T. brucei 427 Tb427tmp.160.2970 Tb427.01.3030 Tb947.08.620 
T. brucei gambiense Tbg972.9.2300 Tbg972.1.1840 Tbg972.8.220 
T. evansi STIB805  -unpublished -unpublished -unpublished 
T. congolense TcIL3000.9.1420 TcIL3000.1.1450 TcIL3000.8.100 
T. vivax TvY486_0901490 TvY486_0101350 TvY486_0800080 
T. cruzi  
(Brener Esmeraldo-like) 
Tc00.1047053511585.20 Tc00.1047053506363.110 Tc00.1047053510857.40 
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4.2.1 Phylogenetic tree construction of REL1 and REL2 
The evolutionary history between trypanosome species and strains of T. brucei 
(totalling 8 amino acid sequences, listed in Table 4.1) were inferred using the 
neighbour-joining method and the bootstrap consensus trees shown in Section 4.3 
were inferred from 1000 replicates (Felsenstein, 1985; Saitou and Nei, 1987). The 
evolutionary distances were computed using the JTT matrix-based method (Jones et 
al., 1992). Editosome protein ORFs were translated in accordance to the Standard 
Genetic Code. Evolutionary analyses were conducted in MEGA (version 5.1) 
(Tamura et al., 2011). 
 
4.2.2 Analysis of selection acting upon RELs using codon-
based Z-test  
The variance of the ratio of non-synonymous to synonymous mutations (variance 
dN/dS) was computed for all 8 sequences using the bootstrap method (1000 
replicates). Analyses were conducted using the Kumar method, using MEGA 
(version 5.1). P values were considered significant at the 5% level. 
The following null hypotheses were considered for the analysis of selection: 
1) Neutral selection: dN = dS 
2) Positive selection:  The probability of rejecting the null hypothesis of strict 
neutrality (dN = dS) in favour of the alternative hypothesis (dN > dS) 
3) Purifying selection: The probability of rejecting the null hypothesis of strict 
neutrality (dN = dS) in favour of the alternative hypothesis (dN < dS). 
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Here, dS and dN are the numbers of synonymous and non-synonymous substitutions 
per site, respectively. The first of these tests was considered a more stringent two-
tailed test, since for neutrality to be rejected the dN/dS ratio could go either way, 
signifying purifying or positive selection. Tests for positive and purifying selection 
were one-tailed as the direction of the tests was already defined. The computational 
chi-squared analysis assumed normal distribution of dN/dS. All significant results are 
asterisked in the Results Section (Section 4.3). 
 
4.2.3 Testing for sites of positive selection  
As very few sequence sites may be under positive selection at any one time, positive 
selection may be easily overlooked in evolutionary analysis (Pond and Frost, 2005). 
Six of the eight sequences available (excluding Tb427tmp.160.2970 and 
Tbg972.9.2300 for REL and Tb427.01.3030 and Tbg972.1.1840 for REL2 and 
Tb947.08.620 and Tbg972.8.220 for KREPA3) were used in the analysis, using the 
open source HyPhy package (Hypothesis testing using Phylogenies) available at the 
free public server, http://www.Datamonkey.org. Sequences that were omitted 
represented strains and sub-species of six sent for HyPhy analysis. All start and stop 
codons were removed from the sequences prior to analysis. 
We used Random Effective Likelihood and a general Reversible model of nucleotide 
substitution (REV). Random Effective Likelihood is a codon-based maximum 
likelihood selection method developed by Nielsen and Yang (1998). This method 
allows both synonymous and non-synonymous rate variation across different sites 
and can be used with low divergence alignments (Pond and Frost, 2005). REV 
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allowed correction for the different biases of nucleotides.  
 
4.2.4 Calculation of dN/dS ratios of RELs to infer rate of 
evolution 
If REL2 is non-essential, it will be subject to neutral evolution and therefore 
accumulate a greater proportion of non-synonymous mutations over time compared 
with REL1. This analysis is also a measure of selective pressure, but does not create 
a test statistic as with the analysis of selection (Nielsen and Yang, 1998; Yang, 
2000). All 8 nucleotide sequences were subjected to separate synonymous and non-
synonymous analyses, conducted using the Kumar model (Tamura et al., 2011). 
Evolutionary analyses were conducted in MEGA5.1, where all positions containing 
gaps and missing data were eliminated (leaving a total of 456 positions). The dN/dS 
ratios for REL1 and REL2 were subjected further to a Mann-Whitney U test using 
Minitab 16 and dN/dS ratios were expressed graphically as a box plot (Minitab 16) 
and scatter plot (Graphpad prism 6). 
 
4.2.5 Pairwise comparisons of REL evolution  
This approach was taken to determine whether the rate of divergence of REL1 and 
REL2 differed. MEGA5.1 was used to compare the number of amino acid 
substitutions per site for each of the 8 gene sequences shown in Table 4.1. Analyses 
were conducted using a JTT based matrix model (Jones et al., 1992). 
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4.2.6 Attempted construction of a REL2 null mutant 
The following approach was undertaken to ascertain whether there was a possibility 
of REL2 being essential in T. brucei BSFs, since RNAi is never complete in ablating 
gene expression. No ectopic copy was constructed or transfected into 427 or cKO 
REL1 cells, since REL2 is thought to be non-essential. This method aimed to replace 
the REL2 alleles (gene ID Tb.11.01.8470) by a drug resistant cassette, initially for 
blasticidin and nourseothricin and subsequently for puromycin, using ends out 
recombination, employing a plasmid (see Figure 4.1) and later a PCR-based 
approach to disrupt gene loci (see Table 4.2). 
Drug resistant cassettes for nourseothricin and puromycin were amplified 
from plasmids pLEXSY-hyg-SAT2 and pGEM-PURO (kind gifts from Sean Dean 
and Matt Gould) using primers sets D and E and F and G, respectively. Primer sets 
are listed in Figure 4.1. REL2 flanking regions were amplified from wt427 gDNA 
using standard 50 µl Expand High Fidelity PCR (Roche). Briefly, 2.6 U Taq Expand, 
100 mM of each of dNTPs, 300 nM of each primer and 1 × buffer (with MgCl2) were 
used for each PCR reaction. PCR reactions were subjected to the following 
conditions: 95 °C 120s and 35 cycles of (95 °C 30s, 50 °C 60s and 72 °C 120s), 
followed by incubation at 72 °C for 8 minutes.  PCR products were verified by 
electrophoresis before Nucleospin clean up, ligation into pGEM. Miniprep DNA was 
sent for Sanger sequencing (big dye reaction) to verify the sequences. 500 ng of 
pLEW100v51d-BSD plasmid and 250 ng of 5’REL2-pGEM were digested with 10 U  
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Name Sequence Details 
A 5’-ATAGCGGCCGCTCCTTGCTGAAGATGTTGCGTC F' 5' REL2 flanking region 
B 5’-ATACTCGAGGCAACTCAGGGATCAATATATGATAG R' 5’ REL2 flanking region 
C 5’-ATACCCGGGAAGGAGGAAATGACACCAGACCAG F' 3' REL2 flanking region 
D 5’-ATACCATGGCACCACCAATTCTCCGCAG R' 3’ REL2 flanking region 
E 5’-ATACCATGGATGAAGATTTCGGTGATCCCTG F’ SAT 
F 5’-ATACTCGAGGTTAGGCGTCATCCTGTGCTC R’ SAT 
G 5’-ATACCATGGATGACCGAGTACAAGCCCAC F’ PURO 
H 5’-ATACTCGAGTCAGGCACCGGGCTTG R’ PURO 
Figure 4.1. pLEW100v51d-BSD based REL2 KO constructs 
This approach made use of ends out recombination events during cell division to 
replace the ORF of each REL2 with that of a nourseothricin (SAT) or puromycin 
(PURO) drug resistant cassette. Blasticidin (BSD) was already present in this vector. 
Only the 1st KO construct is shown here (blasticidin-based). The 2nd KO constructs 
were derived from the 1st through excision of the BSD gene with NcoI and XhoI and 
ligation of the SAT or PURO genes in its stead. 
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of BamHI and KpnI (NEB) as per manufacturer’s instruction. A total of 10 μg of 
digested plasmid (firstly NotI and subsequently BamHI/AgeI) was used to transfect 
log phase cKO REL1 and wt 427 bloodstream trypanosomes (for transfection 
protocol, see Section 2.2.4). 
 Full digestion was verified by gel electrophoresis, gel bands corresponding to 
pLEW100vBSD backbone and the 5’REL2 fragment were excised and purified. 0.5 
ng of 5’ REL2 flanking sequence was ligated into 10 ng plasmid. Minipreps were 
screened for correct inserts before this process was repeated with the insertion of the 
REL2 3’ flanking region. 10ng the pLEW100vBSD-5’REL2 plasmid and 250 ng of 
3’REL2 were digested with 10 U AflII and SacII (NEB). Once 1st knock-out (KO) 
construct (pLEW100vBSD-KO1) sequences were verified by Sanger sequencing, 
plasmids were cloned and extracted maxiprep DNA was used for transfections. To 
create the two versions of the 2nd KO construct the 1st KO construct was doubly 
digested, alongside pGEM-PURO or pGEM-SAT with 10 U NcoI and Xho1, this 
directly replaced the blasticidin resistance cassette with puromycin or nourseothricin, 
respectively. Details of cloning procedures used here can be found in Sections 2.2.2 
and 3.2.10. 
For the PCR-based knock out approach, blasticidin and puromycin-specific 
primers (Table 4.2) were used to amplify drug resistant cassettes from available 
vectors pLEW100v51d-BSD, and pGEM-PURO, kind gifts from Sean Dean and 
Matt Gould. This strategy was designed using the techniques described by Gaud et 
al., 1997 and Oberholzer et al., 2006. Initially a 50 bp overhang was used, and 
subsequently a further PCR step was used to lengthen these to 100 bp. PCR 
fragments were amplified from the primer sets in Table 4.2 in 50 μl reactions using 
Chapter 4 
  158 
expand High fidelity PCR system (Roche) and a gradient PCR reaction. Puromycin 
and blasticidin were amplified from 2 ng of pGEM plasmids containing the 
respective drug resistant cassettes, using standard reaction condition described 
before. PCR reactions were subjected to the following conditions: 95 °C 120s and 30 
cycles of (95 °C 60s, 55 °C +/- 10 °C and 72 °C 120s), followed by incubation at 
72 °C for 8 minutes. Cleaned PCR products were sent for Sanger sequencing (Big 
dye) reaction to verify they were the correct sequence. 2 μg of PCR product and 10 
μg of digested plasmid was used for each transfection. Prior to transfection, the PCR 
reactions were cleaned with Nucleospin II (Machery-Nagel) and by ethanol 
precipitation in the presence of glycogen. 
Aside from the amount of PCR product used, transfections with prepared, 
digested plasmids and PCR products were performed as previously described in 
Chapter 2, Section 2.2.2. Both plasmid and PCR product transfectants were selected 
for with 5 μg/ml of blasticidin and 0.1 μg of puromycin, alongside positive controls 
(pLEW79-TDP1-BSD, kind gift Roberta Carloni) containing the blasticidin drug 
resistance cassette. Clones were picked after 5 days of growth in HMI-9 media with 
selective drugs. 
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Table 4.2. Forward and reverse primers used in the PCR REL2 KO strategy 
 Blasticidin 1st KO 
1 F’  
5’ GTTTGTTGGGCGCCGGTGTGGTCAGGGGGGGCGCCTCCTTGCTGAAGATGGCCAAGCCTTTGTCTCAAGAAGAATC 
 2 R’   
5’-TCCGCAGCCATGCACTATTTCCACGCTCTCTGGGGAGCCATATCTTTTCAGCCCTCCCACACATAACCAGAG 











The 5' and 3' gene flanking regions of REL2 are highlighted in bold/italic. Primers 1 
- 4 provided a 50 bp overhang enabling recombination of a drug resistant cassette 
between the REL2 flanking regions in place of the ORF. Primers 5 and 6 were used 
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 4.3 Results 
4.3.1 Phylogenetic trees of REL1 and REL2 
Neighbour-joining trees using JTT for REL1, REL2 and KREPA3 are shown 
respectively in Figure 4.2. Branches corresponding to partitions reproduced in less 
than 50% bootstrap replicates are collapsed. The percentage of replicate trees in 
which the associated taxa clustered together in the bootstrap test (1000 replicates) is 
shown next to the branches (Felsenstein, 1985). The evolutionary distances (relative 
to bottom scale) are representative of the number of amino acid substitutions per site. 
It should be noted that the evolutionary scale of KREPA3 is twice that of the RELs. 
For all trees constructed, L. tarentolae is placed at the root. The near-
collapsed branches of the T. brucei clade (i) group indicate a very recent divergence, 
and bootstrap values relaxing to 48, 66 and 70 (Figure 4.2A - C respectively) also 
pertain to this. In general the divergence of the proteins occurred in an identical 
species order, however there were exceptions to this. Figure 4.2A shows that REL1 
diverged later in T. cruzi than in T. vivax, and Figure 4.2B illustrates the opposite 
pattern of divergence for REL2. Figure 4.2C, on the other hand, indicates a common 
point of divergence in KREPA3 from T. vivax and T. cruzi. 
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Figure 4.2. Neighbour-joining trees showing phylogenetic relationships  
Numerical values pertain to bootstrap values. Trees were constructed for REL1 (A), 
REL2 (B) and KREPA3 (C). The evolutionary distances (expressed as a scale below 
the trees) is expressed as the observed proportions of amino acid pairs, between a 
pair of sequences, with their divergence time. For ease, the T. brucei clade is marked 
i and all other trypanosomatids ii.  
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4.3.2 Codon-based Z-tests to test for selection 
This test was selected to determine the kind of selective pressure(s), if any, acting 
upon REL1 (Table 4.3), REL2 (Table 4.4) or KREPA3 (Table 4.5) by specifically 
comparing the relative abundance, or variance, of synonymous and non-synonymous 
mutations within the gene sequence. From this variance a Z-score, a standard score 
based upon normal distribution, is given and a P value assigned.  
In the case of REL1, the null hypothesis of neutrality could be rejected (at 5% 
level) in 19/24 pairwise comparisons (as p < 0.05). The hypothesis of neutrality 
cannot be rejected in favour of positive selection for REL1, since no pairwise 
examples displayed a significant P value for their corresponding test statistic. 
However, the same 19/24 comparisons showed a significant P value after a test of 
purifying selection. This indicates that in these instances neutrality may be rejected 
in favour of purifying selection. In addition to these 19 comparisons there were a 
further two (T. b brucei 927 vs. T. b brucei 427, T. b gambiense) with borderline 
significance.  
A similar pattern can be seen for REL2 and KREPA3 (Table 4.4 and 4.5), 
where 20/24 and 21/26 cases of neutrality could be rejected in favour of purifying 
selection at the 5% level. As with REL1, no cases of positive selection acting upon 
REL2 or KREPA3 could be found. It is clear from Tables 4.3 – 4.5 that a number of 
pairwise comparisons produced non-significant test statistic (in favour of the null 
hypothesis).  These sequences can be assigned to the T. brucei clade (Figure 4.2), 
meaning a Z-score and corresponding P-value will reflect the few nucleotide changes 
between species and sub-species.  
Chapter 4 
  163 
Table 4.3. Tests for neutrality, positive selection and purifying selection acting upon 
REL1 across trypanosome species and strains 
 






Species 1 Species 2 Z-score P value Z-score P value Z-score P value 
T b gambiense T. evansi -0.523 0.602 -0.526 1.000 0.513 0.304 
T b gambiense T. congolense -2.813 0.006* -2.973 1.000 2.941 0.002* 
T b gambiense T. vivax -2.733 0.007* -2.752 1.000 2.690 0.004* 
T b gambiense T. cruzi  -3.018 0.003* -3.013 1.000 3.119 0.001* 
T brucei 427 T b gambiense 1.469 0.144 1.505 0.067 -1.517 1.000 
T brucei 427 T. evansi -0.416 0.678 -0.406 1.000 0.402 0.344 
T brucei 427 T. congolense -2.818 0.006* -2.961 1.000 2.909 0.002* 
T brucei 427 T. vivax -2.757 0.007* -2.771 1.000 2.694 0.004* 
T brucei 427 T. cruzi  -3.112 0.002* -3.142 1.000 3.326 0.001* 
T brucei 927 T brucei 427 -1.572 0.118 -1.566 1.000 1.584 0.058+ 
T brucei 927 T b gambiense -1.601 0.112 -1.588 1.000 1.619 0.054+ 
T brucei 927 T. evansi -2.037 0.044* -2.030 1.000 2.040 0.022* 
T brucei 927 T. congolense -2.827 0.006* -2.955 1.000 2.922 0,002* 
T brucei 927 T. vivax -2.803 0.006* -2.792 1.000 2.738 0.004* 
T brucei 927 T. cruzi  -2.734 0.007* -2.771 1.000 2.846 0.003* 
T. congolense T. vivax -6.924 0.000* -6.393 1.000 6.131 0.000* 
T. congolense T. cruzi  -2.158 0.033* -2.180 1.000 2.167 0.016* 
T. congolense L. tarentolae -7.150 0.000* -6.992 1.000 7.163 0.000* 
T. cruzi  L. tarentolae -3.612 0.000* -4.073 1.000 4.404 0.000* 
T. evansi T. congolense -2.671 0.009* -2.759 1.000 2.774 0.003* 
T. evansi T. vivax -2.620 0.010* -2.606 1.000 2.576 0.006* 
T. evansi T. cruzi  -2.841 0.005* -2.757 1.000 2.924 0.002* 
T. vivax T. cruzi  -2.347 0.021* -2.411 1.000 2.389 0.009* 
T. vivax L. tarentolae -2.303 0.023* -2.304 1.000 2.304 0.011* 
 
* denotes significant P value (5% level) based upon variance of dN-dS. 
+ denotes borderline significance at 5% level. 
In all cases the null hypothesis is that the protein is subject to neutrality (dN = dS). 
Therefore the asterisks present under neutral and purifying selection, pertaining to a 
significant P value, and requires rejection of the null hypothesis in favour of 
purifying selection, where dN<dS. Pairwise comparisons that could not be calculated 
are not shown. 
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Table 4.4. Tests for neutrality, positive selection and purifying selection acting upon 
REL2 across trypanosome species and strains 
 






Species 1 Species 2 Z-Score P value Z-Score P value Z-Score P value 
T b gambiense T. congolense -5.639 0.000* -5.673 1.000 5.445 0.000* 
T b gambiense T. vivax -2.211 0.029* -2.183 1.000 2.189 0.015* 
T b gambiense T. cruzi  -3.471 0.001* -3.605 1.000 3.529 0.000* 
T b gambiense L. tarentolae -2.075 0.040* -2.095 1.000 2.079 0.020* 
T brucei 427 T.evansi 1.003 0.318 1.043 0.150 0.000 1.000 
T brucei 427 T. congolense -5.700 0.000* -5.748 1.000 -1.036 0.000* 
T brucei 427 T. vivax -2.234 0.027* -2.203 1.000 5.649 0.015* 
T brucei 427 T. cruzi  -3.558 0.001* -3.682 1.000 2.203 0.000* 
T brucei 427 L. tarentolae -2.095 0.038* -2.110 1.000 3.620 0.019* 
T brucei 927 T brucei 427 -1.869 0.064 -1.837 1.000 2.102 0.034* 
T brucei 927 T b gambiense -1.690 0.094 -1.662 1.000 1.842 0.048+ 
T brucei 927 T. evansi -1.639 0.104 -1.633 1.000 1.675 0.053+ 
T brucei 927 T. congolense -6.504 0.000* -6.572 1.000 1.625 0.000* 
T brucei 927 T. vivax -2.252 0.026* -2.219 1.000 6.339 0.014* 
T brucei 927 T. cruzi  -3.313 0.001* -3.381 1.000 2.223 0.001* 
T brucei 927 L. tarentolae -2.378 0.019* -2.378 1.000 3.365 0.009* 
T. congolense T. vivax -2.179 0.031* -2.145 1.000 2.391 0.017* 
T. congolense T. cruzi  -2.169 0.032* -2.164 1.000 2.156 0.016* 
T. cruzi  L. tarentolae -2.067 0.041* -2.064 1.000 2.172 0.021* 
T. evansi T. congolense -5.695 0.000* -5.743 1.000 0.744 0.000* 
T. evansi T. vivax -2.234 0.027* -2.203 1.000 2.064 0.015* 
T. evansi T. cruzi  -3.557 0.001* -3.681 1.000 5.643 0.000* 
T. evansi L. tarentolae -2.095 0.038* -2.110 1.000 2.203 0.019* 
T. vivax T. cruzi  -3.572 0.001* -3.721 1.000 3.671 0.000* 
 
* denotes significant P value (at 5% level) based upon variance of dN-dS. 
+ denotes borderline significance at 5% level. 
In all cases the null hypothesis is that the protein is subject to neutrality (dN = dS). 
Therefore the asterisks present under neutral and purifying selection, pertaining to a 
significant P value, and requires rejection of the null hypothesis in favour of 
purifying selection, where dN<dS. Pairwise comparisons that could not be calculated 
are not shown. 
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Table 4.5. Tests for neutrality, positive selection and purifying selection acting upon 
KREPA3 across trypanosome species and strains 
 






Species 1 Species 2 Z-Score P value Z-Score P value Z-Score P value 
T. b. gambiense T. evansi -1.047 0.297 -1.030 1.000 1.050 0.148 
T. b. gambiense T. congolense -2.161 0.033* -2.151 1.000 2.147 0.017* 
T. b. gambiense T. vivax -2.072 0.040* -2.075 1.000 2.108 0.019* 
T. b. gambiense T. cruzi  -2.146 0.034* -2.154 1.000 2.156 0.017* 
T. b. gambiense L. tarentolae -2.176 0.032* -2.170 1.000 2.171 0.016* 
T. b. gambiense T.b. brucei 427 -0.474 0.636 -0.473 1.000 0.494 0.311 
T. b. brucei 427 T.evansi 1.054 0.294 1.042 0.150 -1.045 1.000 
T brucei 427 T. congolense -2.247 0.026* -2.218 1.000 2.221 0.014* 
T brucei 427 T. vivax -2.051 0.042* -2.062 1.000 2.080 0.020* 
T brucei 427 T. cruzi  -2.078 0.040* -2.096 1.000 2.119 0.018* 
T brucei 427 L. tarentolae -2.080 0.040* -2.081 1.000 2.067 0.020* 
T brucei 927 T brucei 427 -1.046 0.298 -1.074 1.000 1.070 0.143 
T brucei 927 T b gambiense -1.074 0.285 -1.092 1.000 1.123 0.132 
T brucei 927 T. evansi -0.474 0.636 -0.479 1.000 0.491 0.312 
T brucei 927 T. congolense -2.271 0.025* -2.247 1.000 2.246 0.013* 
T brucei 927 T. vivax -2.041 0.043* -2.053 1.000 2.068 0.020* 
T brucei 927 T. cruzi  -2.063 0.041* -2.055 1.000 2.065 0.021* 
T brucei 927 L. tarentolae -2.079 0.040* -2.080 1.000 2.068 0.020* 
T. congolense T. vivax -2.589 0.011* -2.564 1.000 2.540 0.006* 
T. congolense T. cruzi  -4.202 0.000* -3.844 1.000 4.180 0.000* 
T. congolense L. tarentolae  -2.193 0.030* -2.200 1.000 2.198 0.015* 
T. cruzi  L. tarentolae -2.104 0.037* -2.067 1.000 2.090 0.019* 
T. evansi T. congolense -2.249 0.026* -2.223 1.000 2.227 0.014* 
T. evansi T. vivax -2.053 0.042* -2.056 1.000 2.080 0.020* 
T. evansi T. cruzi  -2.076 0.040* -2.089 1.000 2.113 0.018* 
T. evansi L. tarentolae -2.106 0.037* -2.116 1.000 2.091 0.019* 
T. vivax T. cruzi  -2.419 0.017* -2.350 1.000 2.394 0.009* 
 
* denotes significant P value (at 5% level) based upon variance of dN-dS. 
+ denotes borderline significance at 5% level. 
In all cases the null hypothesis is that the protein is subject to neutrality (dN = dS). 
Therefore the asterisks present under neutral and purifying selection, pertaining to a 
significant P value, and requires rejection of the null hypothesis in favour of 
purifying selection, where dN<dS. Pairwise comparisons that could not be calculated 
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4.3.3 HyPhy analysis to test for positive selection 
Since positive selection is easily overlooked, http://www.Datamonkey.org was used 
to determine if any sites were under positive selection (Pond and Frost, 2005). 
Analysis of REL2 sequences revealed that no sites had a rate where dN > dS, 
inferring that all sites were under purifying selection (see Appendix 8 for analysis 
read out). Analysis of REL1 sequences found no sites under positive selection, and 
298 (out of the 489 sites) were found to be under purifying selection. This indicates 
that, even with 31% of sites neutrally evolving, purifying selection remains a strong 
evolutionary force on this ligase at these sites. When subjecting KREPA3 sequences 
to the same analysis, no sites were found to be under positive selection, or with 
dN>dS, inferring that all sites were under purifying selection. 
 
4.3.4 Using dN/dS to discern rate of evolution of editosome 
proteins 
The dN/dS ratio was used in this study, since it is widely accepted as a measure of 
selection pressure (Nielsen and Yang, 1998; Yang, 2000). 
Since the dN/dS ratio in all calculable cases (Table 4.6) was between 0.058 
and 0.491, it was determined that the number of synonymous mutations occurring 
over time is considerably higher than that of non-synonymous mutations.  In all but 
one case (T. b brucei 927 vs. T. b gambiense) KREPA3 portrayed a greater 
accumulation of non-synonymous compared to synonymous mutations over time 
than REL1 or REL2. In this example, dN/dS is greater for REL2 than for KREPA3. 
Mann-Whitney U test revealed that the median dN/dS ratios of REL2 and REL1 
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were 0.096 and 0.077, respectively (displayed as a box plot Figure 4.3 A). The 
difference between these two medians was significant at 0.027 (Mann-Whitney U 
test; 95% CI values of 0.002 and 0.027, respectively). This indicates a statistically 
significant difference between the rates of evolution between the two ligases. REL1 
is evolving significantly slower than REL2.  
The dN/dS values for the two ligases reveal a general trend for more relaxed 
purifying selection acting upon REL2 in comparison to REL1, shown by the 
deviation of the regression line towards the REL2 axis (Figure 4.3 B, left panel). 
Since data points are matched pairwise, this relationship between the two datasets is 
not related to phylogeny; rather the slope represents a functional relationship 
between the two ligases. This indicates that coevolution may have occurred, although 
the R2 value of 0.681 does not indicate a robust relationship. This dN/dS relationship 
between REL1 and KREPA3 is more difficult to interpret from the graphical data 
(Figure 4.3 B, right panel), but from the dN/dS values given in Table 4.5 it is clear 
that the purifying selection is a weaker force on KREPA3 in comparison to REL1.  





Comparison REL2 REL1 KREPA3 
Species 1 Species 2 dN dS dN/dS ratio dN dS dN/dS ratio dN dS dN/dS ratio 
T b gambiense T.evansi 0.002 / / 0.001 0.002 0.427 0.000 0.003 / 
T b gambiense T. congolense 0.101 1.287 0.078 0.088 1.502 0.058 0.264 2.126 0.124 
T b gambiense T. vivax 0.151 1.781 0.085 0.129 1.696 0.076 0.337 2.101 0.161 
T b gambiense T. cruzi 0.143 1.423 0.100 0.133 1.728 0.077 0.303 1.992 0.152 
T b gambiense L. tarentolae 0.282 2.155 0.131 0.247 2.168 0.114 0.462 2.516 0.184 
T brucei 427 T b gambiense 0.001 / / 0.001 0.000 / 0.001 0.003 0.492 
T brucei 427 T.evansi 0.001 0.000 / 0.000 0.002 / 0.001 0.000 / 
T brucei 427 T. congolense 0.100 1.277 0.078 0.088 1.504 0.058 0.264 2.206 0.119 
T brucei 427 T. vivax 0.150 1.760 0.085 0.130 1.693 0.077 0.337 2.143 0.157 
T brucei 427 T. cruzi 0.142 1.422 0.100 0.134 1.727 0.077 0.304 2.027 0.150 
T brucei 427 L. tarentolae 0.280 2.129 0.132 0.248 2.204 0.112 0.464 2.388 0.194 
T brucei 927 T brucei 427 0.005 0.016 0.294 0.002 0.012 0.162 0.000 0.003 / 
T brucei 927 T b gambiense 0.006 0.016 0.352 0.003 0.012 0.233 0.001 0.005 0.246 
T brucei 927 T.evansi 0.006 0.016 0.368 0.002 0.014 0.138 0.001 0.003 0.491 
T brucei 927 T. congolense 0.098 1.233 0.079 0.088 1.491 0.059 0.264 2.242 0.118 
T brucei 927 T. vivax 0.148 1.750 0.085 0.130 1.668 0.078 0.337 2.169 0.155 
T brucei 927 T. cruzi 0.139 1.431 0.097 0.133 1.791 0.074 0.304 2.056 0.148 
T brucei 927 L. tarentolae 0.281 1.997 0.141 0.248 2.121 0.117 0.464 2.356 0.197 
T. congolense T. vivax 0.133 1.758 0.076 0.129 1.334 0.097 0.351 1.862 0.189 
T. congolense T. cruzi 0.120 1.703 0.070 0.125 1.848 0.068 0.358 1.493 0.240 
T. congolense L. tarentolae / / / 0.261 1.405 0.186 0.494 1.839 0.269 
T. cruzi L. tarentolae 0.277 2.207 0.125 0.267 1.618 0.165 0.420 2.477 0.169 
T.evansi T. congolense 0.101 1.277 0.079 0.088 1.527 0.058 0.264 2.207 0.120 
T.evansi T. vivax 0.151 1.760 0.086 0.130 1.716 0.076 0.337 2.143 0.157 
T.evansi T. cruzi 0.143 1.422 0.101 0.134 1.757 0.076 0.303 2.035 0.149 
T.evansi L. tarentolae 0.282 2.129 0.133 / / / 0.462 2.441 0.189 
T. vivax T. cruzi 0.134 1.417 0.094 0.133 1.796 0.074 0.292 1.865 0.157 
T. vivax L. tarentolae / / / 0.256 1.945 0.132 / / / 
Table 4.6. Using dN/dS ratios to quantify selection pressure 
e presence of / in the results denotes cases in which it was not possible to estimate evolutionary distances. Highlighted in blue is the 
only example where dN/dS is greater for the RELs in comparison to the A3 protein. 
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Figure 4.3. Graphical comparisons of dN/dS  
A) Blot plots were drawn for REL1 vs. REL2 and a Mann-Whitney U test was 
carried out giving: medians for REL2 0.096 and REL1 0.077, P = 0.027. 
B) dN/dS values were plotted for two separate protein comparisons and a regression 
line was drawn. Left panel: REL1 vs. REL2 (R2 = 0.681, P = < 0.0001). Right panel: 
REL1 vs. A3 (R2 = 0.073, P = 0.2248).   
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4.3.5 Pairwise comparison of the RELs 
This method was used to crudely infer the differences in the evolutionary divergence 
(or the variance of speed of evolution) between the two ligases. The distributions of 
the mean evolutionary divergence were found to differ slightly across all examined 
trypanosomatid species (see Table 4.7 below). If the ligases were evolving at exactly 
the same pace, then the difference between the mean would be 0, but the difference 
in the means indicates greater sequence divergence of REL2 over time, in 
comparison to REL1. 
 
Table 4.7 Pairwise comparisons of RELs to infer evolutionary divergence 
Comparison REL1 REL2 
Difference  
in means 
(REL2-1) Species 1 Species 2 Dist Std. Err -2SE Dist Std. Err +2SE 
T brucei 927 T.evansi 0.004 0.003 -0.002 0.012 0.005 0.023 0.025 
T brucei 927 T. congolense 0.131 0.018 0.096 0.183 0.020 0.224 0.128 
T brucei 927 T. vivax 0.185 0.023 0.140 0.238 0.025 0.288 0.148 
T brucei 927 T. cruzi 0.199 0.022 0.156 0.255 0.026 0.306 0.150 
T brucei 927 L. tarentolae 0.430 0.035 0.361 0.484 0.041 0.566 0.206 
T. congolense T. vivax 0.184 0.023 0.138 0.222 0.023 0.268 0.130 
T. congolense T. cruzi 0.207 0.023 0.161 0.230 0.024 0.277 0.115 
T. congolense L. tarentolae 0.423 0.035 0.353 0.460 0.041 0.542 0.189 
T.evansi T. congolense 0.131 0.017 0.096 0.187 0.021 0.229 0.133 
T.evansi T. vivax 0.185 0.023 0.140 0.242 0.025 0.293 0.153 
T.evansi T. cruzi 0.199 0.022 0.156 0.261 0.026 0.313 0.158 
T.evansi L. tarentolae 0.428 0.035 0.358 0.485 0.041 0.567 0.209 
T. vivax T. cruzi 0.214 0.024 0.167 0.233 0.024 0.282 0.115 
T. vivax L. tarentolae 0.432 0.037 0.358 0.485 0.040 0.566 0.221 
T. cruzi L. tarentolae 0.460 0.037 0.385 0.451 0.040 0.531 0.145 
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4.3.6 Creation of a REL2 null mutant 
All attempts at creating a null mutant using plasmid or PCR derived constructs were 
unsuccessful in both the cKO REL1 and wt 427 parental backgrounds. Unsuccessful 
transfections are tabulated below in Table 4.8. Due to time constraints this part of the 
study was not pursued further, but from the evolutionary analyses REL2 would be 
expected to confer a selective advantage to cell growth and survival, as REL1 does. 
Positive controls were used throughout from a blasticidin containing plasmids 
(pLEW79-TDP1-BSD, kind gift Roberta Carloni), which allowed us to determine 
that at least one of the selective drugs was working as expected.  
 
Table 4.8 Transfections for REL2, using ends out recombination approach 




1st KO (Nourseothrycin) 4 attempts in wt/cKO REL1 cell lines 
1st KO (Blasticidin) 3 attempts in wt/cKO REL1 cells  
2nd KO (Puromycin) 3 attempts in wt cells 
PCR product  
REL2 3’UTRs 
1st KO 50 bp overhang (Blasticidin) 2 attempts wt cells 
St KO 100 bp overhang (Blasticidin) 1 attempt wt cells 
2nd KO 50 bp overhang (Puromycin) 2 attempts wt cells 
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4.4 Discussion 
This Chapter aimed to assess the essentiality of REL2, in comparison to REL1, 
through evolutionary analysis. Prior hypotheses have suggested that the editosome 
proteins had previously evolved neutrally, whereby the accumulation of synonymous 
mutations has lead to molecular complexity. Once editing became an essential 
process, these proteins could be conserved through the actions of purifying selection 
(Lukeš et al., 2005; Lukeš et al., 2009; Gray, 2012). There are two potential 
opposing evolutionary forces acting upon the editosome proteins when neutral 
evolution is not acting. These consist of purifying selection aiming to preserve the 
protein function, and therefore sequence, and positive selection driving protein 
evolution over time. 
Protein evolution was visualised using phylogenetic methods. A branch 
corresponding to partitions reproduced with less than 50% bootstrap replicates is 
considered collapsed, and may be indicative of close genetic distance (Felsenstein, 
1985). This phenomenon can be clearly seen in the T. brucei clade, and suggests a 
very recent speciation event.  
The results summarised in Table 4.3 suggest REL1 evolves neutrally in 
certain pairwise comparisons. However, it must be recognised that the small genetic 
distances between T. b brucei 927, T. b brucei 427, T. b gambiense and T. evansi 
confounds the dN/dS calculations employed in this analysis. Of the five non-
significant cases (T. b gambiense vs. T. evansi, T. b brucei 427, T. b brucei 927 and 
T. b brucei 427 vs. T. b brucei 927, T. evansi) all were present in the T. brucei clade 
and exhibited near-collapsed branches (Figure 4.2). The near-collapsed branches 
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indicate that these sequences are not divergent enough to confidently analyse the 
sequence difference, which was taken into consideration with the subsequent 
comparative evolutionary comparisons. Even taking this into account, the RELs of T. 
b gambiense and T. evansi were found to be as closely related to T. b brucei strains 
as 927 and 427 RELs are to each other. The pattern of evolution illustrated by the 
editosome genes generally adhere to the pattern of trypanosome evolution seen in the 
major housekeeping genes; glycosomal glyceraldehyde phosphate dehydrogenase 
(gGAPDH) and small subunit (SSU) rRNA. These studies suggested a monophyletic 
origin for T. brucei and distinct clustering of T. brucei, T. equiperdum and T. evansi 
sequences (Maslov et al., 1996; Brun et al., 1998; Hughes and Piontkivska, 2003; 
Claes et al., 2005; Hamilton et al., 2007). Results presented here indicate a recent 
speciation event between T. brucei and T. evansi (Figure 4.2). A more recent study, 
using SL RNA repeat sequences, presented by Lai et al. (2008) suggests that T. 
brucei, T. equiperdum and T. evansi have also undergone a recent divergence, but 
does not suggest a monophyletic origin. However, results presented here suggest, as 
with the housekeeping genes, monophyly, and also reveal a T. brucei clade that 
encompasses T. evansi (Maslov et al., 1996; Brun et al., 1998; Hughes and 
Piontkivska, 2003; Claes et al., 2005; Hamilton et al., 2007). The only difference 
across the three trees pertained to the positioning of T. vivax and T. cruzi. The T. 
vivax sequences used here are from an African isolate. However T. vivax escaped 
Africa due to its ability to be mechanically transmitted and this discrepancy in tree 
positioning may reflect this, as it has been observed that species of trypanosomes 
cluster phylogenetically according to their hosts reflecting adaptation of proteins and 
genes to the host environment (Hamilton et al., 2007). 
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It was taken into consideration that the number of sequences involved in this study 
was small, which may have decreased the robustness of the Z-score value, and 
corresponding P-value, calculated from the test of selection. But it was clear from the 
tests for selection that purifying selection was acting upon all three proteins used in 
this analysis. Assumptions of normality were also made when generating the test for 
selection P-value. To determine the strength of this selective force, dN/dS ratios were 
calculated separately, without a test statistic. What can be obtained from these 
analyses is that positive selective forces appear to be the weaker forces acting upon 
these editosome proteins, and so the proteins are not evolving neutrally. It should 
also be noted that the strength of purifying selection pressure seems to increase on 
the proteins in the order: KREPA3, REL2, and REL1. 
Mann-Whitney U test results indicate that the difference in the median dN/dS 
values were significantly greater for REL2 than REL1. Not all cases of dN/dS could 
be calculated, most likely due to a very recent evolutionary divergence (in the case of 
within the T. brucei clade) or a highly divergent lineage as found with the 
comparison between the salivarian trypanosomes and the L. tarentolae out-group. 
Nonetheless, the evolutionary distance calculated from both REL1 and REL2 
sequence data is low, indicating that both genes have important roles due to the small 
number of non-synonymous mutations picked up over time. Put differently, the 
strength of purifying selection acting upon the RELs is high, as the dN/dS ratios are 
low, indicating a need for trypanosomatids to retain REL function, and consequently, 
sequence over evolutionary time. This dN/dS ratio is noticeably higher in KREPA3 
in comparison to the RELs, indicating a greater accumulation of non- synonymous 
mutations in this protein over time in all but a single case (highlighted in Table 4.6). 
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It should also be noted that there were several instances of dS being greater than 1, 
inferring saturation of the test parameter, which is indicative of multiple substitutions 
at the same site (Graur and Li, 2000). As a consequence, these calculated dN/dS 
ratios may obscure the magnitude of positive selection acting upon the editosome 
proteins. Because of this, and since positive selection can be easily overlooked in 
such evolutionary analyses, it was important to subject the editosome sequences to 
HyPhy analysis. This was used to demonstrate that all REL2 and KREPA3 codons 
are sites where purifying selection occurs. In comparison 61% of REL1 sites are 
under purifying selection. On closer inspection of the alignment of the 6 REL1 
genes, it was apparent that the sites indicated to be under purifying selection were 
located across the 5 motifs involved in ATP and substrate binding. From this 
evolutionary perspective, it can be inferred that functional REL2, like KREPA3, 
confers a selective advantage to the cell, since all codons of this ligase have been 
selected for conservation across the trypanosome species analysed. Hyphy is a 
sophisticated method to detect codons under positive selection as it allows transition 
and transversions to take place at different rates, since the mutation rate of a 
nucleotide sequence is affected by the sequence itself (Charlesworth and 
Charlesworth, 2010). Hyphy also takes the whole phylogenetic tree generated from 
sequence alignment, increasing the robustness of results, even if few sites are 
analysed and data points cannot be treated separately due to multiple pairwise 
comparisons. This is important to note because multiple testing can lead to false 
positive and negative results (Charlesworth and Charlesworth, 2010). 
The distance values, as calculated from Pairwise Analysis, for REL1 and 
REL2 also suggest a greater divergence of sequence, through the accumulation of 
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non-synonymous mutations, for REL2.  
HyPhy analysis seemingly contradicts the other pairwise comparisons of 
selection, since the dN/dS values were greater for KREPA3 and REL2 than for 
REL1. The Datamonkey output suggested that 298 sites, but not 100% of sites were 
under negative selection for REL1. It is important to note that, whilst these sites were 
flagged for negative selection, these do not reflect the catalytically essential sites, 
since the codons influence this result. What should be focused on is the absence of 
sites under positive selection, which can be easily overlooked in dN/dS pairwise 
testing (Pond and Frost, 2005).  
REL1 may also have a role in general RNA repair (See Chapter 3), having 
substrates born of deletion and miscleavage events. In this model, REL2 is 
discriminating of its substrates and therefore may be essential to work alongside 
REL1 as a proofreading ligase (Cruz-Reyes et al., 2002).  It is possible that both 
plasmid and PCR-based approaches failed due technical difficulties, such as the 
presence of two stabilising actin UTRs flanking the drug resistance cassettes. It is 
also possible that transfections using PCR-products may require optimisation, since it 
has been reported that this approach has varying efficiency and requires varying 
amounts of PCR-product to produce stable transfectants (Oberholzer et al., 2006). 
The viability of REL2 RNAi cells, which show signs of deformation in one instance 
(O’Hearn et al., 2003), may indicate that only a small amount of REL2 enzyme may 
be required to function within the editosome as a proofreading enzyme. Indeed, it is 
also possible that the difficulties in obtaining a REL2 null mutant may also reflect its 
importance to the cell. However, the approaches described here did not yield a 
single, stable KO cell line, which is unusual since, RNAi lines described in the 
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literature repress REL2 mRNA by more than 50% (Huang et al., 2001; Schnaufer et 
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4.5 Conclusions and Outlook 
All of these analyses highlight the importance of the REL2 protein in an evolutionary 
context, and may add weight to the working hypothesis that both REL1 and REL2 
function are important to the cell. This may be due to their distinct catalytic 
properties, as previously described in vitro (Huang et al., 2001; Cruz-Reyes et al., 
2002; Palazzo et al., 2003; Schnaufer et al., 2003). In this hypothesis, which is 
perhaps contrary to current RNAi data on REL2, both ligases have their own 
important role in RNA editing.  
It would be important to try and obtain a REL2 null mutant to validate a non-
essential role of REL2, which did not succeed in the time frame available, especially 
since the evolutionary data presented here suggests importance of REL2 to the cell.  
Interestingly, KREPA3 also appears to be under purifying selection, as with 
both ligases. This data on its own suggests that the editing machinery has been under 
the purifying selection in the genuses Leishmania and Trypanosoma. This is not in 
itself contrary to the idea of constructive neutral evolution, since the editosome 
machinery may have been evolving neutrally long before the branching of 
Leishmania and Trypanosoma.  What is important to note is that the evolution of the 
editosome since this split has not been spurned by positive selection. It would be 
interesting to determine whether constructive neutral evolution can be proven. To 
discern this, more editosome genes from more species at the foot of the Euglenozoa 
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5.1 Summary of main findings 
This study aimed to provide fundamental knowledge concerning the essentiality of 
REL1 (Chapter 1). Genetic complementation was used to assess whether it was the 
subcomplex positioning or catalytic properties that made REL1 essential (Chapter 2). 
Next, the 5’ ends of ND7 and RPS12 transcripts were mapped, via a 5' linker 
ligation, from cells before and after REL1 ablation to determine what editing events 
were governed by REL1 ligation, hypothesising that this would provide clues to its 
essential role in the process (Chapter 3). Finally, REL1, REL2 and KREPA3 protein 
sequences were subjected to evolutionary analysis to determine the relative strength 
of selective forces acting upon them to conserve sequence, and hence catalytic 
activity, and thus determine the importance of the ligases through evolutionary 
analysis (Chapter 4). The three complementary experimental approaches provided 
scope to assess this topic from the level of protein function and RNA processing, as 
well as providing an evolutionary perspective on the presence of two ligases within 
the 20S editosome.  
The present suggest that the REL1 catalytic domain (CD) is essential at its 
specific position within the deletion subcomplex, since only full length, tagged REL1 
(REL1-TAP) could rescue the growth phenotype caused by ectopic REL1 ablation. 
Whilst data presented in Chapter 2 shows (as suggested from glycerol gradient 
sedimentation) that all tagged chimeric ligases integrated into their intended 
positions within the editosome, the CD and interactive domain (ID) swap had greatly 
reduced the proteins catalytic activities of the proteins compared to REL1-TAP in 
vitro. It is known from studies with REL1, T4Rnl1 and T4Rnl2 that the CDs of these 
ligases can form covalent AMP-enzyme (“adenylylated”) intermediates, and hence 
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are at least partially active, without the presence of their full C-terminal domain (Ho 
et al., 2004; Deng et al., 2004; Wang et al., 2007). However, results presented in 
Chapter 2 indicate more cross-talk than expected between the REL CDs and IDs, 
which made it difficult to create catalytically competent chimeric ligases than 
expected. The catalytically repressed chimeric ligases confounded the interpretation 
of the growth curve data slightly: it cannot be ruled out that the failure to rescue the 
growth phenotype from ablating REL1 were caused by insufficient catalytic activity 
of the chimeric ligases, rather than a strict requirement for the REL1 CD in the 
deletion subcomplex. As with some previous studies involving integration of ligases 
into native editosomes, the RECC lost integrity when REL1 was ablated (Huang et 
al., 2001; Cruz-Reyes et al., 2002). This was apparent only after glycerol gradient 
and subsequent TAP analysis and the significance of this observation in vivo is 
uncertain, but is important to take into consideration since this may have also 
affected the ability of these editosomes in processing RNA. 
Shallow and deep sequencing analyses of REL1 substrates revealed frequent 
products of deletion editing at deletion editing sites and misediting at editing and 
non-editing sites, in the absence of REL1. Peaks illustrated by the 5’ start graphs 
correspond to the substrates that had accumulated in the absence of REL1 and 
indicate the products of endonucleolytic cleavage that REL2 is unable to re-ligate. To 
add to this, there were fewer examples of expected addition editing substrates at 
editing sites, in the absence of REL1 than in its presence. Misediting events seem to 
be the most abundant type unable to be re-ligated efficiently by endogenous REL2. 
Partially edited cDNAs and truncated sequences indicative of miscleavage during 
RNA editing has also previously been reported in the literature (Decker and Sollner-
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Webb, 1990; Koslowsky et al., 1990; Sturm and Simpson, 1990b; Koslowsky et al., 
1991). Results from this Chapter also confirm the general, but not strict, 3' to 5' 
progression of editing, as has previously been reported in the literature (Decker and 
Sollner-Webb, 1990; Sturm and Simpson, 1990b; Koslowsky et al., 1991). Thus, the 
essentiality of REL1 may be due to this role as a general RNA repair enzyme, which 
has previously been suggested (Huang et al., 2001). When the percentage editing was 
taken at each position along the Category 2 ND7 sequences, an apparent reduction in 
fully edited sequence was observed at each position on knock-down of REL1. This 
reduction in fully edited sites on REL1 knock-down was more apparent across 
RPS12, where RNA editing was severely repressed. This study demonstrates a novel 
sequencing approach that is successful in capturing the true 5' ends of RNA 
substrates, and in doing so, emphasise the types of editing event that REL1 is 
responsible for. 
Finally, we were able to assess the essentiality of REL2 in relation to REL1 
and KREPA3 through the detection of selection pressures acting upon the proteins. 
Results from this Chapter emphasize the importance of maintaining the protein 
sequence and catalytic activity of REL2, through the actions of purifying selection. 
All three editosome proteins were strongly influenced by purifying selection, this 
may suggest that after neutral evolution and expansion of the editing process, 
proteins retained sequences once editing became essential (Lukeš et al., 2009). 
Results also suggest coevolution has occurred between REL1 and REL2, further 
emphasising their relative importance in RNA editing, presumably by fulfilling 
differential roles of ligation. 
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5.2 Recommendation for further research 
Potential plans for future research have already been discussed in the relevant 
Chapters and are outlined in more detail below. Sections 5.2.1 and 5.2.2 describe 
methods mentioned in Chapter 2, Sections 5.2.3 and 5.2.4 expand upon ideas 
discussed in Chapter 3, and Section 5.2.5 discusses the potential creation of a REL2 
null mutant, the current attempts of which are discussed in Chapter 4. 
 
5.2.1 Addition of catalytically dead REL1 to cKO REL1/TAP 
cells 
It has been previously reported in the literature that the absence of REL1 causes 
instability of the editosome in PCFs (Huang et al., 2001; Cruz-Reyes et al., 2002). 
The results described here also support a role of REL1 in 20S editosome 
stabilisation, and suggest that the presence of either a full length REL1, or chimeric 
REL2CD:1ID chimera at REL1s original site in the deletion subcomplex is enough 
to protect editosome structure. 
Prior experimental design for introducing an over-expressed and catalytically 
dead REL1 ligase has involved site directed mutagenesis of REL1 to introduce a 
lysine to arginine mutation within a KXXY motif (Huang et al., 2001).  This mutated 
ligase could be then introduced into BSFs using a plasmid, such as a newly 
constructed pHD309-BSD (adapted from pHD309-HYG-PUR, 
http://tryps.rockefeller.edu/trypsru2_plasmids.html) allowing the mutated REL1 to 
be expressed in cKO cell lines that also possessed REL2ID containing tagged ligases. 
This should alleviate any potential instability within the editosome caused by REL1s 
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loss from the deletion subcomplex, however, it is not known if this approach will 
result in a dominant-negative effect until it is attempted.  
 
5.2.2 Further quantification of TAP tagged ligase activity 
through auto-adenylylation and in vitro U-insertion and U-
deletion assays 
Once experimental conditions have been established wherein comparable amount of 
TAP tagged ligases can be isolated and subjected to in vitro assays, the ligases could 
be subjected to full round activity or autoadenylylation assays. Although a FRET 
based, full round activity assay provides a means to specifically monitor rREL1 
activity in vitro (Hall and Schnaufer, in preparation) it cannot distinguish the 
activities of REL1 and REL2 within an isolated editosome. This is yet another reason 
to knock-out REL2 in REL cKO cell lines. Auto-adenylylation, either after miniTAP 
purification or subcomplex isolation from glycerol gradient sedimentation, can be 
used to distinguish the two relative activities of REL1 and REL2, which can be 
quantitated. If U-insertion and U-deletion assays, using pre-cleaved mRNA 
substrates (synthesised in vitro using T7 RNA polymerase), were performed at 
various ATP concentrations, then quantification would reveal whether the tagged 
ligases were acting as expected, since REL1 and REL2 have different affinities for 
ATP (see Cruz-Reyes et al., 2002 and Igo Jr. et al., 2002). It would be important to 
determine if the REL2CD/1ID-TAP ligase behaved catalytically as REL2 in the 
deletion subcomplex, and REL1CD/2ID-TAP chimeras behaved catalytically as 
REL1 when in the addition subcomplex.  
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5.2.3 RNA Repair Assays 
There are many proteins involved in RNA repair in different organisms (Amitsur et 
al., 1987; Martins and Shuman, 2004; Martins and Shuman, 2005; Nandakumar et 
al., 2008; Tanaka and Shuman, 2011). One of the best studied RNA repair systems is 
that of T4 bacteriophage, whereby the polynucleotide kinase-phosphatase 
(PnKp)/Hen1 heterodimer and T4Rnl1 work to repair RNA fragments cleaved by 
ribotoxins (Amitsur et al., 1987; Wang et al., 2012). This system of repair has been 
used to create assays specific to tRNA repair in vitro (Zhang et al., 2012). Building 
on the methods mentioned in Section 5.2.2, in vitro editing assays could be modified 
to ascertain the ability of REL1 in RNA repair. These assays would be performed on 
mitochondrial extracts and use of synthesised substrates that mimic the products of 
misediting cleavage directed by endonucleases, which could be prepared by T7 
transcription from PCR templates (Igo Jr. et al., 2002; Cruz-Reyes et al., 2002). 
These RNA fragments could consist of unexpected cleavage events at both editing 
and non-editing sites. 
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5.2.4 Application of RNA sequencing strategy 
Since meaningful sequences were obtained through capture of 5’ monophosphates 
born of endonucleolytic cleavage, it is possible to expand this study to encompass 
different transcripts and RNA examples. So far only ND7 and RPS12 REL1 
substrates were successfully captured and subjected to deep sequencing, but there 
remain another ten transcripts to be studied, which are edited in BSFs. Since the RTs 
for ND7 and RPS12 were generated using the same tagged hexamer primer, the 
generation of RT-PCRs for deep sequencing will be more streamlined. The tag was 
originally used to aid enrichment of 5’ linked transcripts after the initial RT stage to 
allow the global sequencing of mitochondrial transcripts. This approach could be 
pursued, and PCRs could be optimised, which have been designed with adapters for 
direct attachment to the Illumina sequencing flow cell. 
Another possibility would be to extract RNA for sequencing from REL2 
RNAi, or null mutant cell lines (see Section 5.2.5 below). This would also reveal the 
substrates of REL2, through comparison of samples prepared from cells expressing 
normal and reduced levels of REL2, or none at all. From the results in Chapter 3 it 
would be expected that the absence of REL2 would create fragments indicative of 
expected addition editing substrates. If REL2 is functioning in vivo as a proof-
reading enzyme, as well as in insertion editing as this study and others have 
suggested, then its ablation may also give rise to stretches of misedited sequences in 
the presence of REL1.  
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5.2.5 Creation of a REL2 null mutant 
Originally the REL2 null mutant was attempted to aid integration of the 
REL1CD/2ID tagged chimeric ligases into native editosomes. This experiment was 
also attractive because the RNAi lines available do not completely knock-out the 
protein, and a small amount of REL2 may be sufficient in the cell to maintain 
function in RNA editing (Huang et al., 2001; Schnaufer et al., 2001; Drozdz et al., 
2002; Gao and Simpson, 2003; O’Hearn et al., 2003). The creation of a null mutant 
was not possible in the time frame of this study; however. Both plasmid and PCR 
based disruption, the latter of which was also adopted by Maciej Drozdz (personal 
communication) were attempted, with no success. Whilst the PCR based approach 
tends to produce varying transfection efficiencies, it is surprising that a single allele 
could not be effectively replaced by a drug resistance marker (Oberholzer et al., 
2006). The best future approach would be to construct a plasmid-based REL2 null in 
wt 427 and cKO REL1 cells using robust drug selection markers, such as puromycin 
and blasticidin.  
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5.3 Outlook 
The findings described here provide significant and novel insight into the roles of the 
RNA editing ligases and, in addition, have elucidated a broad range of potential 
future studies within the field of RNA editing biology. One important observation of 
this study is the apparent cross talk between the CD and ID specifically of REL1 and 
REL2, which led to the lower activity of the chimeric ligases. This has not been well 
characterised, and may, if pursued, give further insight into transcript specific 
activities of REL1 and REL2. The results of this research has also elucidated a  novel 
role for REL1 in RNA editing, providing insight into its essentiality to the cell, and 
has provided an approach to sequence the substrates of the final step of RNA editing, 
which in turn can discern the roles of REL1 and REL2 biochemically. 
This future work is of great importance to trypanosome biology, since REL1 has 
been revealed as a potential drug target, and so it is of importance to clarify the 
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Appendix 1 
Below is illustrated the PCR strategy, for cloning and expression via pHD1344-TAP 











7 GACATTTATCGACACGGTACGAAGAGACTCCATCAATC or 
GTTGAAGCACCCCGGTAAGCAAGGGCCTCGCGTAGATG 
8 CACAGACCGAGCGCAAGGGCTGAAGGAGACATTTATCG 
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Appendix 2 
Below is listed the solution, and their methods of preparation, used in the Northern 





10ml of 2.5 M Na-Acetate (pH 7.0) 
10ml of 0.5 M EDTA 
Make up to 500ml with water, Autoclave and store in the dark at 4°C 
 
RNA Gel Loading Buffer  
150µl of formamide 
83µl of formaldehyde (37%) 
50µl of 10 x MOPS 
0.01% Bromophenol blue 
50µl glycerol 
167µl of water (to give a total volume of 500µl) 
 
[20x] SSC    for 1 litre 
3 M NaCl    175.2g 
0.3 M Tri Sodium Citrate    88.2g 
 
Maleic Acid Buffer  for 500ml 
Maleic Acid  5.8g  100mM Maleic acid  
NaCl   4.38g  150mM NaCl  




Below is listed the full length sequences (over two paragraphs, 5’ – 3’) cloned from limited sequencing reactions (Chapter 3).  
Correctly inserted Us - blue, incorrectly inserted Us – red. Non-deleted Us – white. 
ND7 + REL1  
DNA       G TA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  TG   TC  C  A   C  A    G    C A  C C 
RNA-ed    G UAuCAuuuuA  uGuuAuuuuuGGuA GuuuuuuuA  CAuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C 
+RT 433   G UAuCA uuuA  uGuuAuuuuuGGuA GuuuuuuuA  CAuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C 
+RT 512   G UAuCA uuuA  uGuuAuuuuuGGuA GtuuuuuuA  CAuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C 
+RT 422   GuUAuCA uuuA  uGuuAuuuuuGGuA GuuuuuuuA  CAuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C  
+RT 411   GuUA CA u  A  uGuuAuuuuuGGuA GuuuuuuuA  CAuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C  
+RT 412   GuUA CA u  A  uGuuAuuuuuGGuA GuuuuuuuA  CAuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C  
+RT 421   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   UC  C  A   C  A    G    C A  C C  
+RT 423   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G CUG   UC  C  A   C  A    G    C A  C C  
+RT 431   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   .C  C  A  uC uA    G    C A uC C  
+RT 432   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G   G   .C  C  A  uC  A    G   uC A  C C 
+RT 441   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   UC  C  A   C  A    G    C A  C C 
+RT 442   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   UC  C  A   C  A    G    C A  C C 
+RT 443   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   UC  C  A   C  A    G    C A  C C 
+RT 511   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G uUG   .C  C  A  uC  A    G    CuA uC C 
+RT 513   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G   G uuUC  C  A   C  A    G   uC A uC C 
+RT 521   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G   G uuUC  C  A   C  A    G   uC AuuC C 
+RT 522   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G uUG   UC  C  A   C  A    G    C A  C C 
+RT 523   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   UC  C  A   C  A    G    CuA  C C 
+RT 532   G UA CA    A   G  A     GG A G       A  CA   G  A CG    A   C    A           G  UG   UC  C  A   C  A    G    C A  C C 
 
DNA       C G  TTTC A   G   C  A  C    A     G     TTG   G      A    G  G   A   G  A      G     G  G GA TA   A   G      ATTTA    
RNA-ed    C G     C A   G   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA    
+RT 433   C G     C A   G   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 512   C G     C A   G   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 422   C G     C A  uG   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 411   C G     C A   G   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 412   C G     C A   G   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UG 
+RT 421   C G     CuA  uG   C  A  C    A     G       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 423   C G     CuA  uG   C  A  C    A     G       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 431   C G     CuA  uG   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 432   C G    uC A uuG   C  A  C    A    uG       G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 441   C G  uuuC A   G   C  A  C    A     G     UUG   G      A    G  G   A   G  A     uG     G uG GA UA uuA uuG   uuuA  UA 
+RT 442   C G  uuuC A   G   C  A  C    A     G     UUG   G      A    G  G   A   G  A      G     G  G GA UA   A uuG   uuuA  UA 
+RT 443   C G  uuuC A   G   C  A  C    A     G     UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA 
+RT 511   C G     CuA  uG   C  A  C    A    uG       G   G      .   uGCu.uuuA  uGTTCGCTTTATTGTATCTTTGTGGTGAATTTATTGTATATTATTG 
+RT 513   C G     CuA uuG   T  A  C    A     G      UG uuG     uA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 521   C G     CuA uuG   T  A  C    A     G      UG uuG     uA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 522   C G  uuuC A   G   C  A  C    A     G     UUG   G      A    G  G   A  uG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA 
+RT 523   C G    uC A   G   C  A  C    AuuuuuG      UG   G      A    GuuGuuuA  uG  A      G     G  G GA UA uuA uuG   uuuA  UA 





ND7 - REL1  
DNA       A   G  A CG    A   C    A           G  TG   TC  C  A   C  A    G    C A  C C C G  TTTC A   G   C  A  C    A     G 
RNA-ed    AuuuG uAuCGuuuuA   C    A        uuuG   G   UC  C  A   C  A    G    C A uC C C G     C A   G   C  A  C    A    uG 
+RT 832   A   G  A CG  uuA  uC    A         uuG uUG    C  C  A   C  A    G    C A                    G   C  A  C    A  uuuG        
+RT 813   A   G  A CG    A   C   uA           G  UG    C  C  A  uC  A    G    CuA  C C C G  uuuCuA  uG   C  A  C    A    uG        
+RT 911   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C CuC G     CuA  uG   C  A  C    A     G       
+RT 822   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G   uC A  C C C G     T A  uG uuC  A  C    A     G       
+RT 823   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G     
+RT 833   A   G  A CG    A   C    A           G uUG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G      
+RT 841   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G      
+RT 912   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G      
+RT 913   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G      
+RT 921   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G      
+RT 922   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G      
+RT 933   A   G  A CG    A   C    A           G  UG   uC  C  A   C  A    G    C A  C C C G  uuuC A   G   C  A  C    A     G  
+RT 811                                                                                  G     C A  uG   C  A  C    A    uG        
+RT 932                                                                                              G   C  A  C    A    uG        
                                                                                                                                      
 
DNA       TTG   G      A    G  G   A   G  A      G     G  G GA TA   A   G      ATTTA   TTG   A  TG    A   A  ATTTGTG   A  
RNA-ed      G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UUG   A uUG   uA uuA uA   G G uuA  
+RT 832     GuuuG     uA uuuGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UUG   A uUG   uA uuA uA   G G uuA 
+RT 813     G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UUG   A uUG   uA uuA uA   G G uuA 
+RT 922   UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA   UUG   A  UG    A   A  AUUUGUG   A 
+RT 911    UG  uG   uuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uCuA  UA   UUG   A uUG   uA uuA uA   G G uuA 
+RT 933   UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA   UUG   A  UG    A   A  AUUUGUG   A 
+RT 822    UG   G   uuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UUG   A uUG   uA uuA uG   G G uuA  
+RT 823   UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA   UUG   A  UG    AuuuAuuA  UG GGuuA 
+RT 833   UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA   UUG   A  UG    A   A  A  UG G uuA 
+RT 841   UUG   G      A    G  G   A   G  A      G     G  G GA UAuuuA uuG   uuuA  UA   UUG   A   G    A uuA uA   G G uuA 
+RT 912   UUG   G      A    G  G   A   G  A     uG     G  G .A UA   A   G      AUUUA   UUG   A  UG    A   A  AUUUGUG   A 
+RT 913   UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA   UUG   A  UG    A   A  AUUUGUG   A 
+RT 921   UUG   G      A    G  G   A   G  A      G     G  G GA UA   A   G      AUUUA   UUG   A  UG    A   A  AUUUGUG   A 
+RT 811     G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UUG   A uUG   uA uuA uA   G G uuA 
+RT 932     G  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UAG   AGGUG   uA uuA uA   G G uuA 
+RT        UG  uG  uuuuA   uGuuGuuuA uuG uA uuuuuG    uG  GuGA  AuuuA uuG   uuuA  UA   UUG   A uUG   uA uuA uA   G G uuA 
+RT                                                                               UA   UUG   A uUG   uA uuA uA   G G uuA 
+RT                                                                                A   UUG  uA   G   uA   G  A   G G uuA 
+RT 942                                                                                 UG uuA  ..    AuuuAuuA UAG G uuA 
+RT                                                                                          A uUG   uA uuA uA   G G uuA 
+RT 853                                                                                      A uUG   uA uuA uA   G G uuA 
+RT                                                                                                     uuA uA   G G uuA 
+RT 852                                                                                                  uAuuA  UG GGuuA 
+RT                                                                                                      uA uA   G G uuA 
+RT                                                                                                              G G uuA 
+RT                                                                                                              G G uuA 




RPS12 + REL1  
DNA CCGG AACCGACG G A  G A GCTTCTTTTG A    A  TA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GTTTC                                                                                      
RNA-ed CCGGuAACCGACGuGuAuuGuAuGC  C    GuAuuuuA uUAuAuA  AuuuuGuuuG G        AuGuuGCGuuGuuuuuuuuGuuGuuuuAuuGGuuuAGuuAuG  UC 
E (A) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A G  UC 
PE1 (B) CCGGuAACCGACGuGuAuuGuAuGC  C    GuAuuuuAuuUAuAuA  AuuuuGuuuG G        AuGuuGCGuuG   uuuuuGuuGuuuuAuuGGuuuAGuuAuG  UC 
PE2 (B) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A AuuA    G   GuGuuuuuuuuAuGuuGCGuuG    uuuuG uG   uA  GGuuuAGuuAuG  UC 
U1 (C) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GUUUC 
U1 (C) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GUUUC 
U3 (C) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GUUUC 
 
DNA  A  A   A  A A G ATTTGGG TGG G G    G  G A   AC C CTTTGTTTTG   GTT  A A  A  G A  A   A  CA TCGTTTA  G AAG  AGATTTTAGA AT 
RNA-ed AuuAuuuAuuAuA G A   GGG UGGuG GuuuuGuuG AuuuAC C C   G    G  uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
E(A) A  A   A  AuAuGuA   GGGuUGG GuG  uuGuuGuA  uAC C C   G  UUGuuuGUUuuAuAuuAuuGuAuuA   AuuCA  CG   AuuGuAAGuuAGA UUUAGAuAU 
PE1(B) AuuAuuuAuuAuA G A   GGG UGGuG GuuuuGuuG AuuuAC C C   G    G  uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
PE2(B) AuuAuuuAuuAuA G A   GGG UGGuG GuuuuGuuG AuuuAC C C   G    G  uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
U1 (C) A  A   A  A A G AUUUGGG UGG G G    G  G A   AC C C   G    G   G U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
U1 (C) A  A   A  A A G AUUUGGG UGG G GuuuuGuuG AuuuAC C C   G    G  uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
U3 (C) A  A   A  A A G AUUUGGG UGG G G    G  G A   AC C CUUUGUUUUG   GUU  A A  A  G A  A   A  CA UCGUUUA  G AAG  AGAUUUUAGAuAU 
 
 
RPS12 - REL1 
DNA    CCGG AACCGACG G A  G A GCTTCTTTTG A    A  TA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GTTTC                                                                                      
RNA  CCGGuAACCGACGuGuAuuGuAuGC  C    GuAuuuuA uUAuAuA  AuuuuGuuuG G        AuGuuGCGuuGuuuuuuuuGuuGuuuuAuuGGuuuAGuuAuG  UC 
U1 (D) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GUUUC 
U2 (D) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GUUUC 
U3 (D) CCGG AACCGACG G A  G A GCUUCUUUUG A    A  UA A A  A    G   G G        A G  GCG  G        G  G    A  GG   AG  A GUUUC 
 
 
DNA   A  A   A  A A G ATTTGGG TGG G G    G  G A   AC C CTTTGTTTTG   GTT  A A  A  G A  A   A  CA TCGTTTA  G AAG  AGATTTTAGA AT 
RNA-ed AuuAuuuAuuAuA G A   GGG UGGuG GuuuuGuuG AuuuAC C C   G    G  uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
U1 (C) A  A   A  A A G AUUUGGG UGG G G    G  G A   AC C CUUUGUUUUG   GUU  A A  A  G A  A uuA  CA     UUAuuGuAAGuuAGA UUUAGAuAU 
U1 (C) A  A   A  A A G AUUUGGG UGG G G    G  G A   AC CuC UUG  UUG   GUU uAuA  A  G A uA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
U3 (C) A  A   A  A A G AUUUGGG UGG G G    G  GuA   ACuC C   G  UUG   -UU uAuA uA  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
F1 (E)                                            uG U  A A  A  GuA uA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
F1 (E)                                                               ACUC uAuA uA  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
F1 (E)                                                               uG U  A A  A  GuAuuA  uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU  
F1 (E)                                                                                 uAuuuA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
F1 (E)                                                                                     uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
F2 (F)                                                       G  UUG   GUU uAuA uA  GuA uA uuA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU                                                      
F2 (F)                                                                                 uGuuuA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU                                                                                     
F2 (F)                                                                                     uA  CA  CG  UAuuGuAAGuuAGA UUUAGAuAU                                                                                     
F2 (F)                                                                                         CA  CG  UAuuGuAAGuuAGA UUUAGAuAU 
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Appendix 4 
Below is collated the reads out for both Ion Torrent runs (Chapter 3) performed on 
+REL1 (Ion_Xpress 011) and –REL1 (Ion_Xpress 012) ND71 samples.  
First run 
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Appendix 5 
Tabulated overleaf is the data collated from Ion Torrent sequencing that has been subjected to the pipeline described in Chapter 3. The 
most 5’ and 3’ end of ND7 and the edited region are highlighted in yellow. The 3’ primer sequences used in the sequencing reaction is 
marked in red. Deletion (ESd) and insertion (ESi) editing sites are indicated in blue and pink respectively. The expected number of 
uridylyls in fully/correctly editied ND7 at each edited site is highlighted in turquoise. 
The tables are collated in the order: Category 1 +REL1, Category 1 –REL1, Category 2 +REL1 and Category 2 -REL1. 
 
 
   
 
Category 1 
ND7 – Ion Torrent 
+REL1 
no of Ts present 
before that 
position 










= del; + = 
ins) 




0 1 2 3 4 5 6 7 8 9 10 11 
 A 108 1 1 0 2 0 5 0 0 0 0 0 0 0 0 0 0  
 A 110 1 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0  
 A 112 2 2 0 3 0 3 4 0 0 0 0 0 0 0 0 0  
 A 114 0 0 0 3 7 0 0 0 0 0 0 0 0 0 0 0  
 A 116 3 3 0 170 2 1 32 15 2 0 0 0 0 0 0 0  
 A 118 1 1 0 170 32 164 0 0 0 0 0 0 0 0 0 0  
5' end G 120 1 1 0 11017 9 11084 115 0 0 0 0 0 0 0 0 0  
 A 122 0 0 0 8079 11366 181 3 0 0 0 0 0 0 0 0 0  
 A 124 1 1 0 7406 60 20020 28 0 1 0 0 0 0 0 0 0  
 
   
 C 126 0 0 0 861 26834 22 2 0 0 0 0 0 0 0 0 0  
 A 128 0 0 0 97 27713 1 0 0 0 0 0 0 0 0 0 0  
 A 130 0 0 0 26 27804 7 0 0 0 0 0 0 0 0 0 0  
 A 132 0 0 0 9 27835 1 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 0 27845 0 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 0 27844 1 0 0 0 0 0 0 0 0 0 0  
 A 138 0 0 0 5 27845 0 0 0 0 0 0 0 0 0 0 0  
 A 140 0 0 0 10 27850 0 0 0 0 0 0 0 0 0 0 0  
 C 142 0 0 0 0 27840 20 0 0 0 0 0 0 0 0 0 0  
 A 144 0 0 0 0 27857 3 0 0 0 0 0 0 0 0 0 0  
 G 146 1 1 0 0 44 27739 77 0 0 0 0 0 0 0 0 0  
 A 148 0 0 0 0 27843 17 0 0 0 0 0 0 0 0 0 0  
 C 150 0 0 0 9 27839 21 0 0 0 0 0 0 0 0 0 0  
 A 152 1 1 0 0 32 27750 87 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 8 27866 3 0 0 0 0 0 0 0 0 0 0  
 
   
 A 156 0 0 0 0 27874 3 0 0 0 0 0 0 0 0 0 0  
 G 158 1 1 0 0 81 27634 162 0 0 0 0 0 0 0 0 0  
 A 160 0 0 0 12 27867 7 0 0 0 0 0 0 0 0 0 0  
 A 162 1 1 0 0 14 27788 83 0 0 0 0 0 0 0 0 0  
 A 164 0 0 0 0 27838 38 4 0 0 0 0 0 0 0 0 0  
 G 166 0 0 0 0 27325 249 285 9 0 0 0 0 0 0 0 0  
 A 168 1 1 0 5 216 26850 646 15 6 1 0 0 0 0 0 0  
ES39i C 170 0 1 1 0 25674 1644 16 1 0 0 0 0 0 0 0 0  
 A 172 0 0 0 6 27253 9 1 0 0 0 0 0 0 0 0 0  
ES38i A 174 0 4 4 5 25041 508 132 1371 52 0 0 0 0 0 0 0  
ES37i G 176 0 1 1 27 24614 1798 459 12 3 0 0 0 0 0 0 0  
ES36i A 178 0 2 2 8 24300 60 2202 47 0 0 1 1 0 0 0 0  
ES35i G 180 0 5 5 57 24267 40 449 39 105 1537 132 3 0 0 0 0  
 G 182 0 0 0 1 26407 31 5 0 0 0 0 0 0 0 0 0  
ES34i A 184 0 1 1 1 23998 2303 29 3 0 0 0 0 0 0 0 0  
 
   
 G 186 0 0 0 0 25989 89 6 0 4 0 0 0 0 0 0 0  
ES33i A 188 0 7 7 23 23546 53 12 35 19 29 75 1456 594 77 5 2  
 C 190 0 0 0 5 25728 8 6 5 5 3 0 0 0 0 0 0  
 A 192 0 0 0 3 25618 35 4 0 0 0 0 0 0 0 0 0  
ES32i G 194 0 3 3 25 22956 154 204 2091 156 0 0 0 0 0 0 0  
ES31i A 196 0 1 1 0 22940 2350 119 5 0 0 0 0 0 0 0 0  
ES30i C 198 0 1 1 0 22919 2293 46 0 0 0 0 0 0 0 0 0  
 G 200 0 0 0 0 24979 9 0 0 1 0 0 0 0 0 0 0  
ES29i A 202 0 4 4 17 21766 226 496 122 1912 228 0 1 0 0 2 3  
 C 204 0 0 0 0 24193 103 28 37 2 0 0 0 0 0 0 0  
 A 206 0 0 0 0 23880 86 12 4 37 12 0 0 0 0 0 0  
ES28i G 208 0 3 3 40 21351 74 247 1894 171 0 0 0 2 0 0 0  
ES27d G 210 1 0 -1 0 2749 20163 291 19 8 2 0 0 0 0 0 0  
 C 212 1 1 0 0 2302 19944 42 6 8 2 0 0 1 0 1 3  
 C 214 0 0 0 0 21899 99 0 6 0 0 0 0 0 0 0 0  
 
   
 A 216 0 0 0 0 21657 88 5 0 0 0 0 0 0 0 0 0  
 C 218 0 0 0 7 20091 1132 26 58 2 0 0 0 0 0 0 0  
 A 220 0 0 0 0 20813 69 88 1 9 0 0 0 0 0 0 0  
 G 222 0 0 0 3 19945 270 186 161 30 0 0 0 0 0 0 0  
 C 224 0 0 0 20 19188 759 25 175 9 1 1 0 0 0 0 0  
 A 226 0 0 0 4 19420 369 20 0 0 0 0 0 0 0 0 0  
ES26i C 228 0 1 1 0 16964 2695 57 7 2 4 0 0 0 0 0 0  
 C 230 0 0 0 0 19694 18 3 0 0 0 0 0 0 0 0 0  
 C 232 0 0 0 37 19112 424 2 0 0 0 0 0 0 0 0 0  
 G 234 0 0 0 0 19373 41 13 2 0 0 0 0 0 0 0 0  
ES25d C 236 3 0 -3 96 3441 902 585 14184 244 29 6 0 0 0 0 0  
 A 238 0 0 0 110 17904 874 36 3 1 0 2 0 0 0 0 0  
 G 240 0 0 0 146 16000 2004 532 116 44 7 9 2 0 0 1 3  
 C 242 0 0 0 65 18067 239 28 33 57 49 8 0 0 1 0 0  
 A 244 0 0 0 24 18170 93 57 2 2 2 0 0 0 0 0 0  
 
   
 C 246 0 0 0 72 17662 305 69 40 14 26 0 0 0 0 1 0  
 A 248 0 0 0 117 17741 154 52 27 1 0 0 0 0 0 0 0  
ES24i G 250 0 1 1 44 13906 3479 221 93 19 107 11 1 4 1 0 0  
ES23d G 252 2 0 -2 308 3856 659 12904 394 71 22 3 4 0 0 0 0  
Es22i G 254 0 1 1 118 12895 4481 370 194 37 36 3 0 0 0 0 0  
Es21i A 256 0 4 4 186 12608 949 217 399 3579 197 35 4 0 0 0 0  
ES20i G 258 0 1 1 87 12537 4440 217 170 604 20 0 0 0 0 0 0  
ES19i G 260 0 2 2 68 12125 46 5282 157 204 47 3 0 0 0 0 0  
ES18i A 262 0 3 3 93 12006 87 579 4841 343 1 2 1 0 0 0 0  
ES17i G 264 0 2 2 100 11878 593 5170 98 1 14 2 0 0 0 0 0  
ES16i A 266 0 1 1 32 12330 5231 56 44 0 7 1 0 0 0 2 0  
ES15i G 268 0 5 5 105 11799 134 559 82 194 4628 312 5 2 0 0 0  
ES14i G 270 0 1 1 14 11939 4998 83 560 15 1 0 0 0 0 0 0  
 G 272 0 0 0 30 17440 82 10 1 0 0 0 0 0 0 0 0  
ES13i G 274 0 1 1 164 11756 5563 123 0 0 1 0 0 0 0 0 0  
 
   
 A 276 0 0 0 60 17251 215 2 1 0 0 0 0 0 0 0 0  
ES12d A 278 1 0 -1 158 5845 11535 71 41 0 0 0 0 0 0 0 0  
ES11i A 280 0 3 3 299 11315 899 393 4789 269 0 0 0 0 0 0 0  
ES10i G 282 0 2 2 32 11167 759 5514 211 7 1 0 0 0 0 0 0  
ES9i A 284 0 3 3 247 11656 106 252 5460 184 6 14 8 0 0 0 0  
ES8d A 286 3 1 -2 174 47 5738 457 11247 159 13 0 0 0 0 0 0  
 G 288 2 2 0 86 22 235 16677 715 5 32 7 0 0 0 0 0  
 A 290 0 0 0 95 17220 84 145 70 1 3 0 0 0 0 0 0  
ES7i G 292 1 2 1 98 338 11097 5634 412 4 11 1 0 0 0 0 0  
ES6i A 294 0 1 1 496 11326 5718 143 9 75 1 0 0 0 0 0 0  
ES5i A 296 0 2 2 267 11148 735 5795 121 14 0 0 0 0 0 0 0  
ES4i A 298 0 1 1 9 11038 6021 662 24 0 0 0 6 0 0 0 0  
ES3d G 300 3 0 -3 31 6129 704 248 9998 585 2 0 0 0 0 0 0  
ES2d G 302 1 0 -1 185 6873 10439 87 6 0 0 0 0 0 0 0 0  
ES1i A 304 0 2 2 693 9896 461 5917 1204 39 1 0 0 0 0 0 0  
 
   
 G 306 3 3 0 196 4 60 565 15482 1623 94 5 0 3 1 0 0  
 C 308 0 0 0 72 17287 174 3 1 0 0 0 0 0 0 0 0  
 A 310 0 0 0 7 17359 9 0 0 0 0 0 0 0 0 0 0  
 C 312 1 1 0 98 50 16961 261 0 0 0 0 0 0 0 0 0  
 G 314 0 0 0 14 16825 33 2 0 0 0 0 0 0 0 0 0  
 G 316 1 1 0 6 29 16210 359 0 0 0 0 0 0 0 0 0  
 G 318 0 0 0 173 16357 12 1 0 0 0 0 0 0 0 0 0  
 A 320 1 1 0 218 83 16373 142 0 0 0 0 0 0 0 0 0  
 C 322 0 0 0 64 16288 0 0 0 0 0 0 0 0 0 0 0  
 A 324 0 0 0 7 16184 12 0 0 0 0 0 0 0 0 0 0  
 G 326 0 0 0 0 15940 0 0 0 0 0 0 0 0 0 0 0  
 A 328 0 0 0 60 15925 11 0 0 0 0 0 0 0 0 0 0  
 A 330 0 0 0 209 15993 0 0 0 0 0 0 0 0 0 0 0  
 A 332 0 0 0 4 16186 1 0 0 0 0 0 0 0 0 0 0  
 A 334 0 0 0 199 16003 2 0 0 0 0 0 0 0 0 0 0  
 
   
 G 336 0 0 0 0 15902 276 0 0 0 0 0 0 0 0 0 0  
 A 338 2 2 0 1 11 116 15574 442 0 0 0 0 0 0 0 0  
 G 340 1 1 0 203 37 15858 100 0 0 0 0 0 0 0 0 0  
 G 342 1 1 0 1106 6 16537 48 0 0 0 0 0 0 0 0 0  
 A 344 0 0 0 1 16390 58 0 0 0 0 0 0 0 0 0 0  
 A 346 0 0 0 0 16328 29 2 0 0 0 0 0 0 0 0 0  
 A 348 1 1 0 0 50 15931 287 1 0 0 0 0 0 0 0 0  
 A 350 1 1 0 0 26 15782 83 0 0 0 0 0 0 0 0 0  
 A 352 0 0 0 0 15828 32 0 0 0 0 0 0 0 0 0 0  
 A 354 0 0 0 0 15852 1 0 0 0 0 0 0 0 0 0 0  
 A 356 0 0 0 0 15771 0 0 0 0 0 0 0 0 0 0 0  
 G 358 0 0 0 0 15713 33 1 0 0 0 0 0 0 0 0 0  
 G 360 1 1 0 0 4 15450 141 0 0 0 0 0 0 0 0 0  
 A 362 1 1 0 0 24 15193 190 0 0 0 0 0 0 0 0 0  
 G 364 0 0 0 0 15125 52 2 0 0 0 0 0 0 0 0 0  
 
   
 A 366 0 0 0 0 15082 66 1 0 0 0 0 0 0 0 0 0  
 A 368 0 0 0 0 15125 0 0 0 0 0 0 0 0 0 0 0  
 C 370 0 0 0 0 15091 4 0 0 0 0 0 0 0 0 0 0  
 A 372 0 0 0 0 15044 7 0 0 0 0 0 0 0 0 0 0  
 A 374 0 0 0 0 15026 4 0 0 0 0 0 0 0 0 0 0  
 G 376 1 1 0 0 21 14895 80 0 0 0 0 0 0 0 0 0  
 C 378 1 1 0 0 88 14650 114 3 0 0 0 0 0 0 0 0  
 C 380 2 2 0 0 4 488 14146 27 0 0 0 0 0 0 0 0  
 C 382 0 0 0 0 14537 0 3 0 0 0 0 0 0 0 0 0  
3' end G 384 0 0 0 0 14349 15 0 0 0 0 0 0 0 0 0 0  
  
 
   
 
Category 1 
ND7 – Ion Torrent -
REL1 













(- = del; 





0 1 2 3 4 5 6 7 8 9 10 11 
 A 108 1 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0  
 A 110 1 1 0 0 0 3 1 0 0 0 0 0 0 0 0 0  
 A 112 2 2 0 1 0 1 4 0 0 0 0 0 0 0 0 0  
 A 114 0 0 0 3 5 0 0 0 0 0 0 0 0 0 0 0  
 A 116 3 3 0 121 3 0 23 5 0 0 0 0 0 0 0 0  
 A 118 1 1 0 232 33 107 0 0 0 0 0 0 0 0 0 0  
5' end G 120 1 1 0 10920 14 11044 119 1 0 0 0 0 0 0 0 0  
 A 122 0 0 0 6791 11277 143 2 4 0 0 0 0 0 0 0 0  
 A 124 1 1 0 5815 110 18529 42 1 0 0 0 0 0 0 0 0  
 
   
 C 126 0 0 0 600 23874 14 0 0 0 0 0 0 0 0 0 1  
 A 128 0 0 0 115 24482 3 0 0 0 0 0 0 0 0 0 1  
 A 130 0 0 0 29 24587 12 0 0 0 0 0 0 0 0 0 0  
 A 132 0 0 0 3 24625 3 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 1 24628 3 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 0 24631 1 0 0 0 0 0 0 0 0 0 0  
 A 138 0 0 0 4 24631 0 0 0 0 0 0 0 0 0 0 0  
 A 140 0 0 0 5 24634 1 0 0 0 0 0 0 0 0 0 0  
 C 142 0 0 0 0 24625 15 0 0 0 0 0 0 0 0 0 0  
 A 144 0 0 0 4 24637 3 0 0 0 0 0 0 0 0 0 0  
 G 146 1 1 0 1 44 24541 60 0 0 0 0 0 0 0 0 0  
 A 148 0 0 0 0 24633 12 0 0 0 0 0 0 0 0 0 0  
 C 150 0 0 0 4 24636 9 0 0 0 0 0 0 0 0 0 0  
 A 152 1 1 0 4 26 24531 92 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 7 24652 1 0 0 0 0 0 0 0 0 0 0  
 
   
 A 156 0 0 0 9 24656 4 0 0 0 0 0 0 0 0 0 0  
 G 158 1 1 0 0 72 24489 108 0 0 0 0 0 0 0 0 0  
 A 160 0 0 0 6 24665 3 0 0 0 0 0 0 0 0 0 0  
 A 162 1 1 0 2 5 24603 66 0 0 0 0 0 0 0 0 0  
 A 164 0 0 0 0 24672 2 0 0 0 0 0 0 0 0 0 0  
 G 166 0 0 0 0 24617 36 14 0 0 0 0 0 0 0 0 0  
 A 168 1 1 0 5 170 24107 216 1 0 0 0 0 0 0 0 0  
ES39i C 170 0 1 1 0 24013 65 1 0 0 0 0 0 0 0 0 0  
 A 172 0 0 0 3 24055 1 0 0 0 0 0 0 0 0 0 0  
ES38i A 174 0 4 4 13 23862 17 0 59 1 0 0 0 0 0 0 0  
ES37i G 176 0 1 1 18 23699 75 17 0 0 0 0 0 0 0 0 0  
ES36i A 178 0 2 2 0 23314 51 95 2 0 0 0 0 0 0 0 0  
ES35i G 180 0 5 5 0 23297 0 14 0 3 76 3 0 0 0 0 0  
 G 182 0 0 0 0 23268 0 0 0 0 0 0 0 0 0 0 0  
ES34i A 184 0 1 1 3 23008 118 1 0 0 0 0 0 0 0 0 0  
 
   
 G 186 0 0 0 0 22888 1 0 0 0 0 0 0 0 0 0 0  
ES33i A 188 0 7 7 0 22490 47 0 3 0 0 5 62 24 2 0 0  
 C 190 0 0 0 0 22431 4 0 0 5 0 0 0 0 0 0 0  
 A 192 0 0 0 17 22327 2 1 0 0 0 0 0 0 0 0 0  
ES32i G 194 0 3 3 4 22079 56 10 87 6 0 0 0 0 0 0 0  
ES31i A 196 0 1 1 3 21986 112 31 0 0 0 0 0 0 0 0 0  
ES30i C 198 0 1 1 8 21908 151 3 0 0 0 0 0 0 0 0 0  
 G 200 0 0 0 0 22010 0 1 0 0 0 0 0 0 0 0 0  
ES29i A 202 0 4 4 14 21795 20 19 13 99 12 0 0 0 0 0 0  
 C 204 0 0 0 2 21689 56 3 14 1 0 0 0 0 0 0 0  
 A 206 0 0 0 10 21547 25 0 0 12 1 0 0 0 0 0 0  
ES28i G 208 0 3 3 10 21195 37 26 102 5 0 0 0 0 0 0 0  
ES27d G 210 1 0 -1 26 170 20436 283 27 3 1 0 0 0 0 0 0  
 C 212 1 1 0 8 1245 18763 28 1 5 0 0 0 0 0 0 1  
 C 214 0 0 0 3 19746 13 0 0 0 0 0 0 0 0 0 0  
 
   
 A 216 0 0 0 16 19513 54 1 0 1 0 0 0 0 0 0 0  
 C 218 0 0 0 0 19099 78 0 4 3 0 0 0 0 0 0 0  
 A 220 0 0 0 0 18841 9 9 0 2 0 0 0 0 0 0 0  
 G 222 0 0 0 0 18423 45 38 14 0 2 0 0 0 0 0 0  
 C 224 0 0 0 33 17948 167 6 20 2 0 0 0 0 0 0 0  
 A 226 0 0 0 0 17806 41 0 1 0 0 0 0 0 0 0 0  
ES26i C 228 0 1 1 0 17587 215 11 0 0 3 1 0 0 0 0 0  
 C 230 0 0 0 0 17802 4 0 0 0 0 0 0 0 0 0 0  
 C 232 0 0 0 109 17488 145 4 0 0 0 0 0 0 0 0 0  
 G 234 0 0 0 25 17605 22 13 1 0 0 0 0 0 0 0 0  
ES25d C 236 3 0 -3 408 395 390 413 16378 294 5 2 0 0 0 0 0  
 A 238 0 0 0 245 16998 580 25 7 0 0 0 0 0 0 0 0  
 G 240 0 0 0 370 16319 1065 228 50 7 0 5 0 0 0 1 0  
 C 242 0 0 0 140 17385 123 9 30 16 3 1 1 0 0 0 0  
 A 244 0 0 0 23 17332 30 29 1 1 0 0 0 0 0 0 0  
 
   
 C 246 0 0 0 145 17059 87 19 22 12 4 1 0 0 0 0 0  
 A 248 0 0 0 120 16986 57 40 8 7 0 0 0 0 0 0 0  
ES24i G 250 0 1 1 89 15695 1099 96 62 4 29 9 1 7 1 0 0  
ES23d G 252 2 0 -2 799 1449 781 14721 379 32 2 0 3 1 0 0 0  
Es22i G 254 0 1 1 481 15211 2401 143 148 19 45 2 0 0 0 0 0  
Es21i A 256 0 4 4 560 14728 1174 128 512 1791 46 23 2 0 0 0 0  
ES20i G 258 0 1 1 384 14599 2767 142 371 719 23 3 0 1 0 0 0  
ES19i G 260 0 2 2 78 14260 35 4187 50 91 5 4 0 0 0 0 0  
ES18i A 262 0 3 3 93 14113 104 308 3957 99 12 0 0 0 0 0 0  
ES17i G 264 0 2 2 56 13867 377 4135 58 9 42 0 0 0 0 0 0  
ES16i A 266 0 1 1 256 13999 4287 56 142 7 3 0 0 0 0 0 0  
ES15i G 268 0 5 5 108 13716 208 350 38 199 3922 132 0 1 0 0 1  
ES14i G 270 0 1 1 249 13969 4322 67 365 14 18 1 0 0 0 0 0  
 G 272 0 0 0 119 18575 174 31 5 0 1 0 0 0 0 0 0  
ES13i G 274 0 1 1 134 13802 4924 55 7 1 0 0 0 0 0 0 0  
 
   
 A 276 0 0 0 66 18575 236 23 5 0 0 0 0 0 0 0 0  
ES12d A 278 1 0 -1 303 5154 13401 104 140 15 1 0 0 0 0 0 0  
ES11i A 280 0 3 3 278 12987 1263 301 4451 66 0 0 0 0 0 0 0  
ES10i G 282 0 2 2 327 12906 857 5350 114 1 0 0 0 0 1 0 0  
ES9i A 284 0 3 3 733 13482 129 617 5361 134 10 10 1 0 0 0 0  
ES8d A 286 3 1 -2 3812 264 8735 533 13225 400 175 18 0 0 1 0 0  
 G 288 2 2 0 711 86 802 22100 727 168 104 28 0 0 0 0 0  
 A 290 0 0 0 1000 23026 109 478 497 7 31 1 0 0 0 0 0  
ES7i G 292 1 2 1 610 764 13602 10582 194 8 37 10 1 0 0 0 0  
ES6i A 294 0 1 1 1510 13846 11984 102 58 589 4 0 0 0 0 0 0  
ES5i A 296 0 2 2 1804 12949 2530 12584 202 75 1 0 0 0 0 0 0  
ES4i A 298 0 1 1 670 12755 13466 2607 60 7 0 0 0 0 0 0 0  
ES3d G 300 3 0 -3 3093 13549 3680 805 11229 654 40 7 6 2 2 0 1  
ES2d G 302 1 0 -1 1514 19159 12959 313 54 4 1 0 0 0 0 0 0  
ES1i A 304 0 2 2 1748 11327 1000 17825 3959 54 4 0 0 0 0 0 0  
 
   
 G 306 3 3 0 243 0 15 878 30456 3229 141 23 31 4 2 2 2  
 C 308 0 0 0 40 34144 168 0 0 0 0 0 0 0 0 0 0  
 A 310 0 0 0 69 34117 30 0 0 0 0 0 0 0 0 0 0  
 C 312 1 1 0 53 79 33706 261 0 0 0 0 0 0 0 0 0  
 G 314 0 0 0 18 33555 28 0 0 0 0 0 0 0 0 0 0  
 G 316 1 1 0 15 32 32816 412 0 0 0 0 0 0 0 0 0  
 G 318 0 0 0 11 32952 13 1 0 0 0 0 0 0 0 0 0  
 A 320 1 1 0 67 105 32607 139 0 0 0 0 0 0 0 0 0  
 C 322 0 0 0 19 32393 2 0 0 0 0 0 0 0 0 0 0  
 A 324 0 0 0 45 32166 19 0 0 0 0 0 0 0 0 0 0  
 G 326 0 0 0 16 31897 0 0 0 0 0 0 0 0 0 0 0  
 A 328 0 0 0 59 31893 10 0 0 0 0 0 0 0 0 0 0  
 A 330 0 0 0 85 31949 13 0 0 0 0 0 0 0 0 0 0  
 A 332 0 0 0 23 32031 0 0 0 0 0 0 0 0 0 0 0  
 A 334 0 0 0 18 31808 2 0 0 0 0 0 0 0 0 0 0  
 
   
 G 336 0 0 0 50 31482 309 2 0 0 0 0 0 0 0 0 0  
 A 338 2 2 0 46 12 192 30982 645 0 0 0 0 0 0 0 0  
 G 340 1 1 0 14 55 31080 104 0 0 0 0 0 0 0 0 0  
 G 342 1 1 0 68 3 30594 75 0 0 0 0 0 0 0 0 0  
 A 344 0 0 0 2 30174 71 0 0 0 0 0 0 0 0 0 0  
 A 346 0 0 0 0 30065 52 0 0 0 0 0 0 0 0 0 0  
 A 348 1 1 0 0 72 29530 318 0 0 0 0 0 0 0 0 0  
 A 350 1 1 0 0 63 29134 114 0 0 0 0 0 0 0 0 0  
 A 352 0 0 0 0 29195 53 0 0 0 0 0 0 0 0 0 0  
 A 354 0 0 0 0 29236 1 0 0 0 0 0 0 0 0 0 0  
 A 356 0 0 0 0 29091 0 0 0 0 0 0 0 0 0 0 0  
 G 358 0 0 0 0 29014 29 0 0 0 0 0 0 0 0 0 0  
 G 360 1 1 0 0 6 28583 227 1 0 0 0 0 0 0 0 0  
 A 362 1 1 0 0 30 28278 211 0 0 0 0 0 0 0 0 0  
 G 364 0 0 0 0 27947 99 0 0 0 0 0 0 0 0 0 0  
 
   
 A 366 0 0 0 0 27897 114 0 0 0 0 0 0 0 0 0 0  
 A 368 0 0 0 0 27963 2 0 0 0 0 0 0 0 0 0 0  
 C 370 0 0 0 0 27926 0 0 0 0 0 0 0 0 0 0 0  
 A 372 0 0 0 0 27865 13 0 0 0 0 0 0 0 0 0 0  
 A 374 0 0 0 0 27832 5 0 0 0 0 0 0 0 0 0 0  
 G 376 1 1 0 0 47 27626 114 0 0 0 0 0 0 0 0 0  
 C 378 1 1 0 0 147 27309 116 1 0 0 0 0 0 0 0 0  
 C 380 2 2 0 0 6 686 26560 51 0 0 0 0 0 0 0 0  
 C 382 0 0 0 0 27045 1 3 0 0 0 0 0 0 0 0 0  
3' end G 384 0 0 0 0 26779 25 0 0 0 0 0 0 0 0 0 0  
 
   
 
Category 2 
ND7 – Ion Torrent 
+REL1 
no of Ts 
present before 
that position    











in no. of 
cat1 
reads 
0 1 2 3 4 5 6 7 8 9 10 11 
 A 108 1 1 0             
 
 A 110 1 1 0              
 A 112 2 2 0              
 A 114 0 0 0              
 A 116 3 3 0              
 A 118 1 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0  
5' end G 120 1 1 0 86 0 37 0 0 0 0 0 0 0 0 0 0  
 A 122 0 0 0 43 87 2 0 0 0 0 0 0 0 0 0 0  
 A 124 1 1 0 185 2 225 7 0 0 0 0 0 0 0 0 0  
 
   
 C 126 0 0 0 91 312 8 1 0 0 0 0 0 0 0 0 0  
 A 128 0 0 0 129 406 0 0 0 0 0 0 0 0 0 0 0  
 A 130 0 0 0 24 534 1 0 0 0 0 0 0 0 0 0 0  
 A 132 0 0 0 1 559 0 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 2 560 0 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 1 562 0 0 0 0 0 0 0 0 0 0 0  
 A 138 0 0 0 1 563 0 0 0 0 0 0 0 0 0 0 0  
 A 140 0 0 0 2 564 0 0 0 0 0 0 0 0 0 0 0  
 C 142 0 0 0 3 565 1 0 0 0 0 0 0 0 0 0 0  
 A 144 0 0 0 290 566 88 1 0 0 0 0 0 0 0 0 0  
 G 146 1 1 0 428 135 931 2 0 0 0 0 0 0 0 0 0  
 A 148 0 0 0 144 1285 4 0 0 0 0 0 0 0 0 0 0  
 C 150 0 0 0 209 1429 3 0 0 0 0 0 0 0 0 0 0  
 A 152 1 1 0 677 9 2095 15 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 255 2295 25 0 0 0 0 0 0 0 0 0 0  
 
   
 A 156 0 0 0 416 2572 44 0 0 0 0 0 0 0 0 0 0  
 G 158 1 1 0 1930 101 4402 21 0 0 0 0 0 0 0 0 0  
 A 160 0 0 0 317 4890 59 1 0 0 0 0 0 0 0 0 0  
 A 162 1 1 0 645 54 5583 19 0 0 0 0 0 0 0 0 0  
 A 164 0 0 0 5 5874 8 0 0 0 0 0 0 0 0 0 0  
 G 166 0 0 0 34 5871 12 3 0 0 0 0 0 0 0 0 0  
 A 168 1 1 0 126 119 5814 47 2 0 0 0 0 0 0 0 0  
ES39i C 170 0 1 1 112 5972 70 10 1 0 0 0 0 0 0 0 0  
 A 172 0 0 0 113 6148 10 0 0 0 0 0 0 0 0 0 0  
ES38i A 174 0 4 4 10 6201 18 6 47 5 0 0 0 0 0 0 0  
ES37i G 176 0 1 1 24 6174 78 26 3 1 0 0 0 0 0 0 0  
ES36i A 178 0 2 2 123 6201 10 93 6 0 1 0 0 0 0 0 0  
ES35i G 180 0 5 5 145 6302 24 15 1 37 54 0 0 0 0 0 0  
 G 182 0 0 0 5 6571 1 0 0 0 0 0 0 0 0 0 0  
ES34i A 184 0 1 1 74 6451 111 18 0 0 0 0 0 0 0 0 0  
 
   
 G 186 0 0 0 174 6647 5 0 0 0 0 0 0 0 0 0 0  
ES33i A 188 0 7 7 176 6695 2 1 0 2 5 12 82 35 2 0 0  
 C 190 0 0 0 218 6990 8 1 0 3 0 0 0 0 0 0 0  
 A 192 0 0 0 241 7170 49 1 0 0 0 0 0 0 0 0 0  
ES32i G 194 0 3 3 190 7248 17 27 170 6 0 0 0 0 0 0 0  
ES31i A 196 0 1 1 210 7420 205 23 3 0 0 0 0 0 0 0 0  
ES30i C 198 0 1 1 253 7639 126 97 1 0 0 0 0 0 0 0 0  
 G 200 0 0 0 234 8104 9 0 0 0 0 0 0 0 0 0 0  
ES29i A 202 0 4 4 188 7938 71 85 10 207 45 1 0 0 0 0 0  
 C 204 0 0 0 274 8485 40 4 10 0 0 0 0 0 0 0 0  
 A 206 0 0 0 342 8771 15 6 5 12 2 0 0 0 0 0 0  
ES28i G 208 0 3 3 276 8750 37 65 266 72 0 0 0 0 0 0 0  
ES27d G 210 1 0 -1 836 526 9296 29 4 0 0 0 0 0 0 0 0  
 C 212 1 1 0 768 294 10167 93 1 2 0 0 0 1 1 0 0  
 C 214 0 0 0 26 11006 26 0 4 0 0 0 0 0 0 0 0  
 
   
 A 216 0 0 0 333 10880 178 0 0 0 0 0 0 0 0 0 0  
 C 218 0 0 0 341 11083 284 11 18 0 0 0 0 0 0 0 0  
 A 220 0 0 0 405 11663 39 28 2 3 0 0 0 0 0 0 0  
 G 222 0 0 0 369 11925 108 59 44 5 1 0 0 0 0 0 0  
 C 224 0 0 0 748 12096 348 15 65 2 0 0 0 0 0 0 0  
 A 226 0 0 0 1280 13150 100 7 0 0 0 0 0 0 0 0 0  
ES26i C 228 0 1 1 459 13678 864 18 2 1 0 0 0 0 0 0 0  
 C 230 0 0 0 18 14985 6 2 0 0 0 0 0 0 0 0 0  
 C 232 0 0 0 19 14827 180 6 0 0 0 0 0 0 0 0 0  
 G 234 0 0 0 105 14988 35 7 0 0 0 0 0 0 0 0 0  
ES25d C 236 3 0 -3 556 1206 326 192 13293 595 3 2 0 0 0 0 0  
 A 238 0 0 0 731 15395 312 22 4 1 0 0 0 0 0 0 0  
 G 240 0 0 0 423 15356 803 215 54 18 2 8 2 2 0 0 0  
 C 242 0 0 0 863 16686 109 9 13 22 14 2 0 0 0 0 0  
 A 244 0 0 0 1561 17406 333 38 4 1 0 0 0 0 0 0 0  
 
   
 C 246 0 0 0 278 18995 205 38 25 9 6 3 0 0 0 0 0  
 A 248 0 0 0 605 19397 111 42 5 1 2 0 0 0 0 0 0  
ES24i G 250 0 1 1 398 17810 2147 166 42 21 39 7 4 0 0 0 0  
ES23d G 252 2 0 -2 361 2625 434 17255 485 33 18 3 2 0 0 0 0  
Es22i G 254 0 1 1 292 17779 2727 294 121 29 5 0 1 0 0 0 0  
Es21i A 256 0 4 4 278 17634 500 151 142 1548 1345 33 5 1 1 0 0  
ES20i G 258 0 1 1 737 17556 3444 267 125 249 75 1 0 0 0 0 0  
ES19i G 260 0 2 2 190 17829 116 4173 103 128 23 2 0 0 0 0 0  
ES18i A 262 0 3 3 229 17796 44 344 3377 1018 2 3 1 0 0 0 0  
ES17i G 264 0 2 2 593 17820 457 4369 131 1 10 0 0 0 0 0 0  
ES16i A 266 0 1 1 456 18554 4582 103 15 1 4 0 0 0 0 0 0  
ES15i G 268 0 5 5 554 18584 97 387 32 441 3779 439 3 0 0 0 0  
ES14i G 270 0 1 1 429 19153 4710 83 369 9 4 2 0 0 0 0 0  
 G 272 0 0 0 42 24604 63 5 3 0 0 0 0 0 0 0 0  
ES13i G 274 0 1 1 153 19238 5469 24 2 0 2 0 0 0 0 0 0  
 
   
 A 276 0 0 0 175 24807 58 2 1 0 0 0 0 0 0 0 0  
ES12d A 278 1 0 -1 1080 5942 19351 278 20 1 0 0 0 0 0 0 0  
ES11i A 280 0 3 3 135 19901 649 271 5041 338 0 0 0 0 0 0 0  
ES10i G 282 0 2 2 414 19817 723 5814 87 3 0 0 0 0 0 0 0  
ES9i A 284 0 3 3 707 20393 110 152 5805 399 4 1 0 0 0 0 0  
ES8d A 286 3 1 -2 1163 90 6533 490 20660 407 9 0 0 0 0 0 0  
 G 288 2 2 0 1061 43 249 28833 310 11 27 3 0 0 0 0 0  
 A 290 0 0 0 700 29372 92 82 73 2 10 1 0 0 0 0 0  
ES7i G 292 2 1 -1 1170 177 22903 7808 37 3 16 0 0 0 0 0 0  
ES6i A 294 1 2 1 817 23490 8018 128 8 44 7 0 0 0 0 0 0  
ES5i A 296 0 2 2 564 23264 729 8465 206 29 2 0 0 0 0 0 0  
ES4i A 298 0 1 1 736 23009 9504 709 93 0 0 2 3 0 0 0 0  
ES3d G 300 3 0 -3 691 10011 1143 170 21681 813 2 0 0 0 0 0 0  
ES2d G 302 1 0 -1 1433 11575 23175 131 8 0 0 0 0 0 0 0 0  
ES1i A 304 0 2 2 1432 22978 1464 10382 1172 40 2 0 0 0 0 0 0  
 
   
 G 306 3 3 0 1238 0 6 430 34820 2995 110 2 7 5 0 0 0  
 C 308 0 0 0 1067 38254 135 0 0 0 0 0 0 0 0 0 0  
 A 310 0 0 0 2041 39446 1 0 0 0 0 0 0 0 0 0 0  
 C 312 1 1 0 1710 421 41661 132 0 0 0 0 0 0 0 0 0  
 G 314 0 0 0 1820 43105 134 4 0 0 0 0 0 0 0 0 0  
 G 316 1 1 0 3364 61 45954 420 0 0 0 0 0 0 0 0 1  
 G 318 0 0 0 106 48353 43 2 0 0 0 0 0 0 0 0 0  
 A 320 1 1 0 1640 267 48469 225 0 0 0 0 0 0 0 0 0  
 C 322 0 0 0 1412 50127 12 0 0 0 0 0 0 0 0 0 0  
 A 324 0 0 0 2331 51337 218 0 0 0 0 0 0 0 0 0 0  
 G 326 0 0 0 2088 53730 156 0 0 0 0 0 0 0 0 0 0  
 A 328 0 0 0 967 55805 158 0 0 0 0 0 0 0 0 0 0  
 A 330 0 0 0 105 56924 2 1 0 0 0 0 0 0 0 0 0  
 A 332 0 0 0 98 57029 3 0 0 0 0 0 0 0 0 0 0  
 A 334 0 0 0 54 57128 0 0 0 0 0 0 0 0 0 0 0  
 
   
 G 336 0 0 0 178 56753 430 5 0 0 0 0 0 0 0 0 0  
 A 338 2 2 0 321 10 1067 56228 274 0 0 0 0 0 0 0 0  
 G 340 1 1 0 603 544 57044 422 1 0 0 0 0 0 0 0 0  
 G 342 1 1 0 957 15 58416 249 2 0 0 0 0 0 0 0 0  
 A 344 0 0 0 623 59191 68 8 0 0 0 0 0 0 0 0 0  
 A 346 0 0 0 207 59834 71 2 0 0 0 0 0 0 0 0 0  
 A 348 1 1 0 1058 182 59575 581 0 0 0 0 0 0 0 0 0  
 A 350 1 1 0 2130 320 61601 297 0 0 0 0 0 0 0 0 0  
 A 352 0 0 0 274 62958 430 13 0 0 0 0 0 0 0 0 0  
 A 354 0 0 0 186 63427 153 34 0 0 0 0 0 0 0 0 0  
 A 356 0 0 0 108 63664 92 11 0 0 0 0 0 0 0 0 0  
 G 358 0 0 0 181 63742 111 13 1 0 2 0 0 1 0 0 0  
 G 360 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 A 362 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 G 364 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 
   
 A 366 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 A 368 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 C 370 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 A 372 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 A 374 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 G 376 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 C 378 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 C 380 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 C 382 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
3' end G 384 0 0 0 0 64008 0 0 0 0 0 0 0 0 0 0 0  
 
   
 
Category 2 
ND7 – Ion Torrent -
REL1 
no of Ts present 
before that 
position    















0 1 2 3 4 5 6 7 8 9 10 11 
 A 108 1 1 0              
 A 110 1 1 0              
 A 112 2 2 0              
 A 114 0 0 0              
 A 116 3 3 0              
 A 118 1 1 0 6 6 0 0 0 0 0 0 0 0 0 0 0  
5' end G 120 1 1 0 69 1 68 0 0 0 0 0 0 0 0 0 0  
 A 122 0 0 0 140 138 2 0 0 0 0 0 0 0 0 0 0  
 A 124 1 1 0 386 9 367 10 0 0 0 0 0 0 0 0 0  
 
   
 C 126 0 0 0 508 495 13 0 0 0 0 0 0 0 0 0 0  
 A 128 0 0 0 649 640 9 0 0 0 0 0 0 0 0 0 0  
 A 130 0 0 0 801 800 1 0 0 0 0 0 0 0 0 0 0  
 A 132 0 0 0 825 824 1 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 828 827 1 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 830 829 1 0 0 0 0 0 0 0 0 0 0  
 A 138 0 0 0 831 831 0 0 0 0 0 0 0 0 0 0 0  
 A 140 0 0 0 835 835 0 0 0 0 0 0 0 0 0 0 0  
 C 142 0 0 0 835 834 1 0 0 0 0 0 0 0 0 0 0  
 A 144 0 0 0 908 836 71 1 0 0 0 0 0 0 0 0 0  
 G 146 1 1 0 1443 112 1326 5 0 0 0 0 0 0 0 0 0  
 A 148 0 0 0 1658 1653 5 0 0 0 0 0 0 0 0 0 0  
 C 150 0 0 0 1863 1850 13 0 0 0 0 0 0 0 0 0 0  
 A 152 1 1 0 2688 18 2654 16 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 2992 2960 32 0 0 0 0 0 0 0 0 0 0  
 
   
 A 156 0 0 0 3390 3338 52 0 0 0 0 0 0 0 0 0 0  
 G 158 1 1 0 5607 108 5471 28 0 0 0 0 0 0 0 0 0  
 A 160 0 0 0 6073 6018 54 1 0 0 0 0 0 0 0 0 0  
 A 162 1 1 0 6442 10 6402 30 0 0 0 0 0 0 0 0 0  
 A 164 0 0 0 6503 6494 9 0 0 0 0 0 0 0 0 0 0  
 G 166 0 0 0 6506 6493 13 0 0 0 0 0 0 0 0 0 0  
 A 168 1 1 0 6560 118 6382 59 1 0 0 0 0 0 0 0 0  
ES39i C 170 0 1 1 6632 6566 66 0 0 0 0 0 0 0 0 0 0  
 A 172 0 0 0 6791 6789 2 0 0 0 0 0 0 0 0 0 0  
ES38i A 174 0 4 4 6977 6974 1 1 1 0 0 0 0 0 0 0 0  
ES37i G 176 0 1 1 6982 6926 55 1 0 0 0 0 0 0 0 0 0  
ES36i A 178 0 2 2 7021 7010 5 6 0 0 0 0 0 0 0 0 0  
ES35i G 180 0 5 5 7195 7148 41 0 0 2 4 0 0 0 0 0 0  
 G 182 0 0 0 7371 7371 0 0 0 0 0 0 0 0 0 0 0  
ES34i A 184 0 1 1 7376 7346 28 2 0 0 0 0 0 0 0 0 0  
 
   
 G 186 0 0 0 7447 7444 3 0 0 0 0 0 0 0 0 0 0  
ES33i A 188 0 7 7 7715 7707 1 0 1 0 0 2 3 1 0 0 0  
 C 190 0 0 0 7931 7929 2 0 0 0 0 0 0 0 0 0 0  
 A 192 0 0 0 8202 8130 72 0 0 0 0 0 0 0 0 0 0  
ES32i G 194 0 3 3 8546 8529 6 1 10 0 0 0 0 0 0 0 0  
ES31i A 196 0 1 1 8823 8796 21 6 0 0 0 0 0 0 0 0 0  
ES30i C 198 0 1 1 9113 9098 11 4 0 0 0 0 0 0 0 0 0  
 G 200 0 0 0 9445 9434 11 0 0 0 0 0 0 0 0 0 0  
ES29i A 202 0 4 4 9758 9693 46 3 2 13 1 0 0 0 0 0 0  
 C 204 0 0 0 10048 10000 44 0 4 0 0 0 0 0 0 0 0  
 A 206 0 0 0 10397 10387 7 0 1 1 1 0 0 0 0 0 0  
ES28i G 208 0 3 3 10945 10886 34 6 15 4 0 0 0 0 0 0 0  
ES27d G 210 1 0 -1 11885 51 11795 32 6 0 1 0 0 0 0 0 0  
 C 212 1 1 0 12741 51 12522 166 0 2 0 0 0 0 0 0 0  
 C 214 0 0 0 13348 13326 21 1 0 0 0 0 0 0 0 0 0  
 
   
 A 216 0 0 0 13380 13218 162 0 0 0 0 0 0 0 0 0 0  
 C 218 0 0 0 13835 13815 19 0 1 0 0 0 0 0 0 0 0  
 A 220 0 0 0 14254 14210 40 4 0 0 0 0 0 0 0 0 0  
 G 222 0 0 0 14836 14753 66 14 2 1 0 0 0 0 0 0 0  
 C 224 0 0 0 15327 15065 247 7 7 1 0 0 0 0 0 0 0  
 A 226 0 0 0 16337 16327 10 0 0 0 0 0 0 0 0 0 0  
ES26i C 228 0 1 1 17922 17819 100 2 0 0 1 0 0 0 0 0 0  
 C 230 0 0 0 18443 18441 2 0 0 0 0 0 0 0 0 0 0  
 C 232 0 0 0 18468 18420 42 6 0 0 0 0 0 0 0 0 0  
 G 234 0 0 0 18477 18440 37 0 0 0 0 0 0 0 0 0 0  
ES25d C 236 3 0 -3 19223 132 54 144 17997 894 2 0 0 0 0 0 0  
 A 238 0 0 0 19273 19178 79 4 11 1 0 0 0 0 0 0 0  
 G 240 0 0 0 19893 19688 142 43 17 2 0 1 0 0 0 0 0  
 C 242 0 0 0 20401 20359 18 9 4 6 3 2 0 0 0 0 0  
 A 244 0 0 0 20619 20226 389 3 1 0 0 0 0 0 0 0 0  
 
   
 C 246 0 0 0 20981 20921 42 11 6 1 0 0 0 0 0 0 0  
 A 248 0 0 0 21262 21191 64 6 1 0 0 0 0 0 0 0 0  
ES24i G 250 0 1 1 21863 21413 380 47 9 2 6 3 3 0 0 0 0  
ES23d G 252 2 0 -2 22817 427 201 21448 726 12 2 0 1 0 0 0 0  
Es22i G 254 0 1 1 22917 22346 478 58 24 8 2 1 0 0 0 0 0  
Es21i A 256 0 4 4 23041 22263 124 31 69 338 213 1 2 0 0 0 0  
ES20i G 258 0 1 1 23241 22156 873 63 43 85 15 5 1 0 0 0 0  
ES19i G 260 0 2 2 23854 22782 23 990 20 28 10 1 0 0 0 0 0  
ES18i A 262 0 3 3 23894 22757 25 131 843 138 0 0 0 0 0 0 0  
ES17i G 264 0 2 2 23966 22770 182 959 38 7 8 2 0 0 0 0 0  
ES16i A 266 0 1 1 24647 23496 1091 46 8 2 4 0 0 0 0 0 0  
ES15i G 268 0 5 5 25335 24058 51 144 14 123 875 69 0 0 0 1 0  
ES14i G 270 0 1 1 26138 24843 1125 19 138 5 4 4 0 0 0 0 0  
 G 272 0 0 0 26366 26300 59 5 0 1 0 0 1 0 0 0 0  
ES13i G 274 0 1 1 26394 24888 1489 17 0 0 0 0 0 0 0 0 0  
 
   
 A 276 0 0 0 26493 26446 40 7 0 0 0 0 0 0 0 0 0  
ES12d A 278 1 0 -1 27442 1788 25285 357 9 3 0 0 0 0 0 0 0  
ES11i A 280 0 3 3 28281 26244 412 112 1429 83 1 0 0 0 0 0 0  
ES10i G 282 0 2 2 28435 26149 422 1820 39 5 0 0 0 0 0 0 0  
ES9i A 284 0 3 3 28896 26564 96 221 1900 107 7 1 0 0 0 0 0  
ES8d A 286 3 1 -2 30747 99 2256 545 26967 820 54 6 0 0 0 0 0  
 G 288 2 2 0 32227 52 291 31498 324 24 30 8 0 0 0 0 0  
 A 290 0 0 0 32509 32129 174 103 88 6 9 0 0 0 0 0 0  
ES7i G 292 2 1 -1 34235 175 30374 3635 28 8 11 4 0 0 0 0 0  
ES6i A 294 1 2 1 35264 31328 3731 89 30 82 4 0 0 0 0 0 0  
ES5i A 296 0 2 2 36524 31382 649 4291 179 21 2 0 0 0 0 0 0  
ES4i A 298 0 1 1 37303 31159 5236 765 135 8 0 0 0 0 0 0 0  
ES3d G 300 3 0 -3 37981 5802 1745 677 28604 1074 40 28 9 2 0 0 0  
ES2d G 302 1 0 -1 39484 8470 30562 411 27 7 7 0 0 0 0 0 0  
ES1i A 304 0 2 2 41205 30147 1829 7846 1340 41 2 0 0 0 0 0 0  
 
   
 G 306 3 3 0 44534 0 12 515 41622 2298 62 14 5 1 4 1 0  
 C 308 0 0 0 44575 44360 214 0 1 0 0 0 0 0 0 0 0  
 A 310 0 0 0 46130 46126 3 1 0 0 0 0 0 0 0 0 0  
 C 312 1 1 0 49747 486 49052 209 0 0 0 0 0 0 0 0 0  
 G 314 0 0 0 51147 50869 274 4 0 0 0 0 0 0 0 0 0  
 G 316 1 1 0 55504 77 54752 675 0 0 0 0 0 0 0 0 0  
 G 318 0 0 0 58383 58280 102 1 0 0 0 0 0 0 0 0 0  
 A 320 1 1 0 59270 283 58551 436 0 0 0 0 0 0 0 0 0  
 C 322 0 0 0 60957 60916 41 0 0 0 0 0 0 0 0 0 0  
 A 324 0 0 0 63266 62949 317 0 0 0 0 0 0 0 0 0 0  
 G 326 0 0 0 65923 65656 267 0 0 0 0 0 0 0 0 0 0  
 A 328 0 0 0 66269 65995 274 0 0 0 0 0 0 0 0 0 0  
 A 330 0 0 0 66493 66492 1 0 0 0 0 0 0 0 0 0 0  
 A 332 0 0 0 66547 66546 1 0 0 0 0 0 0 0 0 0 0  
 A 334 0 0 0 66729 66728 1 0 0 0 0 0 0 0 0 0 0  
 
   
 G 336 0 0 0 66807 66155 649 3 0 0 0 0 0 0 0 0 0  
 A 338 2 2 0 67388 2 1203 65811 372 0 0 0 0 0 0 0 0  
 G 340 1 1 0 68469 479 67354 635 1 0 0 0 0 0 0 0 0  
 G 342 1 1 0 70008 25 69662 321 0 0 0 0 0 0 0 0 0  
 A 344 0 0 0 71159 71063 94 2 0 0 0 0 0 0 0 0 0  
 A 346 0 0 0 72227 72165 56 6 0 0 0 0 0 0 0 0 0  
 A 348 1 1 0 73118 219 72156 743 0 0 0 0 0 0 0 0 0  
 A 350 1 1 0 76503 339 75835 329 0 0 0 0 0 0 0 0 0  
 A 352 0 0 0 78525 77736 769 19 1 0 0 0 0 0 0 0 0  
 A 354 0 0 0 78831 78701 110 18 1 0 1 0 0 0 0 0 0  
 A 356 0 0 0 78977 78897 71 8 1 0 0 0 0 0 0 0 0  
 G 358 0 0 0 79098 78981 88 29 0 0 0 0 0 0 0 0 0  
 G 360 1 1 0 79251 0 0 0 0 0 0 0 0 0 0 0 0  
 A 362 1 1 0 79251 0 0 0 0 0 0 0 0 0 0 0 0  
 G 364 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 
   
 A 366 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 A 368 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 C 370 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 A 372 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 A 374 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 G 376 1 1 0 79251 0 0 0 0 0 0 0 0 0 0 0 0  
 C 378 1 1 0 79251 0 0 0 0 0 0 0 0 0 0 0 0  
 C 380 2 2 0 79251 0 0 0 0 0 0 0 0 0 0 0 0  
 C 382 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
3' end G 384 0 0 0 79251 79251 0 0 0 0 0 0 0 0 0 0 0  
 
   
Appendix 6 
The following tables tabulated overleaf contain MiSeq data that has been subjected to the pipeline described in Chapter 3.  
The most 5’ and 3’ end of ND7 and RPS12 and the edited region are highlighted in yellow. The 3’ primer sequences used in the 
sequencing reaction is marked in red. Deletion (ESd) and insertion (ESi) editing sites are indicated in blue and pink respectively. The 
expected number of uridylyls in fully/correctly editied ND7 at each edited site is highlighted in turquoise. 
There are no Category 2 reads for this data set due to the length of the fully edited sequences, so the following two tables are for +REL1 
and –REL1 samples. 
 
   
 
ND7 MiSeq +REL1 
no of Ts 
present before 
that position    








(- = del; 





0 1 2 3 4 5 6 7 8 9 10 11 
 A 108 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0  
 A 110 1 1 0 8 1 0 0 0 0 0 0 0 0 0 0 0  
 A 112 2 2 0 19 9 0 19 0 0 0 0 0 0 0 0 0  
 A 114 0 0 0 50 28 0 0 0 0 0 0 0 0 0 0 0  
 A 116 3 3 0 1021 59 0 316 77 0 0 0 0 0 0 0 0  
 A 118 1 1 0 908 139 1015 0 0 0 0 0 0 0 0 0 0  
5' end G 120 1 1 0 47433 7 48864 0 0 0 0 0 0 0 0 0 0  
 A 122 0 0 0 32761 49440 0 8 0 0 0 0 0 0 0 0 0  
 A 124 1 1 0 28359 79 84458 14 0 0 0 0 0 0 0 0 0  
 C 126 0 0 0 2439 110535 5 27 0 0 0 0 0 0 0 0 0  
 A 128 0 0 0 317 112999 6 0 0 0 0 0 0 0 0 0 0  
 
   
 A 130 0 0 0 0 113316 0 0 0 0 0 0 0 0 0 0 0  
 A 132 0 0 0 17 113316 0 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 4 113333 0 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 0 113337 0 0 0 0 0 0 0 0 0 0 0  
 A 138 0 0 0 21 113337 0 0 0 0 0 0 0 0 0 0 0  
 A 140 0 0 0 0 113358 0 0 0 0 0 0 0 0 0 0 0  
 C 142 0 0 0 0 113358 0 0 0 0 0 0 0 0 0 0 0  
 A 144 0 0 0 65 113358 0 0 0 0 0 0 0 0 0 0 0  
 G 146 1 1 0 0 0 113423 0 0 0 0 0 0 0 0 0 0  
 A 148 0 0 0 0 113423 0 0 0 0 0 0 0 0 0 0 0  
 C 150 0 0 0 33 113423 0 0 0 0 0 0 0 0 0 0 0  
 A 152 1 1 0 0 1 113455 0 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 0 113456 0 0 0 0 0 0 0 0 0 0 0  
 A 156 0 0 0 0 113456 0 0 0 0 0 0 0 0 0 0 0  
 G 158 1 1 0 0 0 113456 0 0 0 0 0 0 0 0 0 0  
 
   
 A 160 0 0 0 0 113456 0 0 0 0 0 0 0 0 0 0 0  
 A 162 1 1 0 0 154 113261 41 0 0 0 0 0 0 0 0 0  
 A 164 0 0 0 0 112511 621 324 0 0 0 0 0 0 0 0 0  
 G 166 0 0 0 0 104895 3731 4825 5 0 0 0 0 0 0 0 0  
 A 168 1 1 0 127 284 106812 6194 155 117 21 0 0 0 0 0 0  
ES39i C 170 0 1 1 18 87993 25374 108 108 0 0 0 0 0 0 0 0  
 A 172 0 0 0 0 113557 44 0 0 0 0 0 0 0 0 0 0  
ES38i A 174 0 4 4 0 81331 7233 1790 23125 109 1 12 0 0 0 0 0  
ES37i G 176 0 1 1 63 77867 28996 6794 7 0 0 0 0 0 0 0 0  
ES36i A 178 0 2 2 111 77026 97 36569 19 2 0 0 1 0 0 0 0  
ES35i G 180 0 5 5 157 77024 132 7606 295 720 27762 337 0 0 0 0 0  
 G 182 0 0 0 1 113832 89 11 1 0 0 0 0 0 0 0 0  
ES34i A 184 0 1 1 0 76807 37102 24 0 0 0 0 0 0 0 0 0  
 G 186 0 0 0 0 113411 439 30 46 7 0 0 0 0 0 0 0  
ES33i A 188 0 7 7 112 76254 258 67 370 148 80 202 32649 3660 341 5 9  
 
   
 C 190 0 0 0 1 113685 233 23 46 58 0 0 0 0 0 0 0  
 A 192 0 0 0 14 113933 70 43 0 0 0 0 0 0 0 0 0  
ES32i G 194 0 3 3 0 73478 740 1526 38275 0 0 41 0 0 0 0 0  
ES31i A 196 0 1 1 0 73012 40495 520 0 33 0 0 0 0 0 0 0  
ES30i C 198 0 1 1 12 73330 40428 264 0 11 34 0 0 0 0 0 0  
 G 200 0 0 0 0 114044 17 0 11 0 0 0 0 0 0 0 0  
ES29i A 202 0 4 4 119 63289 2692 6847 667 40427 18 39 0 6 94 50 1  
 C 204 0 0 0 0 112723 772 238 332 126 0 0 0 0 0 0 0  
 A 206 0 0 0 30 113217 613 104 15 219 23 0 0 0 0 0 0  
ES28i G 208 0 3 3 23 69674 851 3159 40394 127 19 0 2 9 4 5 0  
ES27d G 210 1 0 -1 11 49609 63457 694 269 193 0 22 0 0 0 0 0  
 C 212 1 1 0 0 18342 95035 244 127 319 17 0 41 14 25 53 20  
 C 214 0 0 0 0 113049 1107 56 43 0 0 0 0 0 0 0 0  
 A 216 0 0 0 0 113732 400 99 24 0 0 0 0 0 0 0 0  
 C 218 0 0 0 0 94394 18085 432 1185 159 0 0 0 0 0 0 0  
 
   
 A 220 0 0 0 6 110354 1216 2662 23 0 0 0 0 0 0 0 0  
 G 222 0 0 0 0 103555 3914 4085 2282 354 17 0 54 0 0 0 0  
 C 224 0 0 0 36 96781 12652 389 4372 59 15 0 0 0 0 0 0  
 A 226 0 0 0 28 106812 7093 309 83 0 0 0 0 0 0 0 0  
ES26i C 228 0 1 1 0 56849 56880 241 251 104 0 0 0 0 0 0 0  
 C 230 0 0 0 1 113798 512 15 0 0 0 0 0 0 0 0 0  
 C 232 0 0 0 9 106792 7416 127 0 0 0 0 0 0 0 0 0  
 G 234 0 0 0 45 113637 530 161 7 0 0 0 0 0 0 0 0  
ES25d C 236 3 0 -3 94 71233 15211 4886 22593 56 457 0 0 0 0 0 0  
 A 238 0 0 0 89 100344 13587 382 159 2 0 0 0 0 0 0 0  
 G 240 0 0 0 203 68481 33559 9497 1214 1029 212 559 0 5 28 7 28  
 C 242 0 0 0 124 108872 2222 494 1270 863 1045 61 0 0 2 9 0  
 A 244 0 0 0 18 112874 910 840 226 4 0 36 0 0 0 0 0  
 C 246 0 0 0 101 107464 4245 1236 264 562 1045 31 0 40 15 5 8  
 A 248 0 0 0 87 111695 2517 603 61 108 0 25 0 0 0 0 0  
 
   
ES24i G 250 0 1 1 51 32609 75627 2676 2203 304 1340 360 0 0 0 0 0  
ES23d G 252 2 0 -2 898 81320 8406 19981 2559 2627 216 56 273 4 0 0 0  
Es22i G 254 0 1 1 388 20911 89331 2788 2797 274 149 0 0 5 25 0 0  
Es21i A 256 0 4 4 422 17621 14016 2659 3094 77476 719 1072 51 0 0 0 2  
ES20i G 258 0 1 1 262 15922 86259 3195 2606 8966 36 108 0 0 0 0 0  
ES19i G 260 0 2 2 106 13655 199 102808 100 313 62 0 0 0 0 0 0  
ES18i A 262 0 3 3 90 13309 537 1041 102282 0 67 6 0 0 0 0 0  
ES17i G 264 0 2 2 40 12654 1511 102538 255 4 364 0 0 0 0 0 0  
ES16i A 266 0 1 1 87 13616 102403 503 758 24 106 0 0 0 0 0 0  
ES15i G 268 0 5 5 40 12862 1281 943 284 129 101721 235 16 1 4 0 0  
ES14i G 270 0 1 1 16 13989 102464 155 793 9 70 0 0 0 0 0 0  
 G 272 0 0 0 1 116167 1070 223 0 0 20 16 0 0 0 0 0  
ES13i G 274 0 1 1 104 13815 103611 72 0 0 0 0 0 0 0 0 0  
 A 276 0 0 0 15 117225 352 24 0 0 0 0 0 0 0 0 0  
ES12d A 278 1 0 -1 58 105264 11335 289 539 194 0 0 0 0 0 0 0  
 
   
ES11i A 280 0 3 3 133 7596 3675 1965 104496 40 0 0 0 0 0 0 0  
ES10i G 282 0 2 2 111 7050 1025 109405 313 0 2 32 0 0 0 0 0  
ES9i A 284 0 3 3 188 7189 125 1834 108660 48 50 94 0 0 0 0 0  
ES8d A 286 3 1 -2 146 638 108612 32 8433 48 394 0 0 0 0 0 0  
 G 288 2 2 0 140 356 1591 115022 133 74 1153 26 0 0 0 0 0  
 A 290 0 0 0 31 115260 203 1591 1318 15 5 0 12 0 0 0 0  
ES7i G 292 1 2 1 58 1817 6969 109621 46 2 6 0 0 0 0 0 0  
ES6i A 294 0 1 1 91 6501 110040 169 308 1494 6 0 17 0 0 0 0  
ES5i A 296 0 2 2 184 4614 2045 111981 17 6 0 0 0 0 0 0 0  
ES4i A 298 0 1 1 165 4058 114007 726 0 17 0 0 0 0 0 0 0  
ES3d G 300 3 0 -3 38533 115126 38742 1847 1277 1 1 0 0 0 0 0 0  
ES2d G 302 1 0 -1 0 157454 0 0 0 0 0 0 0 0 0 0 0  
ES1i A 304 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0  
 G 306 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 C 308 0 0 0 0 157454 0 0 0 0 0 0 0 0 0 0 0  
 
   
 A 310 0 0 0 0 157454 0 0 0 0 0 0 0 0 0 0 0  
 C 312 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 G 314 0 0 0 0 157454 0 0 0 0 0 0 0 0 0 0 0  
 G 316 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 G 318 0 0 0 0 157454 0 0 0 0 0 0 0 0 0 0 0  
 A 320 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0  
 
   
ND7 MiSeq -REL1 
no of Ts present 
before that 
position 
















0 1 2 3 4 5 6 7 8 9 10 11 
 A 108 1 1 0             
 
 A 110 1 1 0             
 
 A 112 2 2 0 15 0 0 15 0 0 0 0 0 0 0 0 0  
 A 114 0 0 0 0 15 0 0 0 0 0 0 0 0 0 0 0  
 A 116 3 3 0 189 0 0 30 15 0 0 0 0 0 0 0 0  
 A 118 1 1 0 467 0 204 0 0 0 0 0 0 0 0 0 0  
5' end G 120 1 1 0 17849 1 18333 0 0 0 0 0 0 0 0 0 0  
 A 122 0 0 0 14755 18520 1 4 0 0 0 0 0 0 0 0 0  
 A 124 1 1 0 15327 127 33670 10 0 0 0 0 0 0 0 0 0  
 C 126 0 0 0 762 48597 8 5 0 0 0 0 0 0 0 0 0  
 A 128 0 0 0 114 49362 3 0 0 0 0 0 0 0 0 0 0  
 A 130 0 0 0 1 49478 0 0 0 0 0 0 0 0 0 0 0  
 
   
 A 132 0 0 0 15 49479 0 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 0 49494 0 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 0 49494 0 0 0 0 0 0 0 0 0 0 0  
 A 138 0 0 0 0 49494 0 0 0 0 0 0 0 0 0 0 0  
 A 140 0 0 0 2 49494 0 0 0 0 0 0 0 0 0 0 0  
 C 142 0 0 0 12 49495 1 0 0 0 0 0 0 0 0 0 0  
 A 144 0 0 0 0 49508 0 0 0 0 0 0 0 0 0 0 0  
 G 146 1 1 0 0 0 49508 0 0 0 0 0 0 0 0 0 0  
 A 148 0 0 0 0 49508 0 0 0 0 0 0 0 0 0 0 0  
 C 150 0 0 0 41 49508 0 0 0 0 0 0 0 0 0 0 0  
 A 152 1 1 0 1 3 49546 1 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 0 49550 0 0 0 0 0 0 0 0 0 0 0  
 A 156 0 0 0 78 49550 0 0 0 0 0 0 0 0 0 0 0  
 G 158 1 1 0 0 0 49628 0 0 0 0 0 0 0 0 0 0  
 A 160 0 0 0 0 49628 0 0 0 0 0 0 0 0 0 0 0  
 
   
 A 162 1 1 0 0 0 49628 0 0 0 0 0 0 0 0 0 0  
 A 164 0 0 0 0 49321 263 44 0 0 0 0 0 0 0 0 0  
 G 166 0 0 0 119 48081 824 780 0 0 0 59 3 0 0 0 0  
 A 168 1 1 0 0 42 48413 1214 0 16 62 0 0 0 0 0 0  
ES39i C 170 0 1 1 0 45028 4679 0 40 0 0 0 0 0 0 0 0  
 A 172 0 0 0 0 49747 0 0 0 0 0 0 0 0 0 0 0  
ES38i A 174 0 4 4 0 43714 1523 247 4259 4 0 0 0 0 0 0 0  
ES37i G 176 0 1 1 42 42804 5528 1366 91 0 0 0 0 0 0 0 0  
ES36i A 178 0 2 2 0 42520 97 7155 0 0 0 0 17 0 0 0 0  
ES35i G 180 0 5 5 26 42460 429 1757 0 158 5010 1 0 0 0 0 0  
 G 182 0 0 0 0 49798 0 0 17 0 0 0 0 0 0 0 0  
ES34i A 184 0 1 1 0 42460 7355 0 0 0 0 0 0 0 0 0 0  
 G 186 0 0 0 11 49596 213 17 0 0 0 0 0 0 0 0 0  
ES33i A 188 0 7 7 0 42276 0 9 170 50 29 38 6749 440 63 2 0  
 C 190 0 0 0 74 49801 13 12 0 13 0 0 0 0 0 0 0  
 
   
 A 192 0 0 0 24 49867 0 33 0 0 0 0 0 0 0 0 0  
ES32i G 194 0 3 3 9 41675 155 484 7619 0 0 0 0 0 0 0 0  
ES31i A 196 0 1 1 0 41680 8161 92 0 0 0 0 0 0 0 0 0  
ES30i C 198 0 1 1 0 41791 8082 16 44 0 0 0 0 0 0 0 0  
 G 200 0 0 0 0 49917 16 0 0 0 0 0 0 0 0 0 0  
ES29i A 202 0 4 4 0 40391 376 845 130 8178 0 13 0 0 0 0 0  
 C 204 0 0 0 0 49734 3 128 68 0 0 0 0 0 0 0 0  
 A 206 0 0 0 0 49695 226 0 0 12 0 0 0 0 0 0 0  
ES28i G 208 0 3 3 0 40397 219 1043 8194 77 0 0 1 2 0 0 0  
ES27d G 210 1 0 -1 41 10113 39393 320 134 0 0 0 0 0 0 0 0  
 
 C 212 1 1 0 50 3073 46674 71 75 62 19 0 0 0 0 0  
 C 214 0 0 0 23 49562 438 24 0 0 0 0 0 0 0 0  
 A 216 0 0 0 8 49849 162 44 0 0 0 0 0 0 0 0  
 C 218 0 0 0 0 47055 2608 87 305 0 0 0 0 0 0 0  
 A 220 0 0 0 0 48984 606 402 54 9 0 0 0 0 0 0  
 G 222 0 0 0 0 48063 719 666 442 165 0 0 0 0 0 0  
 
   
 C 224 0 0 0 41 45843 3021 88 882 48 98 22 61 0 0 0  
 A 226 0 0 0 32 48874 1092 66 18 61 0 0 0 0 0 0  
ES
26i C 228 0 1 1 0 39225 10604 216 73 0 10 0 0 0 0 0  
 C 230 0 0 0 14 49942 178 8 0 0 0 0 0 0 0 0  
 C 232 0 0 0 163 46381 3721 73 14 0 0 0 0 0 0 0  
 G 234 0 0 0 29 50162 139 22 0 0 0 0 0 0 0 0  
ES
25
d C 236 3 0 -3 835 16487 4199 1683 
2802
0 199 133 0 0 0 0 1  
 A 238 0 0 0 515 45378 5426 282 286 10 0 0 0 0 0 0  
 G 240 0 0 0 741 35871 11612 3101 1139 326 52 145 0 0 0 0  
 C 242 0 0 0 231 49602 1216 265 556 566 204 120 0 0 8 0  
 A 244 0 0 0 62 51880 430 308 41 0 11 0 0 0 0 0  
 C 246 0 0 0 415 49309 1818 549 242 453 415 10 0 1 31 15  
 A 248 0 0 0 78 51536 1211 305 24 68 0 0 0 0 0 0  
ES
24i G 250 0 1 1 231 32066 18035 1131 1098 283 565 78 0 0 0 0  
ES
23
d G 252 2 0 -2 1857 21612 4368 25045 1440 1191 80 75 237 44 19 27  
Es2
2i G 254 0 1 1 1429 26215 26728 1545 1702 84 136 3 0 0 0 0  
 
   
Es2
1i A 256 0 4 4 1085 23870 8839 1164 1936 21119 438 385 0 0 0 0  
ES
20i G 258 0 1 1 852 23296 25665 1079 2381 5835 149 22 163 1 0 0  
ES
19i G 260 0 2 2 88 21622 162 36543 112 191 0 4 1 96 0 0  
ES
18i A 262 0 3 3 118 21129 329 1011 
3627
8 15 0 48 14 0 0 0  
ES
17i G 264 0 2 2 101 20379 1242 36942 219 0 151 22 8 0 0 0  
ES
16i A 266 0 1 1 388 21008 37105 251 794 62 98 0 31 0 0 0  
ES
15i G 268 0 5 5 196 20012 1192 852 226 57 #### 132 43 0 0 0  
ES
14i G 270 0 1 1 92 21036 37453 64 675 148 221 19 19 0 0 0  
 G 272 0 0 0 56 58556 821 217 9 6 0 44 0 0 0 0  
ES
13i G 274 0 1 1 37 20399 39253 24 7 23 0 0 0 0 0 0  
 A 276 0 0 0 5 59510 186 45 0 0 0 0 0 0 0 0  
ES
12
d A 278 1 0 -1 107 40974 18007 28 666 82 0 0 0 0 0 0  
ES
11i A 280 0 3 3 224 14824 3829 1224 
4007
0 29 0 0 0 0 0 0  
ES
10i G 282 0 2 2 218 14064 1360 44545 182 28 0 14 0 0 0 0  
 
   
ES
9i A 284 0 3 3 403 14049 131 2146 
4399
6 140 97 11 19 0 0 0  
ES
8d A 286 3 1 -2 1975 652 45236 344 
1497
2 400 675 63 15 0 0 0  
 G 288 2 2 0 282 347 1682 59797 67 242 605 130 1 15 0 0  
 A 290 0 0 0 410 60113 127 1167 1391 19 87 36 11 65 7 0  
ES
7i G 292 1 2 1 100 1239 13020 49011 94 1 39 0 0 0 0 0  
ES
6i A 294 0 1 1 357 12638 49894 69 95 1036 26 0 0 0 0 0  
ES
5i A 296 0 2 2 134 10667 1959 51190 49 68 0 0 0 0 0 0  
ES
4i A 298 0 1 1 158 9959 52815 1235 26 10 0 0 0 0 0 0  
ES
3d G 300 3 0 -3 6296 53654 8835 5962 1546 5 0 0 0 0 0 0  
ES
2d G 302 1 0 -1 0 70410 0 0 0 0 0 0 0 0 0 0  
ES
1i A 304 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0  
 G 306 3 3 0 0 0 0 0 0 0 0 0 0 0 0 0  
 C 308 0 0 0 0 70410 0 0 0 0 0 0 0 0 0 0  
 A 310 0 0 0 0 70410 0 0 0 0 0 0 0 0 0 0  
 C 312 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0  
 G 314 0 0 0 0 70410 0 0 0 0 0 0 0 0 0 0  
 
   
 G 316 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0  
 G 318 0 0 0 0 70410 0 0 0 0 0 0 0 0 0 0  
 A 320 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0  
 
 
   
 
RPS12 MiSeq +REL1 
no of Ts present 
before that 
position 
















0 1 2 3 4 5 6 7 8 9 10 11 
 A 130 0 0 0 10 0 0 0 2 26 0 0 0 0 0 0 0  
 A 132 0 0 0 133 28 0 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 196 161 0 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 1023 357 0 0 0 0 0 0 0 0 0 0 0  
 C 138 1 1 0 1807 1 3031 0 0 0 0 0 0 0 0 0 0  
 C 140 0 0 0 294 3187 9 4 0 0 0 0 0 0 0 0 0  
5' end C 142 0 0 0 22408 3481 4 0 0 0 0 0 0 0 0 0 0  
 A 144 1 1 0 2291 22 28085 54 0 0 0 0 0 0 0 0 0  
 A 146 0 0 0 778 28177 7 1 0 0 0 0 0 0 0 0 0  
 A 148 1 1 0 18 1 28972 1 0 0 0 0 0 0 0 0 0  
 
   
 C 150 0 0 0 0 28975 1 0 0 0 0 0 0 0 0 0 0  
 A 152 0 0 0 2 28976 0 0 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 14 28978 0 0 0 0 0 0 0 0 0 0 0  
 G 156 4 4 0 19 0 7 3 7 28987 7 0 0 0 0 0 0  
 A 158 0 0 0 0 29011 0 0 0 0 0 0 0 0 0 0 0  
 A 160 1 1 0 9 1 29015 0 0 0 0 0 0 0 0 0 0  
 A 162 0 0 0 8 29020 0 0 0 0 0 0 0 0 0 0 0  
 C 164 0 0 0 1 29028 0 0 0 0 0 0 0 0 0 0 0  
 A 166 0 0 0 4 29029 0 0 0 0 0 0 0 0 0 0 0  
 A 168 0 0 0 0 29033 0 0 0 0 0 0 0 0 0 0 0  
 A 170 0 0 0 3 29033 0 0 0 0 0 0 0 0 0 0 0  
 C 172 0 0 0 0 29036 0 0 0 0 0 0 0 0 0 0 0  
 A 174 1 1 0 20 81 28955 0 0 0 0 0 0 0 0 0 0  
 A 176 0 0 0 1 29027 9 11 9 0 0 0 0 0 0 0 0  
 A 178 0 0 0 0 29002 33 6 15 1 0 0 0 0 0 0 0  
 
   
 G 180 0 0 0 4 28928 52 76 0 1 0 0 0 0 0 0 0  
 A 182 1 1 0 2 3210 25664 154 28 3 0 2 0 0 0 0 0  
 A 184 0 0 0 1 26059 731 2174 65 12 5 15 2 0 0 0 0  
 A 186 0 0 0 3 27333 1320 284 74 31 3 19 0 0 0 0 0  
ES77i A 188 0 1 1 3 28099 263 300 301 45 31 23 4 1 0 0 0  
ES76i A 190 0 1 1 19 26022 353 250 168 2069 59 120 3 6 21 1 0  
ES75i G 192 0 4 4 5 24415 481 2196 192 1722 54 26 3 1 0 0 0  
ES74i G 194 0 8 8 51 24078 330 310 240 65 1945 172 111 1498 142 27 43  
 C 196 0 0 0 3 28276 499 227 106 29 4 4 0 0 0 0 0  
 G 198 0 0 0 7 28907 159 65 20 0 0 0 0 0 0 0 0  
ES73i A 200 0 1 1 20 23965 4562 261 278 38 8 44 3 1 0 0 0  
ES72i G 202 0 1 1 13 24058 4591 334 127 35 19 14 1 0 0 0 0  
ES71i G 204 0 1 1 18 24189 4383 364 151 97 3 10 0 0 0 0 0  
 A 206 0 0 0 30 28033 410 365 139 48 163 44 0 15 0 0 0  
ES70d G 208 6 5 -1 49 287 455 742 250 202 4084 21739 1492 21 0 0 0  
 
   
ES69i A 210 0 1 1 8 23669 5001 212 94 80 150 70 2 3 1 2 1  
ES68i G 212 0 1 1 2 23493 4988 530 166 78 21 3 0 2 0 6 4  
ES67d G 214 1 0 -1 10 5212 23556 348 72 70 10 17 0 3 0 9 1  
ES66i G 216 0 2 2 7 23969 207 4951 139 13 11 4 1 12 0 0 0  
ES65i G 218 0 2 2 21 23577 309 5083 154 148 38 0 12 0 0 0 0  
ES64i A 220 0 3 3 12 23287 489 347 4957 33 10 208 8 2 0 0 0  
 C 222 0 0 0 0 28385 739 96 78 40 7 0 0 0 0 0 0  
ES63d G 224 1 0 -1 5 8325 20924 78 15 3 0 0 0 0 0 0 0  
ES62i G 226 0 4 4 14 22889 797 455 264 4894 50 0 1 0 0 0 0  
ES61i A 228 0 4 4 34 20799 922 2565 211 4865 6 0 0 0 2 0 2  
ES60i G 230 0 3 3 7 20631 263 250 8145 106 8 0 0 0 0 0 0  
ES59i A 232 0 4 4 17 20645 61 24 453 8231 0 1 0 0 0 0 0  
ES58i G 234 0 1 1 15 20536 8334 61 90 399 4 1 0 0 0 0 0  
ES57i A 236 0 2 2 4 20504 555 8368 7 3 0 0 0 0 0 0 0  
ES56i A 238 0 2 2 6 20451 143 8840 6 5 0 0 0 0 0 0 0  
 
   
ES55i A 240 0 1 1 7 20549 8454 428 11 3 3 0 0 0 0 0 0  
ES54i G 242 0 1 1 4 20623 8732 88 7 2 0 0 2 0 0 0 0  
 A 244 0 0 0 1 28726 85 616 12 2 1 4 0 12 0 0 0  
 G 246 0 0 0 0 29193 20 240 4 0 2 0 0 0 0 0 0  
ES53i C 248 0 1 1 0 20612 8811 27 4 4 0 1 0 0 0 0 0  
 C 250 0 0 0 3 29432 27 0 0 0 0 0 0 0 0 0 0  
 G 252 0 0 0 3 29441 7 7 7 0 0 0 0 0 0 0 0  
ES52d C 254 2 0 -2 17 9104 244 20092 13 11 0 1 0 0 1 0 0  
 G 256 0 0 0 0 29458 8 16 0 0 0 0 0 0 0 0 0  
 A 258 0 0 0 0 28356 1041 45 27 7 0 4 2 0 0 0 0  
ES51i G 260 0 2 2 5 18252 2510 8619 90 4 0 3 5 1 0 0 0  
 C 262 0 0 0 3 29444 15 9 5 10 2 2 0 0 0 0 0  
 C 264 0 0 0 0 29485 5 0 0 0 0 0 0 0 0 0 0  
 C 266 0 0 0 2 29478 3 9 0 0 0 0 0 0 0 0 0  
 A 268 0 0 0 2 29474 15 3 0 0 0 0 0 0 0 0 0  
 
   
 G 270 0 0 0 2 29009 198 104 175 0 6 2 0 0 0 0 0  
ES50i C 272 0 2 2 4 22564 1230 5518 182 2 1 0 0 0 0 0 0  
 C 274 0 0 0 12 26040 3444 18 0 0 0 0 0 0 0 0 0  
 G 276 0 0 0 9 27209 1767 260 276 0 0 0 0 0 0 0 0  
 G 278 0 0 0 61 28258 310 314 283 377 8 0 3 0 0 0 0  
ES49i A 280 0 1 1 9 18669 10604 267 24 17 0 0 3 0 0 0 0  
 A 282 0 0 0 1 28270 1264 23 12 4 18 0 0 0 0 0 0  
 C 284 0 0 0 6 28085 1499 6 2 0 0 0 0 0 0 0 0  
 C 286 0 0 0 1 29368 221 9 0 0 0 0 0 0 0 0 0  
 G 288 0 0 0 2 29566 24 9 0 0 0 0 0 0 0 0 0  
 A 290 0 0 0 24 29254 85 218 5 25 15 2 0 0 0 0 0  
 C 292 0 0 0 1 29242 224 149 4 6 0 0 0 0 0 0 0  
 G 294 0 0 0 0 29601 20 3 2 0 0 0 0 0 0 0 0  
ES48i G 296 0 1 1 24 17339 12062 53 35 151 3 0 0 1 0 0 0  
ES47i A 298 0 1 1 20 17283 12092 61 205 3 5 7 1 0 0 0 0  
 
   
ES46i G 300 0 2 2 9 17286 527 11810 14 12 10 0 13 0 0 0 0  
ES45i A 302 0 1 1 5 17463 12113 56 20 11 4 0 14 1 0 0 0  
ES44i G 304 0 1 1 3 17117 11354 1104 55 18 33 5 0 0 0 0 0  
 C 306 0 0 0 0 29155 343 169 20 0 0 0 0 0 0 0 0  
ES43d C 308 2 0 -2 14 13418 456 15817 6 0 0 0 0 0 0 0 0  
ES42d G 310 4 0 -4 25 15988 343 187 135 13025 35 0 0 0 0 0 0  
ES41i A 312 0 1 1 19 16864 8921 3817 32 26 59 14 2 0 0 0 0  
ES40i A 314 0 4 4 75 16183 1084 779 584 9012 2108 45 0 0 0 0 0  
ES39i A 316 1 3 2 63 636 15715 864 11809 571 263 1 0 1 0 0 0  
ES38i A 318 0 1 1 9 12202 12991 3680 946 36 8 13 8 2 0 0 0  
ES37i A 320 0 1 1 34 12071 16447 832 197 83 203 46 7 5 0 1 0  
 A 322 0 0 0 34 23596 1420 1063 550 265 165 2597 99 17 33 125 10  
ES36i G 324 0 4 4 43 17003 580 312 110 11888 66 21 5 0 1 1 0  
ES35i G 326 0 3 3 68 14803 1504 417 12402 864 40 5 4 0 1 0 1  
 G 328 0 0 0 62 23768 4721 235 662 638 40 7 25 0 0 0 0  
 
   
 A 330 0 0 0 133 24409 546 316 225 259 115 74 61 190 3484 418 89  
ES34i G 332 0 1 1 37 11343 14032 4694 113 16 55 11 4 21 0 0 2  
ES33i G 334 0 2 2 42 10602 5275 13228 243 853 44 66 20 3 1 0 0  
 C 336 0 0 0 10 23640 6307 104 170 109 4 0 10 3 0 0 0  
 G 338 0 0 0 7 29914 252 35 153 1 0 0 0 0 0 0 0  
ES32i G 340 0 2 2 62 9497 752 19470 137 283 113 14 14 94 21 6 0  
ES31i G 342 0 8 8 89 9461 504 868 165 246 2191 160 478 15834 573 9 3  
ES30i G 344 0 2 2 36 9317 330 20099 223 525 28 7 4 2 1 1 0  
ES29i A 346 0 4 4 171 9258 943 599 204 19492 28 44 3 0 1 0 0  
ES28i G 348 0 2 2 26 9885 805 19948 83 8 0 0 0 0 0 0 0  
 G 350 0 0 0 5 29780 511 118 279 8 51 0 0 0 0 0 0  
ES27i A 352 0 3 3 40 9117 458 278 20905 11 0 2 0 0 0 0 0  
 G 354 0 0 0 9 28535 442 1734 57 16 7 0 1 0 0 0 0  
ES26i A 356 0 2 2 8 6989 1710 22030 34 14 4 12 10 0 0 0 0  
ES25i G 358 0 1 1 25 6485 22656 1635 9 23 6 0 1 0 0 0 0  
 
   
ES24d C 360 3 1 -2 14 1897 23044 121 5765 2 7 0 0 0 0 0 0  
 A 362 0 0 0 8 30496 85 208 58 0 0 0 0 0 0 0 0  
ES23i A 364 0 2 2 11 9286 3487 17932 44 47 60 3 0 0 1 0 0  
ES22i A 366 0 3 3 36 6820 3391 1042 19284 73 141 122 8 0 0 0 0  
ES21i A 368 0 2 2 33 5863 819 20184 3995 34 3 15 3 4 0 0 0  
ES20i A 370 0 1 1 35 5704 19656 3911 1523 114 18 18 1 0 0 0 0  
 G 372 0 0 0 11 25048 3874 1695 154 178 14 7 4 0 0 0 0  
 A 374 0 0 0 14 28696 1498 450 137 68 96 33 0 3 2 3 0  
ES19d G 376 3 0 -3 15 24947 522 236 5136 110 20 19 9 0 0 3 0  
 G 378 0 0 0 1 30003 393 375 102 52 62 6 13 0 1 1 2  
 G 380 0 0 0 14 28901 1109 616 343 21 14 1 3 0 2 0 1  
 G 382 1 1 0 24 2629 27230 436 435 119 179 3 9 0 0 0 1  
 G 384 0 0 0 33 28073 1800 990 112 28 48 3 4 2 0 0 0  
ES18i G 386 0 1 1 25 7385 23114 265 49 39 167 20 42 0 0 1 1  
 G 388 0 0 0 137 27404 1061 2027 171 313 141 60 1 1 0 1 0  
 
   
ES17i G 390 0 4 4 77 4633 230 1469 609 24099 149 66 6 6 2 10 2  
ES16i G 392 0 2 2 91 5226 433 25332 116 212 20 14 16 2 0 2 1  
 A 394 0 0 0 36 29323 1711 367 20 7 0 10 4 1 2 0 0  
ES15i A 396 0 3 3 18 5595 647 269 24915 17 0 9 0 5 2 0 0  
 C 398 0 0 0 8 28933 2297 157 66 13 0 0 1 0 0 0 0  
 C 400 0 0 0 33 30816 585 80 4 1 0 0 0 0 0 0 0  
 C 402 0 0 0 138 30164 1350 37 11 3 6 0 0 0 0 0 0  
ES14d G 404 3 0 -3 677 27735 672 1105 2339 24 7 0 1 0 0 0 0  
ES13d G 406 4 0 -4 171 26257 439 3325 106 2171 19 30 8 1 2 1 2  
ES12i G 408 0 1 1 42 5868 26087 209 319 3 8 0 0 0 0 0 0  
ES11d A 410 2 1 -1 170 404 26678 2072 2829 574 1 14 5 0 0 0 0  
 A 412 0 0 0 107 28795 3536 357 12 2 3 1 0 0 0 0 0  
 A 414 0 0 0 210 28971 3485 347 5 1 0 5 0 0 4 1 0  
 G 416 0 0 0 60 32563 64 397 0 2 0 0 0 0 0 0 0  
ES10i A 418 0 1 1 73 3698 29364 11 0 5 0 0 14 0 0 0 0  
 
   
ES9i A 420 0 2 2 610 4550 6687 22029 220 1 12 0 0 0 0 0 0  
ES8i A 422 0 1 1 5659 2748 30533 593 3374 385 0 1 0 0 0 0 0  
 C 424 0 0 0 433 38743 74 636 3 2 1 0 0 0 0 0 0  
 A 426 0 0 0 119 39852 4 0 2 0 0 0 0 0 0 0 0  
ES7d C 428 1 0 -1 80 36068 3887 35 7 1 0 0 0 0 0 0 0  
 G 430 0 0 0 345 40014 35 8 0 0 0 0 0 0 0 0 0  
ES6d A 432 3 1 -2 145 418 35542 1049 3422 20 0 0 0 0 0 0 0  
ES51 G 434 0 2 2 119 4058 66 36450 10 2 0 0 0 0 0 0 0  
ES4i A 436 0 1 1 80 3882 36757 26 7 7 0 4 0 1 0 0 0  
 A 438 0 0 0 2 40732 4 8 1 0 0 0 0 0 0 0 0  
 G 440 0 0 0 8 40735 1 11 0 0 0 0 0 0 0 0 0  
ES3i A 442 0 2 2 26 2501 40 38219 4 0 0 0 0 0 0 0 0  
 G 444 0 0 0 15 40781 2 0 0 0 0 0 0 0 0 0 0  
 A 446 0 0 0 16 40796 0 0 0 0 0 0 0 0 0 0 0  
ES12d A 448 4 3 -1 36 0 0 0 38442 2399 2 1 4 0 0 0 0  
 
   
 G 450 0 0 0 0 40848 0 0 0 0 0 0 0 0 0 0 0  
 A 452 0 0 0 0 40848 0 0 0 0 0 0 0 0 0 0 0  
ES1i A 454 0 1 1 0 0 40848 0 0 0 0 0 0 0 0 0 0  
 A 456 1 1 0 0 0 40848 0 0 0 0 0 0 0 0 0 0  
 A 458 0 0 0 0 40848 0 0 0 0 0 0 0 0 0 0 0  
 G 460 0 0 0 0 40848 0 0 0 0 0 0 0 0 0 0 0  
 A 462 0 0 0 0 40848 0 0 0 0 0 0 0 0 0 0 0  
 A 464 1 1 0 0 0 40848 0 0 0 0 0 0 0 0 0 0  
3' end G 466 1 1 0 0 0 40848 0 0 0 0 0 0 0 0 0 0  
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in no. of 
cat1 
reads 
0 1 2 3 4 5 6 7 8 9 10 11 
 A 130 0 0 0 1.79748 0 1 0 1 4 0 0 0 0 0 0 0  
 A 132 0 0 0 5.69203 6 1 0 0 0 0 0 0 0 0 0 0  
 A 134 0 0 0 14.979 26 0 0 0 0 0 0 0 0 0 0 0  
 A 136 0 0 0 115.638 76 1 0 0 0 0 0 0 0 0 0 0  
 C 138 1 1 0 272.019 1 1245 0 0 0 0 0 0 0 0 0 0  
 C 140 0 0 0 36.2493 1370 7 0 0 0 0 0 0 0 0 0 0  
5' end C 142 0 0 0 2216 1490 1 1 0 0 0 0 0 0 0 0 0  
 A 144 1 1 0 153.385 5 9362 7 0 0 0 0 0 0 0 0 0  
 A 146 0 0 0 59.0174 9399 4 0 0 0 0 0 0 0 0 0 0  
 A 148 1 1 0 3.59497 3 9597 1 0 0 0 0 0 0 0 0 0  
 
   
 C 150 0 0 0 0 9605 0 4 0 0 0 0 0 0 0 0 0  
 A 152 0 0 0 0.59916 9609 0 0 0 0 0 0 0 0 0 0 0  
 C 154 0 0 0 2.69623 9611 0 0 0 0 0 0 0 0 0 0 0  
 G 156 4 4 0 3.29539 0 0 6 10 9615 0 0 0 0 0 0 0  
 A 158 0 0 0 0 9631 0 0 0 0 0 0 0 0 0 0 0  
 A 160 1 1 0 0.29958 0 9631 0 0 0 0 0 0 0 0 0 0  
 A 162 0 0 0 1.79748 9632 0 0 0 0 0 0 0 0 0 0 0  
 C 164 0 0 0 0.89874 9638 0 0 0 0 0 0 0 0 0 0 0  
 A 166 0 0 0 0.29958 9641 0 0 0 0 0 0 0 0 0 0 0  
 A 168 0 0 0 0 9642 0 0 0 0 0 0 0 0 0 0 0  
 A 170 0 0 0 0 9642 0 0 0 0 0 0 0 0 0 0 0  
 C 172 0 0 0 1.4979 9642 0 0 0 0 0 0 0 0 0 0 0  
 A 174 1 1 0 1.19832 9 9636 2 0 0 0 0 0 0 0 0 0  
 A 176 0 0 0 0 9643 7 1 0 0 0 0 0 0 0 0 0  
 A 178 0 0 0 1.4979 9650 0 1 0 0 0 0 0 0 0 0 0  
 
   
 G 180 0 0 0 0 9642 9 5 0 0 0 0 0 0 0 0 0  
 A 182 1 1 0 0.59916 288 9358 11 1 0 0 0 0 0 0 0 0  
 A 184 0 0 0 0 9401 46 208 2 1 0 0 0 0 0 0 0  
 A 186 0 0 0 0 9530 92 26 8 2 0 0 0 0 0 0 0  
ES77i A 188 0 1 1 0.89874 9605 7 16 18 9 1 2 0 0 0 0 0  
ES76i A 190 0 1 1 0.59916 9392 22 18 15 202 1 9 2 0 0 0 0  
ES75i G 192 0 4 4 0.29958 9280 29 217 10 121 1 5 0 0 0 0 0  
ES74i G 194 0 8 8 2.99581 9256 33 10 9 0 185 24 11 117 7 1 5  
 C 196 0 0 0 0.29958 9616 32 22 4 0 0 0 0 0 0 0 0  
 G 198 0 0 0 2.69623 9663 9 3 0 0 0 0 0 0 0 0 0  
ES73i A 200 0 1 1 0 9256 385 13 21 2 0 7 0 0 0 0 0  
ES72i G 202 0 1 1 2.69623 9250 408 17 5 4 0 0 0 0 0 0 0  
ES71i G 204 0 1 1 3.59497 9257 377 29 23 7 0 0 0 0 0 0 0  
 A 206 0 0 0 0.29958 9601 44 37 7 1 7 3 0 5 0 0 0  
ES70d G 208 6 5 -1 9.88616 13 48 70 25 33 389 8656 484 4 1 0 0  
 
   
ES69i A 210 0 1 1 0.89874 9211 478 15 8 12 9 5 0 0 0 0 1  
ES68i G 212 0 1 1 0 9201 473 50 7 8 0 3 0 0 0 0 0  
ES67d G 214 1 0 -1 1.4979 505 9208 26 3 0 0 0 0 0 0 0 0  
ES66i G 216 0 2 2 2.69623 9257 7 471 8 3 0 0 0 1 0 0 0  
ES65i G 218 0 2 2 1.19832 9203 24 492 10 29 0 0 0 0 0 0 0  
ES64i A 220 0 3 3 0.29958 9181 35 25 487 2 0 29 1 0 0 0 0  
 
ES64i A 220 0 3 3 0.29958 9181 35 25 487 2 0 29 1 0 0 0 0 
 C 222 0 0 0 0 9706 43 10 1 1 0 0 0 0 0 0 0 
ES63d G 224 1 0 -1 1.19832 777 8978 6 0 0 0 0 0 0 0 0 0 
ES62i G 226 0 4 4 0.29958 9143 70 31 24 484 14 0 0 0 0 0 0 
ES61i A 228 0 4 4 1.4979 8965 75 234 11 483 0 0 0 0 0 0 0 
ES60i G 230 0 3 3 1.19832 8936 26 17 791 4 0 0 0 0 0 0 0 
ES59i A 232 0 4 4 3.29539 8934 12 0 41 788 0 4 0 0 0 0 0 
ES58i G 234 0 1 1 1.4979 8925 816 10 0 35 0 0 0 0 0 0 0 
ES57i A 236 0 2 2 0.29958 8932 37 818 4 0 0 0 0 0 0 0 0 
ES56i A 238 0 2 2 0 8928 6 853 5 0 0 0 0 0 0 0 0 
 
   
ES55i A 240 0 1 1 0 8922 824 45 1 0 0 0 0 0 0 0 0 
ES54i G 242 0 1 1 0 8925 862 5 0 0 0 0 0 0 0 0 0 
 A 244 0 0 0 0 9738 0 54 0 0 0 0 0 0 0 0 0 
 G 246 0 0 0 0 9779 1 12 0 0 0 0 0 0 0 0 0 
ES53i C 248 0 1 1 0 8919 867 1 0 5 0 0 0 0 0 0 0 
 C 250 0 0 0 0.89874 9791 1 0 0 0 0 0 0 0 0 0 0 
 G 252 0 0 0 0.29958 9795 0 0 0 0 0 0 0 0 0 0 0 
ES52d C 254 2 0 -2 0 885 8 8902 0 1 0 0 0 0 0 0 0 
 G 256 0 0 0 0.29958 9792 4 0 0 0 0 0 0 0 0 0 0 
 A 258 0 0 0 0 9714 79 4 0 0 0 0 0 0 0 0 0 
ES51i G 260 0 2 2 2.39664 8749 214 833 2 0 0 0 0 0 0 0 0 
 C 262 0 0 0 0 9803 2 0 0 0 0 0 0 0 0 0 0 
 C 264 0 0 0 0 9805 0 0 0 0 0 0 0 0 0 0 0 
 C 266 0 0 0 0 9805 0 0 0 0 0 0 0 0 0 0 0 
 A 268 0 0 0 0.59916 9799 4 2 0 0 0 0 0 0 0 0 0 
 G 270 0 0 0 0 9748 29 2 26 2 0 0 0 0 0 0 0 
ES50i C 272 0 2 2 0.89874 9149 109 528 16 5 0 0 0 0 0 0 0 
 C 274 0 0 0 3.59497 9499 311 0 0 0 0 0 0 0 0 0 0 
 G 276 0 0 0 2.39664 9634 126 29 33 0 0 0 0 0 0 0 0 
 G 278 0 0 0 2.09706 9713 16 27 31 46 0 0 0 0 0 0 0 
 
   
ES49i A 280 0 1 1 0.89874 8814 1004 18 1 0 0 0 0 0 0 0 0 
 A 282 0 0 0 0.89874 9690 144 5 1 0 0 0 0 0 0 0 0 
 C 284 0 0 0 1.19832 9690 153 0 0 0 0 0 0 0 0 0 0 
 C 286 0 0 0 0.29958 9830 16 0 1 0 0 0 0 0 0 0 0 
 G 288 0 0 0 1.79748 9846 1 1 0 0 0 0 0 0 0 0 0 
 A 290 0 0 0 0 9827 1 24 0 2 0 0 0 0 0 0 0 
 C 292 0 0 0 0.29958 9824 17 9 0 4 0 0 0 0 0 0 0 
 G 294 0 0 0 0.29958 9853 2 0 0 0 0 0 0 0 0 0 0 
ES48i G 296 0 1 1 0.89874 8672 1171 4 1 8 0 0 0 0 0 0 0 
ES47i A 298 0 1 1 0 8668 1172 10 9 0 0 0 0 0 0 0 0 
ES46i G 300 0 2 2 3.29539 8674 39 1145 0 3 0 0 0 0 0 0 0 
ES45i A 302 0 1 1 0 8669 1188 4 9 0 0 0 0 0 0 0 0 
ES44i G 304 0 1 1 0.89874 8651 1120 86 10 5 0 0 0 0 0 0 0 
 C 306 0 0 0 0.59916 9808 46 19 0 0 0 0 0 0 0 0 0 
ES43d C 308 2 0 -2 0.89874 1307 32 8539 0 0 0 0 0 0 0 0 0 
ES42d G 310 4 0 -4 4.19413 1499 61 16 13 8293 2 1 0 0 0 0 0 
ES41i A 312 0 1 1 2.09706 8630 891 364 4 5 0 0 0 0 0 0 0 
ES40i A 314 0 4 4 8.38826 8555 101 73 44 946 203 0 0 0 0 0 0 
ES39i A 316 1 3 2 2.99581 50 8513 58 1198 74 39 3 0 0 0 0 0 
ES38i A 318 0 1 1 0.59916 8223 1302 285 121 5 0 0 1 0 0 0 0 
 
   
ES37i A 320 0 1 1 0.89874 8179 1626 88 27 5 6 4 0 0 4 0 0 
 A 322 0 0 0 7.48951 9388 178 106 57 11 8 173 17 0 0 10 0 
ES36i G 324 0 4 4 6.59077 8657 47 28 9 1211 4 11 0 0 0 0 0 
ES35i G 326 0 3 3 24.266 8461 102 45 1263 118 3 7 0 1 0 0 0 
 G 328 0 0 0 8.68784 9427 413 25 93 120 1 2 1 0 0 0 0 
 A 330 0 0 0 21.5698 9598 61 58 26 16 10 17 10 13 280 36 17 
 
 
   
Appendix 7 
Below is listed the fasta formatted sequences used in MEGA5 and Datamonkey analysis. These are listed without stop and start codons.  
(Chapter 4). 
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>T cruzi (CLBEL) Tc00.1047053510857.40 
 

































Below is tabulated the read outs from Datamonkey HyPhy analysis (Chapter 4). 




6 sequences with 1 partition 
These sequences have not been screened for recombination. Selection 
analyses of alignments with recombinants in them using a single tree may 
generate misleading results. 
 
Partition 1: 489 codons 0.842436 subs/site 
Inferred rate distribution 
Rate class has dN>dS Rate class has dN<dS 
Rate Class 1 2 3 4 5 6 7 8 9 Summary 
dS 1.41 1.41 1.10 1.10 1.41 0.53 0.53 1.10 0.53  
dN 0.00 0.10 0.00 0.10 0.73 0.00 0.10 0.73 0.73  
dN-dS -1.41 -1.31 -1.10 -1.00 -0.69 -0.53 -0.43 -0.38 0.19 Mean dN-dS: -0.884 
Prob. 0.000 0.000 0.437 0.294 0.000 0.097 0.065 0.088 0.019 Std.Dev : 0.307 
Found no positively selected sites (Error: Reference source not found significance 






Found 298 negatively selected sites (50 significance level) 
Codon E[dS] E[dN] Normalized E[dN-dS] Posterior Probability Bayes Factor 
60 0.977685 0.017089 -0.960596 0.99999 2062.91 
62 1.04666 0.0201391 -1.02652 0.99999 1933.62 
63 0.978111 0.0838068 -0.894305 0.999739 75.7119 
64 0.932416 0.013633 -0.918783 0.999994 3533.01 
65 0.98705 0.0190393 -0.968011 0.999967 592.955 
66 0.98553 0.0136341 -0.971896 0.999996 5361.86 
68 1.00043 0.017936 -0.982498 0.999987 1548.38 
69 1.02091 0.0198546 -1.00106 0.999984 1260.03 
71 1.02573 0.0181812 -1.00754 0.999988 1646.73 
72 1.01257 0.0150179 -0.997557 0.999996 5198.54 
73 1.05099 0.0153257 -1.03566 0.999998 7935.23 
74 0.983433 0.0826545 -0.900779 0.999731 73.5264 
75 1.02271 0.0201401 -1.00257 0.999985 1337.62 
77 1.03671 0.019479 -1.01723 0.999983 1132.64 
78 0.879629 0.017453 -0.862176 0.999974 770.404 
79 1.02491 0.0181794 -1.00673 0.999988 1639.69 
80 0.954408 0.0222965 -0.932112 0.99986 141.657 
81 1.04705 0.0136345 -1.03341 0.999998 11016.4 
82 1.04745 0.0864293 -0.961024 0.999802 99.9187 
83 1.02092 0.0194671 -1.00145 0.99998 986.473 
84 1.03417 0.0857859 -0.948384 0.999793 95.801 
85 0.985583 0.018614 -0.966969 0.999981 1016.72 
86 0.990126 0.0171389 -0.972987 0.999987 1570.42 
92 1.0442 0.0860313 -0.958173 0.999795 96.468 
97 1.0162 0.019602 -0.996599 0.999986 1391.52 
99 0.999966 0.0167469 -0.983219 0.999997 6286.31 
100 0.962815 0.0209147 -0.9419 0.999916 236.866 
101 1.0172 0.0155729 -1.00162 0.999994 3115.02 
102 1.00023 0.0142284 -0.986004 0.999999 15413.5 
103 1.04376 0.0194697 -1.02429 0.999984 1255.15 
104 1.01803 0.0178972 -1.00013 0.999991 2295.51 
105 1.02963 0.0209113 -1.00872 0.999956 446.83 
106 1.02491 0.0159136 -1.00899 0.999994 3493.92 
107 1.01954 0.019134 -1.0004 0.999986 1382.31 
108 0.974063 0.0151375 -0.958926 0.999994 3423.68 
109 1.01375 0.0176574 -0.996092 0.999992 2439.42 
110 0.981681 0.015194 -0.966487 0.999995 3748.09 
112 1.03377 0.0168881 -1.01688 0.99999 2054.19 
113 1.01278 0.0201416 -0.99264 0.999983 1164.87 
114 1.08141 0.0212204 -1.06019 0.999904 206.7 
115 0.977096 0.0170284 -0.960068 0.999987 1549.43 
116 1.00372 0.0174328 -0.98629 0.999993 2658.45 
121 1.04012 0.0252546 -1.01487 0.99989 180.621 
124 0.997842 0.0198299 -0.978012 0.999959 478.64 
125 0.995284 0.0150189 -0.980265 0.999996 4483.7 
126 1.05403 0.015571 -1.03846 0.999996 5454.12 
127 1.01548 0.0178982 -0.997578 0.999991 2215.48 
128 0.933506 0.0167793 -0.916727 0.99999 1890.97 
129 0.957592 0.0151334 -0.942459 0.999997 6209.64 
130 1.00713 0.0189437 -0.988189 0.999985 1344.92 
131 0.990126 0.0171389 -0.972987 0.999987 1570.42 




133 0.99515 0.017925 -0.977225 0.999987 1481.92 
134 1.02729 0.0136323 -1.01366 0.999997 7806.7 
135 0.995294 0.0179033 -0.977391 0.999989 1757.99 
136 0.955634 0.0190184 -0.936616 0.999975 790.163 
138 0.943996 0.0144313 -0.929564 0.999996 5030.31 
139 1.01473 0.0150167 -0.999709 0.999996 5319.55 
140 1.01722 0.0189498 -0.998273 0.999986 1438.19 
141 0.943618 0.0201382 -0.92348 0.999972 694.986 
142 1.00369 0.0157046 -0.987983 0.999994 3308.33 
144 0.923862 0.0185463 -0.905315 0.999958 466.149 
145 0.987338 0.0172543 -0.970084 0.999986 1433.91 
146 1.02275 0.018177 -1.00458 0.999988 1598.74 
148 0.995068 0.0146162 -0.980451 0.999997 6165.97 
149 1.03715 0.0875544 -0.949595 0.999617 51.5937 
150 1.0172 0.0155729 -1.00162 0.999994 3115.02 
151 1.0476 0.0198605 -1.02774 0.999988 1686.68 
153 1.02132 0.0177375 -1.00358 0.999991 2291.75 
155 1.03163 0.0229643 -1.00867 0.999905 208.815 
158 1.05482 0.022971 -1.03185 0.999934 301.677 
159 1.0411 0.0220932 -1.01901 0.999919 243.958 
160 1.04376 0.0181365 -1.02563 0.999992 2553.51 
162 0.996471 0.0183798 -0.978091 0.999986 1378.3 
163 0.995459 0.0201414 -0.975318 0.99998 984.016 
164 0.930889 0.0196163 -0.911273 0.999963 529.759 
168 0.936881 0.0169984 -0.919882 0.999988 1603.68 
170 1.02615 0.0189686 -1.00718 0.999988 1603.14 
171 0.929599 0.0167802 -0.912819 0.999989 1848.65 
173 0.961864 0.0209228 -0.940942 0.999916 236.774 
174 1.01889 0.0199487 -0.998939 0.999962 525.436 
176 1.04173 0.0190703 -1.02266 0.99999 1914.84 
177 1.02092 0.0194671 -1.00145 0.99998 986.473 
178 0.993492 0.0218749 -0.971617 0.999882 167.643 
179 1.00376 0.0150253 -0.988734 0.999996 4759.18 
180 0.898841 0.0189114 -0.87993 0.999968 626.83 
181 1.02184 0.0155703 -1.00627 0.999994 3337.35 
182 0.95563 0.0177262 -0.937903 0.999988 1620.33 
183 1.02486 0.0201402 -1.00472 0.999986 1372.61 
184 1.0162 0.0179068 -0.998293 0.999991 2204.84 
185 1.02007 0.0160888 -1.00398 0.999993 3018 
186 1.0411 0.0136322 -1.02747 0.999998 9978.1 
187 0.947796 0.0190075 -0.928789 0.999955 435.498 
188 0.973804 0.0209083 -0.952896 0.999923 255.435 
189 0.969176 0.0136448 -0.955532 0.999996 5150.8 
191 1.00037 0.0145447 -0.985823 0.999999 13271 
193 1.02107 0.0178972 -1.00317 0.999992 2378.05 
194 0.999966 0.0167469 -0.983219 0.999997 6286.31 
195 0.994953 0.0142248 -0.980729 0.999999 14699.9 
196 1.01589 0.0151312 -1.00075 0.999996 4934.06 
198 1.01228 0.0136318 -0.998652 0.999997 6660.49 
199 1.02006 0.0178624 -1.0022 0.999991 2312.92 
201 0.95563 0.0177262 -0.937903 0.999988 1620.33 
204 1.05268 0.0136323 -1.03904 0.999998 12252.4 
205 1.00171 0.0171418 -0.984564 0.999989 1722.76 
206 1.03882 0.0864757 -0.952344 0.999694 64.5592 
207 0.898841 0.0189114 -0.87993 0.999968 626.83 




210 1.0431 0.0159421 -1.02716 0.999993 2843.47 
211 1.0162 0.019602 -0.996599 0.999986 1391.52 
213 1.02092 0.0194671 -1.00145 0.99998 986.473 
214 1.02714 0.0824191 -0.944717 0.99979 94.2225 
215 1.00557 0.014823 -0.990749 0.999997 5672.69 
216 0.892542 0.0136345 -0.878908 0.999993 2690.67 
217 1.01803 0.019591 -0.998436 0.999986 1448.12 
218 1.02226 0.0201401 -1.00212 0.999985 1331.29 
219 1.02231 0.0147339 -1.00757 0.999999 13685.9 
220 1.02729 0.0136323 -1.01366 0.999997 7806.7 
221 1.02108 0.0192071 -1.00187 0.999983 1166.27 
222 1.0598 0.0214858 -1.03832 0.999944 352.179 
223 1.01474 0.0161237 -0.998616 0.999993 2736.89 
224 0.943996 0.0144313 -0.929564 0.999996 5030.31 
225 0.957563 0.0152246 -0.942338 0.999994 3103.21 
226 1.01826 0.0155704 -1.00269 0.999994 3191.7 
227 1.01473 0.0150167 -0.999709 0.999996 5319.55 
228 1.01374 0.0181696 -0.995573 0.999987 1469.31 
230 0.95563 0.0177262 -0.937903 0.999988 1620.33 
231 0.994853 0.0201392 -0.974714 0.99998 1010.24 
233 0.838563 0.0209394 -0.817624 0.999848 129.795 
235 1.04963 0.0190766 -1.03055 0.999991 2199.18 
236 1.03956 0.01557 -1.02399 0.999995 4278.61 
237 1.01803 0.019207 -0.998821 0.999982 1125.49 
239 1.00372 0.0179367 -0.985787 0.999988 1592.76 
241 0.945013 0.0209312 -0.924082 0.999907 213.329 
242 0.953056 0.0225234 -0.930532 0.999848 130.229 
243 1.01608 0.0195954 -0.996489 0.999967 601.645 
246 0.944128 0.0176913 -0.926437 0.999984 1215.12 
248 1.01257 0.0150179 -0.997557 0.999996 5198.54 
250 1.01548 0.0192082 -0.996271 0.999982 1086.59 
252 0.993011 0.0826121 -0.910399 0.999892 182.764 
253 1.00765 0.0850477 -0.922605 0.999736 74.8415 
256 1.07312 0.0136369 -1.05948 0.999999 21585.5 
257 1.00206 0.0176226 -0.984438 0.999991 2310.99 
258 1.05101 0.0222877 -1.02872 0.999919 244.851 
259 1.04741 0.0219644 -1.02544 0.999936 308.06 
260 1.00343 0.0201389 -0.983287 0.999982 1100.35 
263 1.03112 0.0865042 -0.944611 0.999657 57.6536 
265 1.01061 0.0209189 -0.989695 0.999945 359.105 
266 0.903617 0.016739 -0.886878 0.999988 1629.7 
267 1.01215 0.0193835 -0.992765 0.999982 1108.1 
268 1.00457 0.0151314 -0.989434 0.999995 4345.92 
269 1.04888 0.0212306 -1.02765 0.999893 184.936 
270 1.00561 0.0181839 -0.987429 0.999985 1354.64 
272 0.981903 0.0144762 -0.967426 0.999998 10998.3 
273 1.06707 0.0217227 -1.04535 0.999926 267.06 
274 1.00671 0.0155716 -0.991141 0.999993 2766.08 
275 0.957563 0.0152246 -0.942338 0.999994 3103.21 
276 0.982323 0.0186437 -0.963679 0.999978 887.781 
277 0.838563 0.0209394 -0.817624 0.999848 129.795 
278 1.02108 0.0192071 -1.00187 0.999983 1166.27 
279 1.00043 0.0174321 -0.983 0.999992 2584.54 
280 1.01002 0.0147813 -0.995243 0.999997 6243.45 
282 0.83778 0.0151547 -0.822625 0.999989 1748.56 




284 0.991921 0.0223922 -0.969529 0.99989 179.311 
285 0.95911 0.0136438 -0.945467 0.999996 4773.7 
286 0.920256 0.0155759 -0.90468 0.999986 1464.08 
287 1.00169 0.0217624 -0.979926 0.999899 196.6 
288 1.00596 0.0195471 -0.986412 0.999897 192.282 
289 1.01763 0.0190529 -0.998581 0.999986 1463.17 
290 1.06421 0.0210261 -1.04318 0.999956 454.828 
291 1.00137 0.0189531 -0.982413 0.999985 1286.43 
292 1.00043 0.0174321 -0.983 0.999992 2584.54 
293 1.02271 0.0201401 -1.00257 0.999985 1337.62 
294 1.03407 0.0136383 -1.02043 0.999998 9460.1 
295 0.982879 0.019061 -0.963818 0.999965 557.962 
296 1.02936 0.0197203 -1.00964 0.999979 935.98 
297 1.01006 0.0189791 -0.991083 0.999985 1302.99 
298 1.01472 0.0179013 -0.996824 0.99999 2081.02 
299 1.052 0.0203551 -1.03164 0.999942 339.855 
300 1.03846 0.01557 -1.02289 0.999995 4156.18 
301 1.02108 0.0192071 -1.00187 0.999983 1166.27 
302 0.89964 0.018936 -0.880704 0.99997 665.409 
303 1.02609 0.0209053 -1.00519 0.999953 424.147 
304 0.912827 0.0209248 -0.891902 0.999889 179.026 
305 1.06831 0.0167263 -1.05158 0.999992 2554.38 
306 0.998753 0.017385 -0.981368 0.999992 2421.4 
307 1.00369 0.0157046 -0.987983 0.999994 3308.33 
308 1.04685 0.0209109 -1.02594 0.999966 580.368 
310 0.912059 0.0167664 -0.895293 0.999988 1683.76 
311 0.919457 0.0189725 -0.900485 0.999971 676.47 
312 1.00375 0.0184336 -0.985316 0.999982 1126.38 
313 0.979381 0.0136322 -0.965749 0.999996 4711.27 
314 0.83856 0.0155758 -0.822984 0.999981 1040.14 
316 1.04833 0.0194819 -1.02885 0.999985 1320.29 
320 1.00374 0.0209142 -0.982828 0.999941 335.503 
322 1.03858 0.0151304 -1.02345 0.999997 6589.43 
323 1.04348 0.0163216 -1.02716 0.999991 2327.94 
325 1.01803 0.0178972 -1.00013 0.999991 2295.51 
326 1.05584 0.0225028 -1.03333 0.999896 189.898 
327 0.906639 0.0167955 -0.889844 0.999988 1624.96 
328 1.0197 0.0143013 -1.0054 0.999999 17207.7 
329 1.00799 0.0144532 -0.993538 0.999998 8007.09 
331 1.01371 0.0148128 -0.9989 0.999997 6165.35 
332 0.999956 0.0138617 -0.986094 0.999998 9300.6 
333 1.04418 0.019477 -1.0247 0.999984 1254.12 
334 0.978987 0.0218963 -0.957091 0.999865 146.103 
335 0.95563 0.0177262 -0.937903 0.999988 1620.33 
336 1.01005 0.0158688 -0.994185 0.999994 3151.18 
337 1.02712 0.013633 -1.01348 0.999997 7718.2 
338 0.89964 0.018936 -0.880704 0.99997 665.409 
339 1.04418 0.0181432 -1.02604 0.999992 2551.26 
340 1.01548 0.0195924 -0.995886 0.999986 1397.26 
342 1.03125 0.0197134 -1.01154 0.999979 959.743 
343 0.982158 0.0225645 -0.959593 0.999872 154.039 
344 0.95563 0.0177262 -0.937903 0.999988 1620.33 
346 1.00825 0.0151335 -0.993118 0.999996 4514.39 
347 0.957563 0.0152246 -0.942338 0.999994 3103.21 
349 1.01256 0.0184242 -0.994135 0.999984 1229.51 




351 0.979077 0.0209232 -0.958154 0.999925 265.527 
352 0.924422 0.0167713 -0.90765 0.999989 1797.5 
354 1.03849 0.0191398 -1.01935 0.999989 1746.59 
355 1.0485 0.0155694 -1.03293 0.999996 4965.01 
356 0.90538 0.0224387 -0.882942 0.999804 100.954 
358 0.960223 0.0179544 -0.942269 0.999978 893.735 
359 0.932631 0.0209293 -0.911701 0.999899 196.867 
360 0.931379 0.0186989 -0.912681 0.999973 740.81 
361 1.02383 0.0193496 -1.00448 0.999985 1320.55 
365 1.01931 0.0209089 -0.998406 0.999949 389.82 
366 1.03988 0.015121 -1.02476 0.999997 6565.46 
367 1.04986 0.0209111 -1.02895 0.999968 613.249 
370 1.01374 0.0181696 -0.995573 0.999987 1469.31 
371 0.927043 0.0840966 -0.842946 0.999636 54.2963 
372 0.998679 0.084203 -0.914476 0.99973 73.2104 
373 1.05398 0.0202327 -1.03375 0.999938 321.711 
374 1.02824 0.0136314 -1.01461 0.999997 7807.37 
377 1.01548 0.0192082 -0.996271 0.999982 1086.59 
378 0.837782 0.0155745 -0.822207 0.99998 1007.66 
379 1.02077 0.0155709 -1.0052 0.999994 3262.33 
380 0.965294 0.0155744 -0.949719 0.99999 1940.08 
381 1.02492 0.0176667 -1.00725 0.999993 2723.44 
383 1.03025 0.0228248 -1.00742 0.999912 223.8 
384 1.04422 0.0223797 -1.02184 0.999901 199.567 
385 1.04668 0.0229286 -1.02376 0.999919 244.699 
386 0.944123 0.017196 -0.926927 0.99999 2033.43 
387 1.00376 0.0179115 -0.985852 0.999989 1862.64 
388 1.03846 0.0209042 -1.01756 0.99996 500.689 
389 1.00366 0.0145452 -0.989115 0.999999 13653.2 
391 1.00832 0.0190552 -0.989268 0.999985 1328.52 
392 1.00428 0.0171459 -0.987131 0.999979 949.312 
394 0.944019 0.0143531 -0.929666 0.999998 10409.1 
395 1.00376 0.0179115 -0.985852 0.999989 1862.64 
396 1.01141 0.0209018 -0.990512 0.999944 354.906 
397 1.05682 0.0210739 -1.03575 0.999949 391.321 
398 1.01519 0.0162654 -0.998922 0.999993 2763.35 
399 1.04418 0.0181432 -1.02604 0.999992 2551.26 
400 0.990076 0.0172536 -0.972822 0.999987 1467.26 
401 1.00832 0.0189441 -0.989374 0.999985 1361.6 
402 1.05437 0.0176988 -1.03667 0.999987 1511.92 
403 1.01713 0.0197677 -0.997364 0.999975 785.075 
404 0.964302 0.0136326 -0.950669 0.999996 4419.48 
405 0.981169 0.022707 -0.958462 0.999858 139.615 
406 1.01121 0.0196853 -0.991522 0.999964 551.419 
407 1.01166 0.0879883 -0.923673 0.999623 52.4744 
408 1.01215 0.0193835 -0.992765 0.999982 1108.1 
410 1.03646 0.0209107 -1.01555 0.999959 486.132 
412 0.955632 0.0194018 -0.93623 0.99998 1008.71 
415 1.01995 0.0209103 -0.999043 0.99995 393.578 
418 0.999956 0.0138617 -0.986094 0.999998 9300.6 
419 0.819679 0.0184319 -0.801247 0.999934 298.558 
420 0.98164 0.0155705 -0.96607 0.999991 2254.03 
422 1.01977 0.0181369 -1.00163 0.999988 1631.69 
423 1.01512 0.0155718 -0.999552 0.999994 3110.62 
424 0.92159 0.0224098 -0.899181 0.99982 109.877 




426 1.02573 0.0181812 -1.00754 0.999988 1646.73 
427 1.01473 0.0150167 -0.999709 0.999996 5319.55 
428 0.992816 0.0198679 -0.972948 0.999953 422.674 
429 0.95563 0.0177262 -0.937903 0.999988 1620.33 
432 0.995281 0.0184251 -0.976856 0.999981 1062.45 
436 1.05801 0.0214127 -1.0366 0.999919 243.344 
437 0.995149 0.0174215 -0.977728 0.999992 2472.04 
438 0.940798 0.0151469 -0.925651 0.999993 2752.54 
440 1.07341 0.0209741 -1.05243 0.999913 228.441 
442 1.02061 0.0149849 -1.00562 0.999997 5946.51 
443 0.986868 0.017447 -0.969421 0.999991 2117.65 
444 0.95563 0.0177262 -0.937903 0.999988 1620.33 
446 1.05679 0.021315 -1.03547 0.999951 406.479 
447 1.04748 0.0170085 -1.03048 0.999991 2193.49 
449 1.025 0.0866128 -0.938387 0.999744 77.2172 
450 1.02718 0.0209119 -1.00627 0.999954 432.629 
452 1.01555 0.0843388 -0.931207 0.999814 106.247 
454 0.978786 0.0840384 -0.894747 0.999741 76.4831 
457 1.06507 0.021751 -1.04332 0.999905 207.835 
462 0.999966 0.0167469 -0.983219 0.999997 6286.31 
463 0.95563 0.0177262 -0.937903 0.999988 1620.33 






6 sequences with 1 partition 
These sequences have not been screened for recombination. Selection 
analyses of alignments with recombinants in them using a single tree may 
generate misleading results. 
 
Partition 1: 418 codons 0.776479 subs/site 
Inferred rate distribution 
Rate class has dN>dS Rate class has dN<dS 
Rate Class 1 2 3 4 5 6 7 8 9 Summary 
dS 1.12 1.12 1.05 1.05 1.12 1.05 0.24 0.24 0.24  
dN 0.01 0.05 0.01 0.05 0.21 0.21 0.01 0.05 0.21  
dN-dS -1.10 -1.07 -1.04 -1.00 -0.91 -0.84 -0.22 -0.19 -0.02 Mean dN-dS: -0.916 
Prob. 0.000 0.000 0.605 0.000 0.000 0.330 0.042 0.000 0.023 Std.Dev : 0.223 





6 sequences with 1 partition 
These sequences have not been screened for recombination. Selection 
analyses of alignments with recombinants in them using a single tree may 
generate misleading results. 
 
Partition 1: 446 codons 1.53592 subs/site 
Inferred rate distribution 
Rate class has dN>dS Rate class has dN<dS 
Rate Class 1 2 3 4 5 6 7 8 9 Summary 
dS 1.36 1.29 1.36 1.29 1.36 1.29 0.29 0.29 0.29  
dN 0.01 0.01 0.08 0.08 0.23 0.23 0.01 0.08 0.23  
dN-dS -1.35 -1.28 -1.27 -1.21 -1.12 -1.06 -0.29 -0.21 -0.06 Mean dN-dS: -0.892 
Prob. 0.266 0.000 0.154 0.000 0.246 0.000 0.134 0.077 0.124 Std.Dev : 0.511 
No rates with dN>dS were inferred for this datasets, suggesting that all sites are under 
purifying selection. 
 
